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Abstract  
Clostridium  difficile  is  a  pathogenic  bacterium  that  can  colonise  both  humans  and 
various  animals.  Toxin production  leads  to  clinical  symptoms  ranging  from  mild to 
severe diarrhoea and can result in potentially fatal pseudomembranous colitis. These 
symptoms are caused by the disruption of the cytoskeleton and tight junctions of gut 
epithelial cells by the toxins. 
Genomic sequencing of C. difficile has indicated the chromosome carries a number of 
mobile  genetic  elements  including  conjugative  transposons,  which  can  encode 
antibiotic resistance genes. Analysing the sequence of a number of C. difficile strains 
indicated  that  each  genome  carries  at  least  one  and  often  multiple  conjugative 
transposons. For many of the genes on these elements, functions were predicted using 
various bioinformatic tools. 
The study of conjugative transposons in C. difficile has been limited by the lack of 
resistance genes encoded by the elements. Therefore, an antibiotic resistance gene 
was inserted into six of the elements in strains 630 and R20291 and filter-matings 
performed. Conjugative transfer was shown for all elements from strain 630 but not 
for Tn6103 from R20291.  
The  study  of  transconjugants  of  these  matings  showed  the  pathogenicity  locus, 
encoding the two major toxins of C. difficile, to transfer at a low frequency into a non-
toxigenic recipient strain. Whole genome sequencing of transconjugants determined 
that the transfer is not limited to the pathogenicity locus but includes varying sizes of 
chromosomal DNA flanking the pathogenicity locus.   
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RNA-seq  was  used  for  the  comparison  of  mutants  for  transcriptional regulators  of 
conjugative transposons CTn2 and CTn4, however no significant differential expression 
was detected. Furthermore, strain 630∆erm, a commonly used laboratory strain for 
the  generation  of  knockout  mutants,  was  compared  to  the  wildtype  strain  630.  A 
predicted  oxidative  stress  operon  was  upregulated  in  630∆erm  which  raises  the 
question of the biological impact of these results on the knockout model.  
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Chapter 1  Introduction 
1.1.   Clostridium difficile  
1.1.1. Isolation, pathogenesis and treatment 
1.1.1.1.   The isolation of Clostridium difficile  
Clostridium  difficile was originally isolated from the faeces of healthy  human new-
borns and designated Bacillus difficilis by Hall and O’Toole in 1935 [1]. This report, as 
well as that of Snyder [2] shortly after, characterised the organism as a Gram-positive 
rod-shaped bacterium (Figure 1.1). Furthermore, the bacterium is obligate anaerobic, 
forms endospores and produces a toxin that was shown to cause convulsions similar to 
tetanus toxin produced by Clostridium tetani when administered subcutaneously in to 
laboratory animals [2]. After the organism had been re-designated C. difficile, it was 
noted that the organism usually infects the human intestinal tract [3]. Later, the toxin 
of  C.  difficile  was  found  in  patients  suffering  from  antibiotic  associated 
pseudomembranous colitis [4] and C. difficile was recognised as the causative agent for 
most cases of clindamycin associated pseudomembranous colitis [5,6].  
C.  difficile  strain  630  was  isolated  from  a  patient  with  severe  pseudomembranous 
colitis  in  a  hospital  outbreak  in  Switzerland  in  1982  [7].  Strain  630  is  extensively 
studied and was therefore the first strain to be sequenced [8]. Epidemic outbreaks of 
C. difficile have become more frequent over the past decade and these isolates were 
described as being hypervirulent due to reports of higher toxin production and higher 
relapse rates in patients [9-11] (section 1.1.3.2). The largest outbreak of hypervirulent 
C. difficile in the UK was in the Stoke Mandeville hospital [12]. The isolate R20291 from  
20 
this outbreak is often used as a representative of hypervirulent strains and was shown 
to be particularly virulent [13]. As a representative strain of the hypervirulent ribotype, 
R20291 was the second strain to be sequenced [14]. 
The genome of C. difficile 630 consists of a 4.29 Mb chromosome and a 7.8 kb plasmid 
[8]. The average GC content of the chromosome is low (29%) however, a large number 
of mobile genetic elements (MGEs) were discovered which were higher in GC content 
(up  to  47%)  and  comprised  approximately  11%  of  the  genome.  Further  genome 
sequencing of strains of C. difficile showed that the organism has very low genome 
conservation [15]. Other organisms described with low genome conservation include 
Streptococcus pneumoniae and Campylobacter jejuni, which respectively have 46.5% 
and 59.2% of the genome conserved between strains [16,17]. Based on the genome 
sequences  of  15  strains,  it  was  calculated  that  C.  difficile  has  23-26%  genome 
conservation and the core genome consists of 947 to 1033 coding sequences (CDS) 
[15]. The pan genome is described as the collection of all genes present in all strains 
pooled together, a number that can be calculated from the core and whole genome 
size [18]. The pan genome of Streptococcus agalactiae is predicted to be 1806 CDS [18] 
and S. pneumoniae is 5100 CDS [16] whereas the pan genome of C. difficile is predicted 
to be 9640 CDS [15]. The reason C. difficile has the largest predicted pan genome 
published so far may be due to the large number of MGEs in this organism as these 
elements contribute greatly to the diversity within the species.  
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Figure 1.1 Gram staining of C. difficile strain 630.  
C. difficile is Gram positive and rod shaped. The image was made using an Olympus BX51 microscope 
equipped with a QImaginig, MicroPublisher 5.0 RTV camera running the Simple PCI software. 
 
1.1.1.2.  C. difficile disease and treatment 
Approximately  5-8%  of  adults  are  asymptomatic  carriers  of  C.  difficile  whereas  in 
children  and  neonates,  prevalence  ranges  from  3-64%  [19,20].  The  normal  colonic 
microflora  is  thought  to  protect  from  colonisation  by  C.  difficile,  a  phenomenon 
referred to as colonisation resistance [19,21]. Disruption of the microflora by antibiotic 
treatment damages this protective barrier and can increase the chance of C. difficile 
colonisation and infection [22]. C. difficile can produce three toxins during infection 
which  can  all  affect  the  gut  epithelia  and  result  in  a  mild  to  severe  diarrhoea  by 
disrupting tight junctions and the cytoskeleton of epithelial cells. In severe cases, the 
infection  in  combination  with  the  influx  of  leukocytes  generated  by  the  immune 
response can cause pseudomembranous colitis, a condition where lesions of necrosis 
of  the  lining  of  the  gut  occur  (Figure  1.2).  This  can  lead  to  toxic  megacolon, 
characterised by a dilated colon where the peristaltic movement is paralysed and for 
which currently the only treatment is colectomy [23,24].   
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Figure 1.2 Effects of C. difficile infection.  
a) Histology of pseudomembranous colitis in a C. difficile patient. The epithelial membrane of the 
mucosa has detached and is indicated by an arrow. b) Colonoscopy image of the colon of a patient 
infected with C. difficile, white pseudomembrane lesions are visible consisting of damaged epithelia and 
leukocytes from the immune system. Figure reproduced from Rupnik et al. [25] 
 
Although C. difficile infection has been reported to occur after treatment with a range 
of antibiotics, there are a few antibiotics that are more commonly associated with C. 
difficile infection. Clindamycin, cephalosporins and fluoroquinolones have been shown 
to increase risk of C. difficile infection [6,23,25]. Initially, it was advised to prescribe 
vancomycin for the treatment of C. difficile, however, for fear of emerging vancomycin 
resistance, this was later changed to treatment with metronidazole in the UK and the 
US [23,26]. Recurrence of infection is a common complication seen in recovering C. 
difficile patients. Reinfection can occur with the strain that initially infected the patient 
although reinfection with a different strain  can also occur  [25]. As treatment with 
antibiotics is not always effective, alternative treatment includes the use of probiotics 
and faecal transplantation to provide the patient with a healthy microbiota and re-
establish colonisation resistance [27,28]. Furthermore, studies are on-going for new 
treatment strategies such as a vaccine against the C. difficile TcdA for which Phase II  
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trials are currently underway [29]. Currently, prevention of spread is one of the most 
important strategies to battle C. difficile in the hospital setting by isolation of infected 
patients, disinfection of the patient environment and good hand hygiene for health 
care workers which has reduced the number of C. difficile outbreaks [30,31].  
 
1.1.2. Virulence of C. difficile 
1.1.2.1.  C. difficile TcdA and TcdB 
The main virulence factors of C. difficile are the cytotoxins TcdA and TcdB encoded on 
the pathogenicity locus (PaLoc) (Figure 1.3). The PaLoc is a genetic locus that is only 
present in toxigenic strains of C. difficile and encodes the toxin genes as well as their 
regulators, TcdD and TcdC. By comparing the sequence at the ends of the element to 
the sequence of non-toxigenic strains, it was concluded that the PaLoc has a single 
integration site in C. difficile and is inserted uni-directionally in all strains [32]. Analysis 
of five non-toxigenic strains identified a 115 bp linker sequence present at this site that 
is well conserved (> 90%) [32]. 
TcdA and TcdB [33] are both members of the family of large clostridial toxins (LCTs). 
This  family  also  includes  the  lethal  and  haemorrhagic  toxins  (TcsL  and  TcsH)  of 
Clostridium  sordelii,    toxin  (TcnA)  of  Clostridium  novyi  and  TpeL  of  Clostridium 
perfringens, which are all structurally similar and have 30-70% amino acid sequence 
identity to TcdB [34,35].  
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Figure 1.3 Schematic representation of the C. difficile PaLoc of strain 630.  
ORFs are represented by blue arrows. The complete locus is 19.6 kb long. 
 
Both TcdA and TcdB consist of functionally separate domains; a C-terminal binding 
domain  for  recognition  of  unknown  receptors  on  the  epithelia  of  the  colon,  a 
translocation domain for entering the target cell and an N-terminal catalytic domain 
for glycosylation of the target molecule [25,36] (Figure 1.4). After the toxin binds to a 
specific cell membrane receptor it is internalised via endocytosis. In the endosome, the 
cysteine  protease  within  the  translocation  domain  is  responsible  for  proteolytic 
cleavage of the catalytic domain, which enters the cytoplasm [35]. Both toxins have 
been shown to inactivate small regulatory proteins of the Rho and Ras superfamilies of 
GTPases via glycosylation of these regulators [36,37]. This results in actin condensation 
and  disruption  of  the  cytoskeleton  and  tight  junctions  of  the  epithelia,  leading  to 
apoptosis [38,39]. 
 
Figure 1.4 Schematic of C. difficile TcdA and TcdB.  
TcdA and TcdB have a similar structure consisting of three functional domains; a catalytic domain, a 
translocation domain and a binding domain. Figure reproduced from Rupnik et al. 2009 [25].  
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Inflammasome  mediated  recognition  of  the  toxins  by  the  innate  immune  system 
causes production of the cytokine IL-1 [40,41]. This causes an influx of phagocytic 
cells such as macrophages resulting in further inflammation of the tissue  [25]. The 
destruction of the epithelia and the inflammatory response cause the formation of the 
pseudomembranes,  loss  of  the  barrier  function  of  the  gut  and  fluid  accumulation 
[25,36]. 
After the discovery that C. difficile produces two separate toxins [42], their relative 
roles in disease have been extensively studied [34,36,39,43-45] and are still subject to 
debate.  Two  recent  studies  from  separate  laboratories  have  independently  made 
knockout mutants in both of the toxin genes and compared these mutants to the 
wildtype strain in an established hamster model [46]. The study by Lyras et al. [44] 
concluded TcdB is essential for virulence as the mortality rate decreased significantly 
for  the  animals  challenged  with  the  tcdB  mutant  whereas  the  mortality  rate  for 
animals challenged with the tcdA mutant was comparable to that of the wildtype. 
Kuehne et al. [45] used a similar methodology but found no significant differences in 
mortality rate for either of the mutants compared to the wildtype strain, although the 
time of death occurred later for the animals colonised by the tcdB mutant. A double 
knockout mutant for tcdA and tcdB was also used in this study and as expected none 
of the animals challenged by this mutant died. Both studies used molecular knockout 
systems based on interrupting the target gene by the insertion of an erythromycin 
resistance gene. Therefore, both studies used erythromycin sensitive derived isolates 
of strain 630 to construct their mutants. However, the erythromycin sensitive isolates 
used  in  these  studies,  JIR8094  or  630E  [47]  and  630∆erm  [48]  respectively,  were  
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obtained in separate labs by repeated sub-culturing in the absence of erythromycin. 
Both isolates were reported to have lost the functional copy of erm(B), which confers 
erythromycin resistance in 630. It is currently hypothesized that additional mutations 
have occurred during the generation of either of the erythromycin sensitive strains 
which affect virulence and have resulted in the opposing results of these two studies 
[46]. Because of the technical difficulties of the genetic manipulation of C. difficile and 
the relatively large size of the toxin genes, neither of the studies has been able to 
complement the mutations that were made.  
In addition to tcdA and tcdB, there are three more ORFs present on the PaLoc; tcdC, 
tcdD and tcdE (Figure 1.3). TcdE is a putative phage-like holin, which was assumed for a 
long time to play a role in the release of the toxins into the extracellular environment. 
It  was  shown  recently  that  TcdE  is  not  essential  for  secretion  of  the  toxins  as  no 
differences  could  be  shown  between  the  secretome  of  wildtype  and  tcdE  mutant 
isolates and the precise function remains unknown [49].  
During growth of C. difficile it was shown that tcdC is mainly transcribed during the lag 
and  early  exponential  phase  and  decreases  towards  stationary  growth.  The 
transcription of the other PaLoc encoded genes is opposite and increases in the late 
exponential and stationary phase [50]. A model was proposed in which TcdD induces 
expression of the PaLoc genes, whereas TcdC reduces expression [50]. Transcriptional 
induction of tcdA and tcdB by TcdD was demonstrated [51], which was redesignated 
TxeR, and was subsequently shown to be an alternative sigma factor essential for toxin 
expression [52]. TcdC was shown to be an anti-sigma factor which negatively regulates 
the production of toxins and was predicted to interact with TcdD or the TcdD-RNA 
polymerase holoenzyme [53]. Furthermore, a study by Carter et al. [54] showed that  
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the introduction of a plasmid-encoded functional copy of tcdC into naturally occuring 
tcdC-mutant strains reduced toxin production in vitro and delayed disease symptoms 
in an in vivo mouse-model. However, these results are not supported by the results of 
the study by Cartman et al. [55], in which a similar tcdC mutation was restored by 
allelic  exchange  without  any  effect  on  toxin  production.  Although  currently  the 
opposing results of these studies cannot be explained, a third study by Bakker et al. (in 
press) has confirmed the lack of any effects on toxin production in a 630∆erm tcdC 
mutant (personal communication). 
1.1.2.2.  C. difficile binary toxin 
In addition to TcdA and TcdB, some C. difficile strains also produce the binary toxin. 
This  is  a  member  of  the  family  of  clostridial  binary  toxins,  which  have  ADP-
ribosyltransferase  activity,  and  include  the  C.  perfringens  iota  toxin,  Clostridium 
spiroforme toxin and the  Clostridium botulinum C2 toxin C & D  [56,57]. C.  difficile 
binary toxin is encoded on the binary toxin locus or CDT locus, which consists of two 
toxins genes cdtA and cdtB as well as the positive transcriptional regulator cdtR [58], 
(Figure 1.5). The toxin consists of two peptides, CdtB which binds an unknown surface 
receptor  and  translocates  CdtA,  the  catalytic  domain,  which  ADP-ribosylates  actin 
molecules and disrupts the cytoskeleton [56]. Natural occurring PaLoc negative but 
CDT positive isolates were shown to cause cytopathic effects (CPE) in in vitro cell line 
models and in an ex vivo rabbit ileal loop model. These isolates were also shown to 
colonise hamsters in vivo but did not cause disease [59]. CDT causes the formation of 
microtubule-based protrusions, which promote adherence of C. difficile to epithelial 
cells and may increase colonisation [60]. Although the presence of CDT alone does not 
cause disease in hamsters, it does affect the cytoskeleton of epithelial cells in vitro and  
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increases colonisation of hamsters. Therefore, the CDT is an interesting subject for 
further study and could prove to be a target for therapy against C. difficile infection. 
 
Figure 1.5 Schematic representation of the C. difficile CDT locus of strain R20291. 
ORFs are represented by blue arrows. The complete locus is  6.1 kb long. 
 
 
1.1.2.3.  Other C. difficile virulence factors 
The  C.  difficile  surface  layer  (S-layer)  consists  mainly  of  the  S-layer  protein  Slp,  a 
heterodimer consisting of the high molecular weight and low molecular weight Slps 
(HMW-SLP and LMW-SLP respectively) [61,62]. These are encoded by slpA, which is 
post-transcriptionally cleaved by cell wall protein 84 (Cwp84) into HMW-SLP and LMW-
SLP  [63].  The  LMW-SLP  is  variable  between  strains,  and  is  hypothesised  to  be  an 
escape  mechanism  from  the  host  immune  system  [62,64].  The  HMW-SLP  binds 
collagen I, thrombospondin and vitronectin, which are components of the extracellular 
matrix in the intestinal mucosa [61]. Other adhesins present in the C. difficile S-layer 
are the fibronectin binding protein Fbp68 [65] and Cwp66, which was shown to bind 
epithelial cells, but for which no precise substrate has been determined [66]. Adhesins 
are important virulence factors for many pathogenic bacteria to facilitate adhesion of 
the cells to specific host tissues [67]. 
A study of the antisera of several C. difficile-infected patients showed that both the 
HMW-SLP and LMW-SLP are recognised by nearly all antisera, whereas a number of  
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other cell wall proteins such as Cwp84 and Cwp2 are only recognised by a proportion 
of the tested antisera [68]. Further investigation into the putative adhesins and cell 
wall proteins of C. difficile is necessary as these proteins are expected to play a major 
role in virulence of the pathogen and they are potential therapeutic targets [67]. 
1.1.2.4.  Sporulation 
C.  difficile  can  form  endospores  which  are  a  metabolically  dormant  form  of  the 
bacterium that is excreted by infected patients. Spores are highly resilient to most 
commonly used disinfectants and can persist upon hospital surfaces, presumably for 
years [69]. New hosts are colonised through oral ingestion of these spores. The spores 
are resistant to gastric acid, which allows the spores to pass through the stomach after 
which bile salts in the gut signal the spores to germinate into vegetative cells [70]. The 
use of antibiotics was shown to increase the excretion of spores by infected patients 
which may account for the success of C. difficile as a nosocomial pathogen [31,71]. 
Although sporulation is considered to be part of the normal life cycle of C. difficile and 
is a feature non-pathogenic strains also exhibit, an increased rate of sporulation has 
been reported in a number of studies of hypervirulent strains [72,73](section 1.1.3.2). 
However, a recent paper criticizes the methods of these studies and uses a much 
larger  number  of  isolates  to  show  the  capacity  of  sporulation  is  highly  variable 
amongst isolates of specific ribotypes (section 1.1.3.1) of C. difficile [74]. Although the 
study has shown that the rate of sporulation is variable among related samples, it 
remains unclear if there is any correlation between the rate of sporulation and the 
severity of disease caused by these isolates.  
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1.1.2.5.  Antibiotic resistance in C. difficile 
The discovery of antibiotics led to a great advance in treatment of bacterial infections. 
Unfortunately, poor regulation and limited knowledge of the mechanisms of emerging 
antibiotic resistance, have quickly led to high occurrence of antimicrobial resistance in 
clinically relevant species due to over usage  [75]. In 1962, early in the study of  C. 
difficile, Smith and King reported that the bacterium was resistant to streptomycin, 
neomycin, colistin or oleandomycin [3]. Later, resistance to p-cresol, D-cycloserine and 
cefoxitin were described [76,77]. D-cycloserine and cefoxitin are now routinely used as 
selective  supplements  for  the  isolation  of  C.  difficile  from  clinical  samples  [78]. 
Clindamycin  and  cephalosporins  were  specifically  reported  to  induce 
pseudomembranous  colitis  [6,23]  although  only  approximately  15%  of  C.  difficile 
isolates are resistant to clindamycin [79]. 
A more recent study compared the resistance to 15 antibiotics of 237 isolates of C. 
difficile from a multi-institutional outbreak in Canada with 21 ‘historic strains’ isolated 
between  1987  and  2001  [79].  This  study  showed  all  isolates  were  resistant  to 
bacitracin  and  cefotaxime  whereas  high  occurrence  of  resistance  (>  85%)  to 
ceftriaxone, clarithromycin, ciprofloxacin, levofloxacin, gatifloxacin and moxifloxacin 
was detected only for specific PFGE-type isolates (section 1.1.3.1). 
Resistance to erythromycin, tetracycline and chloramphenicol are often encoded on 
mobile  genetic  elements  (section  1.2).  These  elements  can  transfer  from  resistant 
isolates to susceptible recipients indicating the clinical importance of these elements 
[80-82].  
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1.1.3. C. difficile epidemiology 
1.1.3.1.  Typing methods 
The most widely accepted typing methods for the study of C. difficile are currently 
restriction endonuclease analysis (REA), pulsed field gel electrophoresis (PFGE), PCR 
ribotyping, toxinotyping and multilocus sequence typing (MLST). REA and PFGE type 
isolates based on the DNA fingerprint after restriction digestion [83,84].  
PCR ribotyping is based on the fact that the intergenic spacer region between the 16S 
and 23S rRNA differs between the multiple pairs of alleles in an individual cell. As most 
bacteria possess multiple copies of these genes, resulting in products of varying sizes in 
a PCR reaction using universal primers. Related isolates will have identical patterns of 
PCR products whereas more distantly related isolates will have variations which allows 
for grouping of isolates based on these  variations [85].  
Toxinotyping  is  a  method  that  amplifies  several  fragments  of  the  PaLoc  in  PCR 
reactions which are restricted with one to four different restriction enzymes in order 
to detect restriction fragment length polymorphisms of the PaLoc amplicons [86]. For 
MLST,  six  to  seven  housekeeping  genes  are  sequenced  to  determine  the  genetic 
relationship between strains [87].  
Recent  studies  of  MLST  data  and  whole  genome  sequence  comparison  have 
discovered that all strains can be divided into six major clades which were shown to 
have  diverged  millions  of  years  ago  [88].  However,  sequence  data  on  specific 
housekeeping genes and the PaLoc suggest that some recombination has occurred 
between members of these six clades [89,90]. Isolates from the epidemic outbreaks 
group together into two specific clades [90,91].  
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All of the different typing schemes have been developed in order to assign phenotypic 
differences, such as hypervirulence (section 1.1.3.2), to specific types. Overlap is seen 
between the results of the typing methods, for instance with the toxinotyping and 
ribotyping methods [92]. Over the past decade most literature has used ribotyping or a 
combination of methods to type isolates, therefore, in this thesis only the ribotypes of 
strains are indicated.  
1.1.3.2.  Hypervirulence 
Since approximately 2000, reports of epidemic outbreaks of C. difficile in hospitals in 
the  UK  and  other  western  countries  increased  [9,10].  The  isolates  from  these 
outbreaks were reported to be more virulent, producing higher levels of toxin, were 
more often resistant to fluoroquinolones and were responsible for a higher relapse 
rate  in  patients  [11].  The  majority  of  these  isolates  were  ribotype  027  and  were 
reported to be hypervirulent [93].  
As  described  above,  TcdD  is  an  alternative  sigma  factor  that  is  required  for  the 
transcription of tcdA and tcdB, whereas TcdC is an anti-sigma factor that negatively 
regulates toxin production (Figure 1.3) [52,53]. It was shown that strains of ribotype 
027  contain  an  18-bp  deletion  in  tcdC  which  results  in  a  truncated  protein  being 
produced that is not capable of regulating toxin production  [9]. In 2010 in the UK, 
ribotype 027 strains were reported to be isolated most frequently from patients [94], 
however, a report from the Netherlands showed the emergence of ribotype 078, of 
which the isolates contain a 39-bp deletion in tcdC as well as an early stop codon [95]. 
Recent  studies  of  complementation  of  the  tcdC  mutation  give  inconclusive  results 
leaving the role of tcdC in toxin regulation unclear [54,55](section 1.1.2.1) and the 
question remains if the tcdC genotype has any effects on hypervirulence.   
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The  emergence  of  ribotype  002  has  been  reported  in  China  [96],  ribotype  001  in 
Germany [97] and ribotype 018 in Italy [98]. Hypervirulence in C. difficile is therefore 
no longer considered to be limited to ribotype 027. A study of samples from the past 
decade from the UK and US revealed that some isolates that were designated ribotype 
027 were actually ribotypes 176, 198 and 244 [99]. These ribotypes are highly similar 
and  are  predicted  to  have  evolved  from  ribotype  027  recently,  however  it  is  not 
reported if samples from these ribotypes contain the mutated tcdC allele.  
Although the in vitro production of TcdA and TcdB was shown to be higher in ribotype 
027 strains [9,72], concern over the biological relevance of toxin production in in vitro 
batch culture experiments has been raised [100]. Furthermore, a human gut model 
shows the production of toxins by ribotype 027 strains is not higher per unit of time 
but has a longer duration of toxin production, which may account for the increased 
severity of symptoms for patients infected with a ribotype 027 isolate [101].  
It was also reported that ribotype 027 strains had a higher level of sporulation [72]. A 
recent study which included a large number of strains showed that the sporulation 
rate  is  very  variable  between  strains  within  a  ribotype,  and  high  and  low  level 
sporulation is seen for both epidemic ribotypes and non-epidemic ribotypes, which 
suggests the amount of sporulation has no effect on severity of disease [74]. Although 
the epidemiology of C. difficile has certainly changed over the past two decades, the 
basis for the claim that certain ribotypes are hypervirulent is not solid and therefore 
these are now often referred to as epidemic isolates. 
Due to the increase in C. difficile infections it became mandatory in the UK to report all 
cases of infection for epidemiological surveillance [31]. Between 2007 and 2010 the 
number of C. difficile related deaths in England and Wales has decreased from >8000  
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to <4000 per year (Figure 1.6). In this period, the number of  C. difficile infections 
decreased from >55,000 to <22,000 in the UK [102]. The decrease in these numbers is 
most likely due to the improvements in hospital procedures. Although the prevalence 
of C. difficile is reducing, the occurrence of epidemic strains is still not understood and 
further study is necessary in order to improve treatment and prevention strategies. 
 
 
Figure 1.6 Number of deaths attributed to C. difficile.  
The blue bar shows the number of patients where C. difficile is mentioned as the cause of death on the 
death certificate whereas the grey bar shows the number of patients where C. difficile is mentioned as a 
possible contributing factor. Figure reproduced from the Office for National Statistics website, last 
accessed 5
th September 2012 [103].  
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1.2.   Mobile genetic elements  
Horizontal gene transfer (HGT) is the exchange of genetic material between organisms, 
a  mechanism  that  is  extensively  used  by  some  prokaryotes.  Three  molecular 
mechanisms  have  been  identified  for  HGT:  transformation,  transduction  and 
conjugation. Transformation is the uptake of naked DNA from the environment, mostly 
originating from damaged cells, and incorporation into the genome [104]. Bacteria that 
have this ability are designated competent cells. C. difficile has never been shown to 
be competent in laboratory settings [105-107] and transformation is therefore not 
further discussed here. Other forms of horizontal gene transfer are discussed below.  
1.2.1. Conjugation 
Conjugation is a form of genetic transfer between bacterial cells that occurs via cell to 
cell contact. The process was first discovered in Escherichia coli for the fertility plasmid 
(F-plasmid) [108]. Tatum and Lederberg [109] had shown that recombination of E. coli 
strains  could  occur  when  two  auxotrophic  mutant  strains  with  specific  nutritional 
requirements where grown in mixed cultures which resulted in prototrophic isolates. It 
was found that recombination depended on a fertility factor (F-factor) which would 
have to be present in at least one of the bacteria for a mating pair to be formed 
efficiently  [110,111].  It  was  recognized  that  the  F-factor  was  an  autonomously 
replicating genetic element which can convert F- recipient strains into F+ donor strains 
and encodes the functions needed to promote conjugation [108,112]. 
The F-plasmid was also shown to integrate into the chromosome through a process of 
‘high frequency recombination’ (Hfr). Transfer of the F-plasmid from Hfr cells leads to 
transfer of part or the whole of the donor chromosome which can recombine with the 
recipient  chromosome  after  conjugation  [112].  Experiments  on  the  resulting  
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phenotypes  of  the  recombinant  cells  showed  that  linear  DNA  was  transferred 
unidirectional as specific genes were transferred more regularly and after a shorter 
time interval than other genes, depending on their distance on the chromosome from 
the origin of transfer (oriT) [113]. Hfr has been described in a number of other Gram 
negative organisms such as Yersinia pseudotuberculosis [114] and Vibrio cholera [115]. 
In the Gram positive organism Lactococcus lactis, a lactose fermentation plasmid is 
present which was shown to turn lactose fermentation negative strains into lactose 
fermentors  [116].  Experiments  on  transfer  from  these  strains  also  showed 
conjugational transfer of chromosomal DNA [117]. Conjugation was shown to be much 
more  efficient  in  cells  with  a  ‘clumping’  phenotype  which  was  shown  later  to  be 
facilitated  by  CluA,  a  chromosomally  encoded  membrane  bound  protein  which  is 
essential for conjugation [118].  
CluA is encoded on the L. lactis sex factor, together with a number of other genes 
involved in conjugation. Recombination of these genes into the lactose fermentation 
plasmid increased the transfer frequency of the plasmid [119], however, the lactose 
fermentation plasmid was also shown to integrate into the chromosome within the 
sequence of the sex factor through recombination by the IS-element located within 
the plasmid [120]. The sex factor was shown to be responsible for the transfer of 
chromosomal DNA in a unidirectional manner, as previously shown for Hfr in E. coli, 
which was determined by the fact that the transfer frequency of genes located close to 
the sex factor in the clockwise orientation was higher than that of the genes lying in 
the anticlockwise direction [121]. Interestingly, the L. lactis sex factor is not present in 
any other lactid acid bacteria [122]. 
 The process of conjugation starts with nicking at a single strand of the plasmid at the 
origin of transfer and unwinding of the strand by a relaxase. This strand is transferred  
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across the membranes to the recipient cell by machinery related to type IV secretion 
systems, where the DNA strand circularizes and the second strand is synthesized [104] 
(Figure 1.7).  
 
 
Figure 1.7 Schematic representation of the transfer of a conjugative plasmid.  
a) The proteins of the conjugation pilus are encoded on the plasmid, shown in red and yellow. b) Cell to 
cell  contact by the  mating pair is made through the pilus, contraction of the pilus brings the cells 
together. c) The yellow strand of the plasmid is nicked, unwound and transferred to the recipient cell. d) 
The plasmid DNA circularizes in the recipient bacterium and a second strand is replicated in both cells. 
The recipient cell has become a potential donor cell of the plasmid. Figure was taken from Juhas et al. 
[123]. 
 
Although the conjugation machinery of Gram-negative and Gram-positive bacteria are 
both related to type IV secretion systems, the main difference is that Gram-negative 
type IV systems contain a pilus to enable cell to cell contact whereas Gram-positive  
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systems use an adhesin protein for this function [124]. Type IV secretion systems have 
three functional substructures; the coupling protein acts as a substrate receptor at the 
donor cytoplasmic side of the structure, a transport channel conducts the substrate 
across to the recipient cell and the pilus or adhesin maintains cell to cell contact during 
transfer  [125].  One  of  the  best  characterized  type  IV  secretion  systems  is  that  of 
Agrobacterium tumefaciens (Figure 1.8). 
 
Figure 1.8 Schematic representation of the type IV secretion system of A. tumefaciens. 
The type IV secretion system of the Gram negative A. tumefaciens consists of 11 VirB proteins VirB1–
VirB11 and VirD4. The functional substructures are color coded. Yellow (including white): nucleoside 
triphosphatases that provide energy for the transfer and act as substrate receptor. Blue: components of 
the transmembrane channel. Red (including pink and orange): components of the pilus. Green: lytic 
transglycosylase  responsible  for  the  degradation  of  the  murein  (peptidoglycan)  layer  at  the  site  of 
assembly. Figure was taken from Juhas et al. [123]. 
 
1.2.1.1.  Conjugative transposons 
CTns, also known as integrative and conjugative elements (ICEs), are genetic elements 
that can transfer into a recipient strain through conjugation and integrate into the host 
genome  through  site-specific  recombination  [126,127]  (section  1.2.1.1.3).  For  
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transposition and conjugation, it was shown that CTns are excised from the genomic 
target site and form a circular DNA molecule [128]. The circular intermediate can then 
insert into the previous target site, transpose to a different target site, transfer to a 
recipient cell via conjugation or can be lost from the host cell [129] (Figure 1.9). 
 
 
 
Figure 1.9 Schematic of transposition and conjugative transfer. 
The  chromosome  is  represented  by  a  green  circular  molecule.  The  linear  CTn  integrated  in  the 
chromosome is represented by a red line. The circular intermediate of the CTn is represented by a red 
circle. A single strand of the CTn, nicked at the oriT, is transferred from this into the recipient cell. Blue 
cells represent a resistant phenotype, conferred by an antibiotic resistance gene on the CTn and orange 
cells represent a susceptible phenotype. 
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Because of their promiscuous nature and ability to integrate into genomes, CTns have 
been used as shuttle vectors in order to introduce new DNA into recipients [130,131]. 
The fitness cost for maintaining CTns and other mobile genetic elements is variable 
although generally not very costly to the bacterium  [132]. A study into the fitness 
burden of the vancomycin resistance element Tn1549 indicated that the element in 
non-induced conditions did not have a high cost whereas constitutive expression of 
the vancomycin resistance operon resulted in a severe growth defect and modulated 
colonisation ability [133].  
Similar to conjugative plasmids, it was shown that CTns contain an origin of transfer 
(oriT)  [134].  Although  replication  of  CTns  was  always  considered  to  occur  while 
integrated  in  the  chromosome,  a  recent  study  by  Lee  et  al.  [135]  shows  that  the 
circular intermediate of ICEBs1 can replicate starting at the oriT through a rolling circle 
replication mechanism, similar to the replication of plasmids. ICEBs1 is a CTn of the 
integrative  and  conjugative  element  (ICE)  family,  originally  identified  in  B.  subtilis 
[136]. It is unknown if this type of replication also occurs in other CTns.  
1.2.1.1.1.  Tn916 
Tn916 is the first designated CTn and was originally discovered in 1981 in Enterococcus 
faecalis DS-16 by Franke and Clewell who described it as a transposon that transferred 
into tetracycline susceptible strains from plasmid free donor strains and was therefore 
predicted to be  self-transferable  [137].  Since then  many  Tn916-like  elements  have 
been found in diverse bacterial species, which all have similar backbones [138]. A large 
number  of  these  elements  encode  ribosomal  protection  proteins  that  confer 
resistance to tetracycline although other antibiotic resistance determinants are also  
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common [139]. Most of the research on this family of elements has been carried out 
on Tn916.  
Comparison of Tn916-like elements and other conjugative transposons has revealed 
that the elements have a modular structure of which the accessory module is most 
diverse and can encode a number of functions such as resistance to tetracyclines, 
macrolides, lantibiotics, mercury and other heavy metals [139-141]. CTns have also 
been reported to encode operons of genes for the production of and resistance to 
antimicrobial  peptides  [142,143],  adhesin  and  virulence  associated  genes  [144], 
chlorocatechol degradation [145] and metabolism of sucrose, biphenyl and salicylate 
[146,147].  The  accessory  module  is  often  surrounded  by  genes  for  transcriptional 
regulation. 
Another  functional  module  of  the  CTns  is  the  integration  module  encoding  the 
recombinase and excisionase proteins responsible for transposition of the element in 
the  genome  (section  1.2.1.1.3).  The final  module  is the  conjugation module  which 
encodes all proteins necessary for conjugation [138] (Figure 1.10). 
 
 
Figure 1.10 Schematic representation of Tn916.  
Blue arrows represent the ORFs of the conjugation module, yellow arrows represent the ORFs involved 
in transcriptional regulation, the red arrow represents tet(M), green arrows represent the ORFs of the 
transposition module. 
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1.2.1.1.2.  Tn1549 
Another family of CTns are the Tn1549-like elements in which the conjugation module 
differs from Tn916 (Figure 1.11). Tn1549 was originally isolated in E. faecalis 268-10 
where it is integrated in the plasmid pAD1. The element confers vancomycin resistance 
encoded by the vanB operon [148]. Transfer of a vancomycin resistance conferring 
Tn1549-like element from Clostridium symbiosum into Enterococcus faecium and E. 
faecalis  was  shown to occur  in  vivo  in  gnotobiotic  mice  [149].  This  is  a  disturbing 
finding as vancomycin is still used as a last resort treatment in recurring cases of C. 
difficile infection. 
 
Figure 1.11 Schematic representation of Tn1549. 
Blue  arrows  represent  the  ORFs  of  the  conjugation  module,  red  arrows  represent  the  ORFs  of  the 
accessory  module,  yellow  arrows  represent  the  ORFs  involved  in  transcriptional  regulation,  green 
arrows represent the ORFs of the transposition module. 
1.2.1.1.3.  Excision and integration by site-specific 
recombination 
The  excision  and  integration  of  CTns  is  most  often  catalysed  by  site-specific 
recombinases  of  two  distinct  protein  families,  tyrosine  recombinases  and  serine 
recombinases, named after the conserved residues that are present in the catalytic 
domains of these protein families [150]. Integrases are part of the family of tyrosine 
recombinases and carry out integration of genetic elements whereas the accessory  
43 
protein Xis promotes the excision function of the recombinase; this type of mechanism 
is encoded by Tn916 and Tn1549 as well as many other MGEs [148,151].  
The tyrosine recombinase Int encoded on Tn916 excises Tn916 by forming staggered 
cuts  at  the  coupling  sequences  at  the  ends  of  the  element.  These  can  form  a 
heteroduplex at the joint of the circular molecule and form heteroduplexes at the site 
of integration on either side of the element [127,152,153]. These heteroduplexes are 
resolved  after  genomic  replication  (Figure  1.12).  Recently  the  integration  sites  of 
Tn916  were  studied  in  three  C.  difficile  strains  (ribotypes  009,  012  and  027).  The 
consensus  sequence  that  was  determined  was  consistent  with  the  sequence 
determined in other hosts [154] and was commonly found (up to 10
5 times) in all three 
C. difficile strains [155]. Although Tn916 was shown to insert in over 100 independent 
target sites in two of the strains, a preference appeared for intergenic regions whereas 
the third strain had a single highly preferred target site [155,156]. This has led to the 
hypothesis that the genomic sequence plays a role in target site selection but other 
factors are involved which have not yet been identified.  
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Figure 1.12 Schematic representation of the insertion of Tn916.  
Tn916 is represented by the blue lines; the chromosomal DNA is represented by the red lines. The 
coupling sequences of the element and in the target site are represented by the primer pairs A-B and Q-
Y.  a)  Tn916  is  in  the  circular  intermediate  form  and  a  suitable  empty  target  site  is  present  in  the 
chromosome. b) Staggered cleavage of Tn916 and the chromosome by the tyrosine recombinase Int. c) 
Tn916  is  ligated  with  the  chromosomal  DNA  generating  heteroduplexes.  d)  Replication  of  the 
chromosome containing Tn916 resolves the heteroduplexes. The figure was recreated based on the 
figure by Scott [157].  
The  insertion  of  CTns  and  the  excision  of  the  element  into  a  circular  transfer 
intermediate can also be facilitated by serine recombinases. Tn5397, the tetracycline 
resistance  conferring  CTn  which  was  originally  discovered  in  C.  difficile  strain  630 
(1.2.1.2.1), encodes the serine recombinase TndX [156]. Tn5397 is flanked on both 
sides by a GA dinucleotide when it is integrated in the genome (Figure 1.13). TndX can 
perform staggered cleavage at these sites leaving a dinucleotide overhang which is 
joined after strand exchange to form the circular molecule of Tn5397 and the original 
regenerated target site [158].   
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Figure 1.13 Schematic representation of the insertion of Tn5397.  
The  blue  lines  represent  Tn5397  and  the  red  lines  represent  the  chromosomal  DNA.  The  coupling 
sequences of the element and within the target site are represented by the nucleotide pairs G-C and A-
T. a) Tn5397 is in the circular intermediate form and a suitable empty target site is present in the 
chromosome. b) Staggered cleavage of Tn5397 and the chromosome by the serine recombinase TndX. c) 
Tn5397 is ligated with the chromosomal DNA generating homoduplexes.  
 
1.2.1.2.  MGEs in C. difficile 
1.2.1.2.1.  Tn5397 
The studies of Ionesco [159] and Smith et al. [106] were the first to demonstrate the 
transfer of tetracycline resistance between C. difficile strains. The groups could not 
isolate a plasmid responsible for the transfer of the resistance determinant although 
the transfer was shown to be cell to cell contact-dependant. As the first report of 
Tn916  had  just  been  published  [137],  it  was  hypothesised  that  the  resistance 
determinant could be encoded on a Tn916-like element. Transfer of the element from 
strain 630 at a low frequency (5x 10
-7 transconjugants per donor) was reported [160]  
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as well as homology between the tetracycline resistance element and Tn916 via DNA 
hybridisation [105]. Finally, the element was shown to be a conjugative transposon 
and designated Tn5397 [81].  
Although the structure of Tn5397 and Tn916 are very similar, several differences were 
found.  Tn916  encodes  a  tyrosine  recombinase  and  an  excisionase  protein,  which 
together  are  responsible  for  the  excision  of  the  element  from  the  genome  into  a 
circular molecule and integration into the genome  [161]. Tn5397 contains a single 
serine recombinase that is responsible for these functions [156]. Tn5397 also contains 
a  group  II  intron  integrated  within  orf14  [81].  This  class  of  mobile  elements  can 
transpose into specific genomic sites and are spliced from mRNA transcripts by the 
formation  of  a  ribonucleo-protein  by  the  mRNA  and  the  protein  encoded  on  the 
intron. orf14 is located within the conjugation module and it is well conserved among 
Tn916-like elements and encodes a NlpC/P60 family protein [138]. The group II intron 
was  shown  to  splice  from  the  orf14  transcript,  however  preventing  this  event  by 
deletion of part of the intronic ORF did not have an effect on the conjugative transfer 
of Tn5397 [162]. It is hypothesised that either the function of Orf14 is substituted by 
host factors in these matings or that the non-spliced partial intron had no effect on the 
function of the protein as the element is integrated at the 3’ end of orf14 (Figure 1.14). 
 
Figure 1.14 Schematic representation of Tn5397.  
Blue arrows represent the ORFs of the conjugation module, the pink arrow represents the interrupted 
orf14, the dark blue arrow represents the intron encoded protein, the red arrow represents tet(M),  
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yellow arrows represent the ORFs involved in transcriptional regulation, the green arrow represents the 
serine recombinase,  
Tn5397 was shown to transfer by filter mating into E. faecalis [163], S. aureus [105] 
and  B.  subtilis  [164].  B.  subtilis::Tn5397  was  subsequently  used  as  donor  of  the 
element to show transfer of Tn5397 to a streptococcal recipient in a model for oral 
biofilms [165].  
1.2.1.2.2.  CTns in C. difficile 630 
Analysis of the genomic sequence of C. difficile strain 630 revealed that another six 
putative CTns (in addition to Tn5397) are present in this strain [8]. Based on their 
location in the genome, the elements are named CTn1, CTn2, CTn4, CTn5, CTn6 and 
CTn7 and Tn5397 was named CTn3 although, mostly, the original designation is used in 
the literature. CTn1, CTn2, CTn4, CTn5, CTn6 and CTn7 were undetected for a long 
time due to the lack of any identifiable phenotypes encoded on these elements.  
CTn1, CTn6 and CTn7 are related to Tn916, similarly to Tn5397 (Figure 1.15). CTn1 and 
CTn7 both encode predicted ABC transporters on their respective accessory modules 
although no substrates for these have been predicted. Furthermore, both elements 
encode  a  surface  protein  with  homology  to  collagen  binding  proteins,  further 
described  in  Chapter  3.  CTn1  and  CTn6  both  encode  a  tyrosine  recombinase  and 
excisionases which are predicted to perform excision and insertion of their respective 
elements, whereas CTn7 encodes a serine recombinase. The accessory module of CTn6 
encodes  a  number  of  hypothetical  proteins  for  which  no  functions  have  been 
predicted.  
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Figure 1.15 Comparison of Tn916 to Tn5397, CTn1, CTn7 and CTn6.  
The CDS on the elements are represented by coloured arrows. CDS are coloured by their function; pink: 
recombination, purple: accessory function, green: conjugation, light blue: transcriptional regulation. The 
dark blue region in Tn5397 is the group II intron. SR is serine recombinase, TR is tyrosine recombinase. 
Red lines between the elements represent protein similarity. Figure is taken from Sebaihia et al. [8]. 
 
CTn2, CTn4 and CTn5 are all part of the Tn1549 family (Figure 1.16). CTn2 and CTn5 
both  encode  serine  recombinases  which  are  predicted  to  insert  and  excise  the 
respective elements from the chromosome, CTn4 encodes a tyrosine recombinase and 
excisionase for these functions. The accessory modules of CTn2, CTn4 and CTn5 all 
encode ABC transporters for which no substrate has been predicted.  
Five of these six putative elements are predicted to encode ABC transporters. The 
substrates of these transporters cannot be predicted however, the transporter of CTn7 
has  homology to  magnesium  ABC transporters  [8].  Currently,  it  is  also  unknown  if 
these ABC transporters function in influx or efflux of specific substrates.  
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Figure 1.16 Comparison of Tn1549 to CTn4, CTn5 and CTn2.  
The CDS on the elements are represented by coloured arrows. CDS are coloured by their function; pink: 
recombination, purple: accessory function, green: conjugation, light blue: transcriptional regulation. SR 
is serine recombinase, TR is tyrosine recombinase. Red lines between the elements represent protein 
similarity. Figure is taken from Sebaihia et al.[8]. 
 
1.2.1.3.  Mobilisable elements in C. difficile 
1.2.1.3.1.  Tn4453 
Mobilisable  transposons  are  elements  that  can  be  mobilised  by  Mob  proteins  to 
transfer via conjugation using the transfer machinery of another conjugative genetic 
element  [166,167].  In  C.  perfringens  chloramphenicol  resistance  is  conferred  by  a 
chloramphenicol  acetyl-transferase  (CatP)  protein  encoded  on  the  mobilisable 
transposon Tn4451 [166]. Analysis of catP in C. difficile strains found that this gene is 
located on a mobilisable transposon with an identical structure to Tn4451 designated 
Tn4453 [82] that has 89% sequence identity with Tn4451 [168,169] (Figure 1.17). The  
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element encodes tnpX, a serine recombinase that is responsible for excision of the 
element into a circular intermediate for transposition and conjugative transfer. Other 
genes  encoded  on  the  element  are  tnpZ  which  is  involved  in  mobilisation  of  the 
element and tnpV, tnpY and tnpW for which the functions are unknown [169]. 
 
Figure 1.17 Schematic representation of Tn4453.  
The green arrow represents tnpX, the red arrow represents catP other ORFs are represented by blue 
arrows. 
 
1.2.1.3.2.  Tn5398 
In addition to the transfer of tetracycline resistance it was noted that erythromycin 
resistance could also be transferred from C. difficile 630 into C. difficile CD37 [160]. 
Subsequently  the  transfer  of  the  resistance  determinant  was  also  shown  from  C. 
difficile 630 into Staphylococcus aureus [170] and B. subtilis [80]. Based on the fact that 
the element can enter the chromosome at specific sites in C. difficile but multiple sites 
in B. subtilis it is suggested that the element could be a conjugative transposon [80].  
Subsequently  it  was  shown  that  Tn5398  contains  two  rRNA  adenine  N-6-
methyltransferase  (erm(B))  genes  [171]  (Figure  1.18).  Erm(B)  confers  erythromycin 
resistance through ribosomal protection but only erm(B)2 on Tn5398 is functional [48]. 
Full characterisation of the element showed that Tn5398 is in fact not a conjugative or 
mobilisable transposon as it does not contain any predicted integration or excision  
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genes, and also no known mobilisation or conjugation related genes are present [172]. 
Apart from the two erm(B) genes, the element contains homologues to Tn916 orf13, 
orf9 and an incomplete copy of orf7, which are predicted to function in regulation of 
the element. The protein encoded by orf298 has similarity to the plasmid partitioning 
proteins ParA and Soj although there is no experimental evidence for this function 
[172]. Further CDS present on the element are effR and effD, which are predicted to 
function as an efflux protein and the associated regulator and two copies of orf3 of 
which the function is unknown [169,172]. 
 
 
 
Figure 1.18 Schematic representation of Tn5398.  
The red arrow represents erm(B)2, other ORFs are represented by blue arrows. 
 
1.2.2. Transduction 
Prophages are genetic elements that can replicate with the genome of the host cells 
during their lysogenic life cycle and can often integrate within the host chromosome. 
Upon induction, the phage can go into a lytic life cycle where it replicates in the host 
cell and its DNA gets packaged into phage particles. Upon lysis of the host cell these 
particles  are  released  into  the  environment  and  can  infect  new  host  cells  [104].  
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Transduction is a process of horizontal gene transfer in which host DNA is packaged 
into a phage head particle and subsequently inserted into the DNA of a recipient cell. 
Prophages  are  furthermore  known  to  carry  genes  encoding  virulence  factors,  for 
instance, nontoxigenic C. botulinum can be converted into toxin producing strains after 
transduction with toxin encoding prophages [173].  
C. difficile strain 630 has been shown to carry two temperate prophages designated 
C630-1  and  C630-2  [8]  which  are  both  Myoviridae  phages  [174,175].  Homology 
between tcdE, tcdA and tcdB and phage sequences has led to the hypothesis that the 
PaLoc was present on a phage that integrated within the genome of an ancestral C. 
difficile  strain  and  conferred  pathogenicity  to  the  host  cell  [32,174,176].  Several 
studies  have  therefore  focussed  on  the  effect  on  virulence  of  the  host  cell  upon 
integration of specific phages. Goh et al. [174] have shown that C2, C8 (Myoviridae) 
and C6 (Siphoviridae) all have different effects on TcdA and TcdB production by the 
host strain. Furthermore, the effects on the levels of tcdA and tcdB transcription were 
not comparable with the  effects on toxin production, which is hypothesized to be 
caused  by  the  acquisition  of  novel  phage  holin  genes  and  effects  on  the  host 
transcriptome by regulation systems present on the prophages. Govind et al. [176] 
found that infection with CD119 (Myoviridae) caused a significant reduction in both 
transcription and production of tcdA and tcdB. The Xre transcriptional regulator RepR 
was shown to cause this effect by binding the transcriptional regulator tcdR on the 
PaLoc.  In  contrast,  Sekulovic  et  al.  [177]  have  recently  shown  that  CD38-2 
(Siphoviridae) can induce the transcription and production of tcdA and tcdB in certain 
strains but will not do so in others. These studies all describe similar experiments with  
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very  different  outcomes,  which  may  be  attributed  to  the  fact  that  all  were  using 
different phages from two distinct families.  
 
1.2.3. Additional C. difficile MGEs 
1.2.3.1.  skin
Cd 
In both B. subtilis and C. difficile, the RNA polymerase sigma factor encoding gene, sigK 
is interrupted by a prophage-like element [178,179]. The elements were designated 
sigK intervening sequence or skin
Bs and skin
Cd. Both elements were shown to excise 
into a circular molecule by site-specific recombination during late sporulation allowing 
transcription of sigK. In B. subtilis absence of the skin
Bs has no effect on sporulation 
[180] although overexpression of skin
Bs genes by repression of the skin repressor sknR 
resulted in a growth defect [181]. Absence of skin
Cd in C. difficile results in a growth 
defect  and  was  only  reported  for  the  non-toxigenic  strain  CD37  and  the  toxigenic 
strain ATCC9689 [179]. All other C. difficile strains that have currently been sequenced 
contain  a  copy  of  skin
Cd  [179,182].  The  element  in  strain  630  encodes  a  serine 
recombinase  hypothesized  to  be  responsible  for  the  excision  of  the  element,  a 
putative lipoprotein, a putative cell surface protein, two putative phage transcriptional 
regulators, seven phage proteins of unknown function and four hypothetical proteins 
(Figure 1.19). Furthermore, a vanZ teicoplanin resistance protein is present on the 
element but as noted by Sebaihia et al. [8], C. difficile strain 630 is sensitive to this 
antibiotic. 
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Figure 1.19 Schematic representation of skin
Cd in strain 630.  
The green arrow represents the serine recombinase, other ORFs are represented by blue arrows. The 
interrupted sigK is represented by an interrupted pink arrow. 
 
 
 
1.2.3.2.  IStrons  
Insertion  sequences  elements  (IS-elements)  are  small  genetic  elements  encoding 
generally  one  transposase  that  allows  transposition  of  the  element  into  different 
target  sites  [183].  Group  I  Introns  on  the  other  hand  are  genetic  elements  which 
encode ribozymes that catalyse their own splicing from mRNA, allowing exons to ligate 
to form mature mRNA molecules [104]. In tcdA in C. difficile C34, a chimeric genetic 
element was found with features of both of these elements that was designated an 
IStron;  CdIst1  [184,185].  CdIst1  was  shown  to  splice  from  the  pre-mRNA  and 
expression of TcdA was normal. The element consists of two CDS which encode a 
putative transposase and a ribozyme. Southern blot and PCR analysis indicated that 
CdIst1 is commonly present in C. difficile strains [184], which was confirmed by the 
genome sequencing of strain 630 [8]. Variants of CdIst1 are present due to (partial) 
deletion  of  the  transposase  genes  and  the  length  of  the  elements  varies  from  
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approximately  0.4-2.2  kb  [178].  Alternative  splice  products  detected  in  cells  that 
contain CdIst1 indicates that the element does not splice 100% accurately. This could 
mean that the element promotes an elevated mutation rate which could benefit C. 
difficile  in  certain  circumstances  although  it  could  also  decrease  fitness  [185].  A 
homolog with 63% sequence identity to CdIst1 has been reported in Bacillus cereus 
after whole genome sequence analysis [186], however, IStrons have not been reported 
in any other organisms. 
 
1.2.4. Transfer of DNA via nanotubes 
The presence of a tubular network between B. subtilis cells was recently reported and 
named  intercellular  nanotubes  [187].  Intercellular  transfer  of  fluorescent  proteins, 
antibiotic  resistance  proteins  and  non-conjugative  plasmids  was  shown  to  occur 
through these tubes which were visualised using scanning electron microscopy. Based 
on  their  appearance  and  the  fact  they  are  sensitive  to  low  concentrations  of  the 
detergent SDS, the nanotubes are proposed to consist of membrane components.  
In contrast to conjugation, the transfer through intercellular nanotubes is bidirectional 
enabling proteins from either bacteria to cross the tubules to the intracellular milieu of 
the other cell. Furthermore, this type of transport is unique in that both hereditary and 
non-hereditary traits are transferred. It is suggested that metabolites and RNA may 
also be shared through the nanotubes, however, this was not tested for in this study. 
Scanning electron microscopy of mixed cultures containing B. subtilis, E. coli and S. 
aureus cells showed the formation of interspecies nanotubes. It is hypothesized that  
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such  multispecies  communities  can  allow  for  the  formation  of  new  phenotypes  in 
order for the communities to adept in changing environments.  
A critical review article addressed concerns regarding the controls used in the study 
such as the potential of extracellular calcein carried over on the celmembranes in the 
fluorescence experiments [188]. Furthermore, it is stated that the nanotubes were 
only  visualised  for  bacteria  grown  on  solid  growth  media,  raising  the  question  if 
nanotubes can also be formed during other growth conditions.  
As C. difficile is related to B. subtilis, there is a possibility that this organism is capable 
of  forming  intercellular  nanotubes.  Furthermore,  transfer  of  the  conjugative 
transposons described above  could take  place  via  this transfer  system  rather than 
conjugation. It is therefore important that the presence of a nanotube system in C. 
difficile  is  investigated  to  identify  if  such  a  system  could  be  responsible  for  the 
previously reported transfer of conjugative elements. 
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1.3.   Aims of this work 
This work focuses on the study of the MGEs of C. difficile and the role these elements 
may  play  in  virulence  and  other  cellular  processes.  Chapter  3  describes  a 
bioinformatics study of recently sequenced genomes of  C. difficile. The aim of this 
chapter was to identify novel CTns and to determine if the previously determined 
elements  in  strain  630  are  present  in  other  strains.  Furthermore,  the  accessory 
modules of the novel elements, and those described in previous studies, were studied 
by bioinformatics in order to determine the likely function of the predicted proteins 
and predict the effect these elements may have on antibiotic resistance and virulence. 
The  aim  of  Chapter  4  was  to  determine  if  the  CTns  of  C.  difficile  are  mobile. 
Experiments were set up to test if the CTns in strains 630, R20291, QCD-32G25, QCD-
23M63, QCD-63Q42 and M120 could excise from the genome. Subsequently, it was 
tested  if  the  elements  from  strains  630,  R20291  and  M120  could  transfer  by 
performing filter-matings. The elements that did not contain a known selection marker 
were targeted by the ClosTron to introduce a selection marker. Transconjugants of the 
matings  between  C.  difficile  strains  were  studied  to  determine  the  number  of 
integration sites of the CTns that were transferred, using Southern blots. To determine 
if the CTns of C. difficile only transfer under selection pressure, the transconjugants 
were examined for co-transfer of elements that do not contain selection markers. 
A single CD37 transconjugant was discovered that contained the 630 PaLoc. The aim of 
Chapter 5 was to find if transfer of the PaLoc was reproducible and to analyse the 
transconjugants. Filter-matings were set up using a donor that contains a ClosTron 
insertion in the PaLoc to select for transfer of this genomic region. Whole genome  
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sequencing of the transconjugants was performed to determine the exact genomic 
regions that were transferred. 
In Chapter 6, it was aimed to determine if the transcriptional regulators on CTns have 
effects on the transcriptome of the cell. Furthermore, it is determined if there are 
differences in the transcriptomes of strains 630 and 630∆erm. RNA-seq was used to 
compare the effects on the transcriptome of the mutations made in the transcriptional 
regulators encoded on CTn2 and CTn4 but also the effects of the mutations that have 
occurred between strains 630 and 630∆erm.  
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Chapter 2  Materials and methods 
2.1.   Bacterial strains and culture methods 
Bacterial strains used in this study are listed in Table 2.1. C. difficile and B. subtilis 
strains were grown on Brain Heart Infusion (BHI) agar plates (Oxoid Ltd, Basingstoke, 
UK)  supplemented  with  5%  defibrinated  horse  blood  (BHIB)  (E  &  O  laboratories, 
Bonnybridge,  UK)  or  in BHI  broth.  Broth  and  agar  plates  were pre-reduced before 
culturing C. difficile. For the cytotoxicity assay described in Chapter 5, C. difficile was 
grown in TY broth consisting of 3% Bacto Tryptose (BD Biosciences, Oxford, UK), 2% 
Yeast extract (Oxoid Ltd) and 0.1% Thioglycolate (Sigma-Aldrich Company Ltd, UK) at 
pH 7.4. All C. difficile strains were grown at 37 C in anaerobic conditions (80% N2, 10% 
H2 and 10% CO2). 
E.  coli  was  grown  on  LB  agar  plates  or  in  LB  broth  (Sigma-Aldrich  Company  Ltd, 
Gillingham, UK). E. coli and B. subtilis strains were grown in aerobic conditions unless 
co-cultured with C. difficile. 
All antibiotics were obtained from Sigma-Aldrich Company Ltd (Gillingham, UK). 
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Bacterium  Ribotype  Properties  Reference or source 
C. difficile:   
   
630  012  Tc
R Erm
R Rif
S  [7,160] 
630Δerm  012  Tc
R Erm
S Rif
S  [48] 
R20291  027  Tc
S Erm
S Rif
S  [13] 
CD37  009  Tc
S Erm
S Rif
R 
Recipient in filter-
mating experiments 
[106] 
CD843      Dr. S. Goh 
QCD-66C26  027  Tc
S Erm
R  Dr. A. Dascal 
QCD-32G58  027  Tc
S Erm
R  Dr. A. Dascal 
QCD-23M63  078  Tc
S Erm
S  Dr. A. Dascal 
M120  078  Tc
R Erm
S  Dr. J. Corver 
CD37 pMTL960/GusA    Thi
R  Dr. H. Hussain 
R20291 pMTL9301    Linc
R  Dr. H. Hussain 
       
ClosTron mutants:   
   
630Δerm CD0364::ErmRAM  012  Tc
R Erm
R Linc
R  Chapter 4 
630Δerm CD0386::ErmRAM  012  Tc
R Erm
R Linc
R  Chapter 4 
630Δerm CD0428::ErmRAM  012  Tc
R Erm
R Linc
R  Chapter 4 
630Δerm CD1099::ErmRAM  012  Tc
R Erm
R Linc
R  Chapter 4 
630Δerm CD1873::ErmRAM  012  Tc
R Erm
R Linc
R  Chapter 4 
630Δerm CD1873::ErmRAM  012  Tc
R Erm
R Linc
R  Chapter 4 
R20291 1803::ErmRAM  027  Erm
R Linc
R  Chapter 4 
630Δerm tcdB::ErmRAM  012  Tc
R Erm
R Linc
R  [45] 
       
Transconjugants:       
CD37::CTn1 CD0364::ErmRAM    4 transconjugants  Chapter 4 
CD37::CTn1 CD0386::ErmRAM    9 transconjugants  Chapter 4 
CD37::CTn2 CD0428::ErmRAM    10 transconjugants  Chapter 4 
CD37::CTn4 CD1099::ErmRAM    6 transconjugants
  Chapter 4 
CD37::CTn5 CD1873::ErmRAM    10 transconjugants  Chapter 4 
CD37::CTn7 CD3392::ErmRAM    6 transconjugants  Chapter 4 
CD37 PaLoc tcdB::ErmRAM    7 transconjugants  Chapter 5 
B. subtilis::CTn5 
CD1873::ErmRAM 
  10 transconjugants  Chapter 4 
       
Other species:       
B. subtilis CU2189    Recipient in filter-
mating experiments
 
[189] 
E. coli CA434    Competent  cells  for 
transformations and 
conjugation  into  C. 
difficile. 
[190] 
Table 2.1 Bacterial strains used in this study 
Tc = tetracycline, Erm = erythromycin, Linc = lincomycin, Thi = thiamphenicol, 
R = resistant,
 S = sensitive 
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2.2.   Molecular techniques 
2.2.1. DNA isolation 
DNA was isolated using the Gentra Puregene Yeast/Bact. Kit (Qiagen) according to the 
manufacturer’s  instructions;  however,  changes  were  made  to  the  amount  of  the 
solutions that were used. Ten millilitres of overnight culture (16 h) was centrifuged for 
5 min at 4,500 x g, and the cell pellet was resuspended in 1 ml PBS. The cell suspension 
was transferred to a microcentrifuge tube and centrifuged for 1 min at 16,000 x g. The 
cell pellet was resuspended in 600 μl cell suspension solution. Five microlitres of lytic 
enzyme  solution  was  added  and  the  tubes  were  inverted  several  times  for  mixing 
before they were incubated at 37 °C for 30 min. Tubes were centrifuged at 16,000 x g 
for 1 min and the supernatant was removed with a pipette. Cells were resuspended in 
600 μl cell lysis solution and incubated at 80°C for 5 min. Next 5 μl of RNase A solution 
was added and the tubes were inverted 10 times to mix and incubated at 37 °C for 30 
min. Samples were transferred to ice and 200 μl protein precipitation solution was 
added and vortexed for 20 sec after which the samples were incubated on ice for 30 
min. The tubes were centrifuged for 3 min at 16,000 x g and the supernatant was 
poured into a microcentrifuge tube containing 600 μl isopropanol. The tubes were 
inverted  approximately  50  times  and  centrifuged  for  1  min  at  16,000  x  g.  The 
supernatant  was  discarded  and the tubes  were  drained  on  tissue  paper.  The  DNA 
pellet was washed by adding 600 μl 70% ethanol and inverting several times. The tubes 
were centrifuged for 1 min at 16.000 x g and the supernatant was discarded and the 
tubes drained on tissue paper. The samples were air dried for 15 minutes and 100 μl 
sterile distilled H2O was added. The DNA was incubated for 1 h at 65 °C and overnight  
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at RT. Samples were analysed using a Nanodrop 1000 for quality and quantity and 
stored at -20 °C. 
2.2.2. PCR 
Standard PCR amplification was carried out using the NEB Taq polymerase kit (New 
England Biolabs) according to the manufacturer’s instructions. Reactions contained 10 
mM dNTPs (NEB) and 0.4 μM primers (Sigma Aldrich, UK). PCR programs consisted of 4 
min  initial  denaturation  at  94  °C,  followed  by  25  to  35  cycles  of  30  seconds 
denaturation at 94 °C, 1 min annealing at primer specific temperatures, extension at 
72 °C for 1 min per 1-kb of expected product. All reactions finish with 10 min of final 
extension at 72 °C and then the sample was cooled to 4 °C. Annealing temperature is 
typically 5 °C below the melting temperature of the primer with the lowest melting 
temperature. Primers are listed in the materials and methods of each chapter. 
PCR products were run on a 1% agarose gel at 80-120 mV for 30-60 min. Agarose gels 
contained Gelred (Biotium, Hayward, USA) at a one 10,000th (V/V) concentration. Gel 
imaging  was  carried  out  using  an  Alphaimager  (AlphaInnotech,  San  Leandro,  USA) 
using the Alphaview software package (version 1.0.1.10). 
2.2.3. Purification of PCR products 
PCR  reactions  for  which  only  a  single  product  was  visible  on  an  agarose  gel  were 
purified using the Spin column purification kit (NBS Biological Ltd, Cambridgeshire, UK) 
according to the manufacturer’s instructions.   
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When  multiple  PCR  products  were  present,  the  required  product  was  agarose  gel 
purified. The DNA was purified from the gel using a Spin column gel purification kit 
(NBS Biological Ltd) according to the manufacturer’s instructions.  
 
2.2.4. Transformation into competent E. coli CA-434 
Competent cells were prepared by growing an overnight culture in LB broth and using 
2 ml to inoculate a further 100 ml of LB broth. Cells were grown to OD600 = 0.3. The 
broth  culture  was  centrifuged  at  4,500  x  g  for  5  min  at  4  C.  The  cells  were 
resuspended in 10 ml ice cold 100 mM CaCl2 and incubated on ice for 20 min. The cells 
were  centrifuged  again,  as  above,  and  resuspended  in  0.5  ml  CaCl2.  After  15  min 
incubation on ice, 70 l DMSO was added, and the cells were incubated on ice for 15 
min. Following this 70 l DMSO was added. Cells were aliquoted and snap frozen in dry 
ice with ethanol. The cells were stored at -80 C. The protocol is based on the papers 
by Mandel and Higa [191] and Cohen et al. [192]. 
Transformation was performed as described for the p-GEM-T vector system (Promega, 
Southampton, UK). Competent cells were thawed on ice and 50 l of cells were added 
to a tube containing the target DNA. The cells were incubated on ice for 30 min after 
which the cells were heat-shocked at 42 C for 45 sec after which the tube was placed 
on ice again for 2 min. 950 l of SOC medium (Sigma Aldrich Ltd, Gillingham, UK) was 
added to the tube and the cells were incubated at 37 C for one hour with shaking at 
200 rpm. After this, the cell suspension was transferred onto selective LB agar (Sigma 
Aldrich Ltd, Gillingham, UK.) plates and incubated O/N at 37 C.  
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2.2.5. DNA Sanger sequencing 
DNA  Sanger  sequencing  of  PCR  products  was  carried  out  by  the  Department  of 
Biochemistry,  University  of  Cambridge  or  the  Wolfson  Institute  for  Biomedical 
Research, University College London.  
PCR products were purified with the Spin column purification kit (NBS Biological Ltd, 
Cambridgeshire,  UK)  as  described  above.  DNA  samples  were  50-100  ng/l.  Both 
strands of the product were sequenced using the primers used for PCR.  
 
   
65 
2.3.  Filter-mating 
This method is based on filter-matings described by Mullany et al. [164]. Cultures of 
both donor and recipient strains were grown overnight for 16 h. These were used to 
start a 10 ml culture of the donor strain and a 50 ml culture of the recipient strain, 
both at an OD600 = 0.1. These were grown shaking at 50 rpm. After 4-6 h, when the 
OD600 was between 0.5 and 0.6, the cells were centrifuged for 10 min at 4,500 x g and 
the pellets were resuspended in 500 l BHI broth. The two cultures were mixed and 
200 l of the mixture was spread onto each of four 0.45 m pore size cellulose nitrate 
filters (Sartorius, Epsom, UK), on BHIB plates.  After 24 h the filters were placed into 25 
ml tubes and 1 ml BHI broth was added. The tubes were vigorously vortexed and the 
resulting  cell  suspension  was  spread  onto  selective  plates,  selective  for 
transconjugants.  In  filter-matings  using  B.  subtilis  as  recipient,  these  plates  are 
incubated aerobically in order to select against the C. difficile donor. Serial dilutions 
were  spread  on  selective  plates to  count the  number  of  donor  and  recipient  cells 
harvested from the filters. After 72-96 h the putative transconjugants were counted 
and sub-cultured onto fresh selective plates.  
Identity  of  the  transconjugants  was  confirmed  by  PCR  using  a  primer  pair  that  is 
specific for the recipient strain and a primer pair that is specific for the transferring 
element; these are specified in the relevant chapters. 
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Chapter 3  Bioinformatics search for novel elements and putative 
virulence factors 
3.1.   Introduction 
The sequencing of the first three C. difficile genomes, strains 630, R20291 and CD196, 
revealed a number of putative CTns and other MGEs in each genome. The CTns are all 
part  of  the  Tn916-like  or  Tn1549-like  families  [8,14].  The  genes  in  the  accessory 
modules  were  often  annotated  as  ABC  transporters  for  unknown  substrates  or  as 
hypothetical proteins. After these genomes were published, several other C. difficile 
genomes were sequenced and deposited in Genbank [88].  
An essential feature for CTns is the recombinase responsible for the integration and 
excision of the element [126]. The sequences of known functional recombinases were 
used here to search for recombinases and associated CTns in the C. difficile genome 
sequences. 
For C. difficile genomes most annotations were performed using gene finder programs 
that predict CDS such as Glimmer [193]. The function of the CDS is predicted based on 
DNA sequence homology alignment algorithms such as tBLASTn [194].  Unfortunately, 
in the ‘omics era’, Genbank and other databases are starting to fill up with sequences 
from genome sequencing studies where no biological data is available on most of the 
annotated CDS. As a result, when performing BLAST searches, a long list of hits is 
returned that have no supporting biological data and their actual functions may be 
unrelated to their current annotations.  
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To predict the biological function of a CDS more accurately another approach is to 
search with the amino acid sequence of the predicted protein using protein prediction 
tools. Hernandez et al. [195] have described a method for the in-depth analysis of 
protein  sequences  using  a  set  of  bioinformatics  tools  to  predict  the  function  of 
proteins annotated as ‘hypothetical protein’. 
PSI-BLAST  is  an  alignment  algorithm  that  performs  BLAST  searches  on  a  protein 
database. The hits of the search can be combined to form a new consensus sequence, 
which is used to search the database again, known as the Position Specific Iteration. 
Several rounds of iterations will increase the number of hits, increasing the chance 
that a homologue with a similar predicted function as the query sequence is identified. 
However, sequences that are identified with the highest E-values do not necessarily 
have the most relevant predicted biological function. High E-values in BLAST searches 
may be caused by a common ancestry of the proteins or structural similarities rather 
than similar biological function [196]. 
The results of a PSI-BLAST search can be rearranged using the BYPASS program. This 
program makes use of a fuzzy logic algorithm that takes into account the amino acid 
content and length of the matched sequence stretch but also the hydrophobicity and 
flexibility profiles of the amino acid sequences [197]. These four parameters were all 
shown to improve the predictive power of the algorithm and therefore, to improve the 
prediction of the biological function of a query sequence. 
Certain  biological  functions  are  localised  to  specific  sites  in  cells.  P-SORT  uses  the 
protein sorting signals encoded in the amino acid sequence in order to predict the 
location of the protein in the cell [198].  
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Both  SMART  [199]  and  PRO-DOM  [200,201]  are  programs  that  can  recognise 
conserved  protein  domains  from  various  databases.  The  presence  of  conserved 
domains in an amino acid sequence can help to support the predicted the function of 
the protein. 
These  programs  all  predict  different  protein  characteristics  and  were  used  on  the 
protein sequences encoded on the C. difficile CTns to aid prediction of their biological 
function.  
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3.2.  Aims of this chapter: 
  Identifying novel CTns in the genome sequences of C. difficile strains. 
  Bioinformatics analyses of accessory CDS on previously identified and novel 
CTns to predict the function of the proteins encoded on the CTns. 
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3.3.  Materials and methods 
3.3.1. Search for novel CTns 
A library of sequences of tyrosine and serine recombinase genes (section 1.2.1.1.3) for 
which biological activity has been shown was assembled by Dr. Philip Warburton (UCL). 
The sequences were used to search the C. difficile genomes specifically using genomic 
BLAST.  Positive  genomes  or  contigs  were  compared  to  the  630  reference  genome 
using DoubleACT [202] and comparisons were visualised using Artemis 12.0 [203] and 
the  Artemis  Comparison  Tool  (ACT)  9.0  [202,204]  in  order  to  determine  if  the 
recombinase genes were associated with a putative MGE. As a positive control, it was 
noted that the recombinases of the previously reported elements CTn1, CTn2, CTn4, 
CTn5, CTn6, CTn7 and Tn5397 all came up as hits when the genome of 630 [8] was 
analysed, as well as the two putative elements reported in R20291 [14]. 
3.3.2. Bioinformatics analysis to predict CDS functions 
All CDS annotated on the CTns in the sequence of  C. difficile strains 630, R20291, 
CD196, QCD-23M63, QCD63Q42, ATCC 43255, QCD37X79, QCD-66C26, QCD-32G58, 
QCD76W55 and QCD-97B34 were studied using the set of bioinformatics programs 
described below.  
For strains BI-1, BI-9, 2007855, M68 and CF5 only the CDS that have no homologues in 
previously  studied  elements  were  examined  with  the  bioinformatics  programs 
described below. For strain M120 part of the bioinformatics analysis was performed by 
Dr J. Corver (Leiden University Medical Centre, Leiden, The Netherlands), using only 
BLAST-P and SMART.  
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Putative CTns in contigs and genome sequences that had not been annotated were 
analysed using the NCBI tool Open Reading Frame (ORF) Finder [205] and BLAST-P in 
order to predict CDS. All data was collected using Artemis. 
Protein sequences were analysed using the following  bioinformatics programs: PSI-
BLAST [196], BYPASS [197], PRODOM [201], SMART [199] and P-SORT [198]. Programs 
that allow custom settings were used at the default settings. PSI-BLAST was performed 
in order to identify distantly related protein sequences. After the fifth iteration, or 
when no new hits were generated, the PSSM matrix was used in BYPASS analysis. 
PRODOM  and  SMART  were  used  to  predict  functional  domains  in  the  protein 
sequences and P-SORT was used to predict the location of the protein in the cell.  
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3.4.  Results and discussion 
A bioinformatics search for novel putative CTns in sequenced strains of C. difficile was 
performed using the nucleotide sequence of functional recombinase genes. During this 
study  a  total  of  33  new  elements  were  discovered  in  15  C.  difficile  strains,  as 
summarised in Table 3.1. New elements in strains ATCC 43255,  QCD-23M63, QCD-
32G58,  QCD-37X79,  QCD-63Q42,  QCD-66C26,  QCD-76W55,  QCD-97B34  were 
described  in  Brouwer  et  al.  [206]  in  which  we  reported  a  thorough  bioinformatics 
analysis of the new elements, as well as the previously described elements in strains 
630, R20291 and CD196. A follow-up study was performed after another five complete 
C. difficile genomes were made publicly available in Genbank (BI1, BI9, 2007855, M68, 
CF5) published in Brouwer et al. [207]. The elements in strain M120 were studied in 
collaboration  with  Dr.  Jeroen  Corver  (LUMC,  Leiden,  The  Netherlands)  and  were 
published recently [208]. 
A Tn number was assigned to new elements for which excision from the genome into a 
circular  intermediate  could  be  shown,  in  agreement  with  the  guidelines  of  the  Tn 
registry  [209],  as  discussed  in  Chapter  4.  For  some  elements  where  the  exact 
integration site could be described, a Tn number was also assigned. 
 
Table 3.1 Overview of CTns and non-conjugative elements in C. difficile.  
Data on strain CD37 is based on the genomic sequence that is presented in Chapter 6. 
Strain  Ribotype  Accession 
number 
Isolation details  Source  Family  of 
element 
Element  Accessory  genes, 
properties 
630  012  AM180355  Zurich, 
Switzerland, 
1982 
Human  with 
severe 
pseudomembra
nous colitis 
Tn916  CTn1  ABC transporter, 
putative cell surface 
protein. 
          Tn916  CTn6  Hypothetical 
proteins  
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Strain  Ribotype  Accession 
number 
Isolation details  Source  Family  of 
element 
Element  Accessory  genes, 
properties 
          Tn916  CTn7  ABC transporter, 
putative cell surface 
protein. 
          Tn916  Tn5397  tet(M) 
          Tn1549  CTn2  ABC transporter  
          Tn1549  CTn4  ABC transporter  
          Tn1549  CTn5  ABC transporter  
          Unknown  Tn5398  erm(B) 
R20291  027  FN545816  Stoke 
Mandeville,  UK, 
2006 
Human  with 
CDAD, 
associated  with 
an outbreak 
Tn916  CTn1-
like 
ABC transporter, 
putative cell surface 
protein. 
          Tn1549  Tn6103  Accessory module of 
CTn5 
          Mobilisable  Tn6104  Integrated in 
Tn6103, ABC 
transporter, toxin-
antitoxin system 
          Mobilisable  Tn6105  Integrated in 
Tn6103, radical SAM 
protein 
          Mobilisable  Tn6106  Integrated in 
Tn6103, multidrug 
efflux pump 
CD196  027  NC013315  Paris,  France, 
1985 
Human  Tn916  CTn1-
like 
98-100% sequence 
ID to the R20291 
CTn1-like element 
ATCC-
43255  
(VPI10463) 
087  CM000604    Human  Tn916  CTn1-
like 
ABC transporter, 
cation family efflux 
protein, tet(A), 
putative cell surface 
protein, integrated 
within skin
CD 
          Unknown  Tn5398-
like 
 
QCD-
23M63 
078  CM000660  Montreal, 
Quebec, 
Canada 
  Tn916  Tn6073 
CTn1-
like 
ABC-transporter, N-
terminal hydrolase, 
putative cell surface 
protein 
          Tn1549  CTn4-
like 
Accessory module of 
CTn4 
          Tn1549  Tn6107 
CTn5-
like 
ABC transporter 
QCD-
32G58 
027  CM000287  Quebec, 
Canada, 2004 
  Tn916  CTn1-
like 
98-100% sequence 
ID to the R20291 
CTn1-like element  
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Strain  Ribotype  Accession 
number 
Isolation details  Source  Family  of 
element 
Element  Accessory  genes, 
properties 
          Tn1549  Tn6111 
CTn5-
like 
99% sequence 
identity to Tn6103 in 
R20291, excluding 
Tn6105 and Tn6106 
QCD-
37X79 
027  CM000658  London, 
Ontario, 
Canada, 2005 
  Tn916  CTn1-
like 
98-100% sequence 
ID to the R20291 
CTn1-like element 
          Tn1549  CTn5-
like 
99% sequence 
identity to Tn6103 in 
R20291, excluding 
Tn6105 and Tn6106 
QCD-
63Q42 
001  CM000637  Quebec  city, 
Quebec, 
Canada, 2005 
  Mobilisable  Tn6115  ABC transporter  
          Tn916  CTn1-
like 
33 kb accessory 
module containing 
ABC transporter, 
antirestriction ardA, 
ABC transporter and 
5 recombinases, 
putative cell surface 
protein 
          Tn916  CTn1-
like 
99% identical to BI9 
element, 
lactoglutathione 
lyase, alpha/beta 
fold hydrolase ABC 
transporters, 
putative cell surface 
protein 
          Tn916  CTn7-
like 
99% identical to 
CTn7, ABC 
transporter, cell 
surface protein 
          Tn1549  CTn5-
like 
Restriction 
modification system, 
helicase. 
QCD-
66C26 
027  CM000441  Quebec, 
Canada, 2004 
  Tn916  CTn1-
like 
98-100% sequence 
ID to the R20291 
CTn1-like element 
          Tn1549  Tn6110 
CTn5-
like 
99% sequence 
identity to Tn6103 in 
R20291, excluding 
Tn6105 and Tn6106 
QCD-
76W55 
027  CM000661  Minnesota, 
Minneapolis, 
USA, 1988 
  Tn916  CTn1-
like 
98-100% sequence 
ID to the R20291 
CTn1-like element 
QCD-
97B34 
027  CM000657  St  John’s, 
Newfoundland, 
Canada, 2004 
  Tn916  CTn1-
like 
98-100% sequence 
ID to the R20291 
CTn1-like element 
BI1  027  FN668941  USA, 1988  Human  Tn916  CTn1-
like 
98-100% sequence 
ID to the R20291 
CTn1-like element  
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Strain  Ribotype  Accession 
number 
Isolation details  Source  Family  of 
element 
Element  Accessory  genes, 
properties 
BI9  001  FN668944  USA, 2001  Human  Tn916  CTn1-
like 
99% identical to 
QCD-63Q42 CTn1-
element 
          Tn1549  CTn5-
like 
99% identical to 
QCD-63Q42 CTn5-
element 
          Tn916  CTn7-
like 
99% identical to 
CTn7, ABC 
transporter, cell 
surface protein part 
of conjugation 
module is not 
present due to a gap 
in the sequence 
2007855  027  FN665654  USA, 2007  Bovine  Tn916  CTn1-
like 
98-100% sequence 
ID to the R20291 
CTn1-like element 
          Tn916  CTn1-
like 
Erythromycin 
resistance gene and 
toxin-antitoxin 
system, 99% 
identical to M68 
CTn1-like element 
          Tn1549  CTn5-
like 
ABC transporter, 
insertion of a 
putative mobilisable 
transposon 
containing 
aminoglycoside 
resistance 
M68  017  FN668375  Ireland, 2006  Human, 
associated  with 
an outbreak 
Tn916  Tn916-
like 
Tetracycline and β-
lactamase 
resistance, cell 
surface protein 
          Tn916  CTn1-
like 
Erythromycin 
resistance and  
toxin-antitoxin 
system, 99% 
identical to 2007855 
CTn1-like element 
          Tn1549  CTn5-
like 
ABC transporter, 
identical to CF5 
CTn5-like element 
CF5  017  FN665652  Belgium, 1995   Human, 
asymptomatic 
patient 
Tn1549  CTn5-
like 
ABC transporter, 
identical to M68 
CTn5-like element 
M120  078  FN665653  Ireland  Human 
diarrhoeal 
patient 
Tn916  Tn6190   Accessory module of 
Tn916 including 
tet(M) 
          Tn1549  Tn6164  Composite element, 
accessory genes 
include tet(44), 
several 
aminoglycoside 
adenylyltransferases
, and a restriction 
modification system  
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Strain  Ribotype  Accession 
number 
Isolation details  Source  Family  of 
element 
Element  Accessory  genes, 
properties 
CD37  009  AHJJ01000
000 
United  States, 
1980 
Clinical sample  Tn916  CTn1-
like 
ABC transporter 
          Tn1549  CTn4-
like 
ABC transporter 
          Tn916  CTn7-
like 
ABC transporter 
 
3.4.1. CTn1-like elements 
CTn1-like elements are CTns of the Tn916 family with high sequence homology to 
CTn1. Strain R20291 contains two putative CTns [14]. One of these elements is a CTn1-
like  element  with  approximately  82%  sequence  identity  to  CTn1,  excluding  the 
accessory region and an insertion in the conjugation module (Figure 3.1). One deletion 
at  the  right  side  of  the  element encompasses genes  encoding  homologues  of  two 
putative hypothetical proteins and the excisionase gene xis, predicted to play a role in 
the excision of CTn1 in strain 630. Experiments described in Chapter 4 could not detect 
the excision of the CTn1-like element. The accessory region of the element differs from 
CTn1 and encodes an ABC transporter system, a TetR family transcriptional regulator 
and  a  cation  efflux  family  protein,  amongst  others.  Information  on  the  putative 
functions of the other CDS in this element are listed in Appendix I. Compared to CTn1 
in  630,  an  insertion  within  the  conjugation  module  contains  further  predicted 
accessory genes. The element is integrated in a novel target site compared to CTn1, 
between  homologues  of  a  hypothetical  protein  (CD3614)  and  a  predicted 
transcriptional regulator (CD03615) from 630. 
Strains  QCD-66C26,  QCD-32G58,  QCD-37X79,  QCD-76W55,  QCD-97B34,  BI1  and 
2007855 all contain a CTn1-like element with 98-100% nucleotide sequence identity  
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with the element described in R20291. All the elements lack xis and are integrated in 
the same target site. 
Strain ATCC 43255 contains a CTn1-like element that has integrated into the skin
CD 
element.  The  skin
CD  is  a  genetic  element  involved  in  transcriptional  regulation  of 
sigmaK that is essential for efficient sporulation in C. difficile [179] (Chapter 1). The 
presence of the CTn1-like element within skin
CD does not prevent efficient sporulation 
[179]. The accessory region of the CTn1-like element differs from CTn1 in 630 and 
includes  genes  predicted  to  encode  an  ABC  transporter  system  and  a  Tet(A) 
tetracycline resistance protein (Figure 3.1). The element contains an insertion within 
the  conjugation  module  which  is  identical  to  the  insertion  seen  in  the  CTn1-like 
element  in  R20291.  Excluding  these  regions,  the  element  has  approximately  73% 
nucleotide sequence identity with CTn1 from 630.  
 
Figure 3.1 Schematic representation of CTn1 and the CTn1-like elements in strains R20291, QCD-66C26, ATCC 43255, 23M63 and QCD-63Q42.  
CDS are represented by arrows. All blue CDS have homologues in CTn1 in strain 630. Green CDS are not present on CTn1. Red, brown and yellow boxes shows regions with 
sequence similarity. Red boxes are part of the recombination module, brown boxes are part of the conjugation module, and yellow boxes show sequence similarity between 
regions of the elements that are not present in CTn1 of 630. Blue boxes are part of the regulation and accessory module but do not show sequence similarity. The element shown 
for QCD-63Q42 also represents the element in strain BI9. The element shown for QCD-66C26 also represents the elements in strains QCD-32G58, QCD-37X79, QCD-76W55, QCD-
97B34, BI1 and 2007855. A digital version of this image is included on the disc at the back of this thesis.  
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Strain QCD-23M63 contains the only CTn1-like element for which excision from the 
genome could be detected (Chapter 4) and was designated Tn6073. Tn6073 contains 3 
small insertions in the conjugation module in addition to a different accessory module, 
compared  to  CTn1,  (Figure  3.1).  Excluding  these  insertions,  the  remainder  of  the 
sequence has 85% nucleotide sequence identity with CTn1. The accessory module of 
the  element  is predicted  to  encode  an  ABC  transporter  system, a two  component 
regulatory  system  and  a  70  sigma  factor.  The  accessory  module  also  encodes  a 
predicted member of the N-terminal hydrolase family, a family which includes bile salt 
hydrolases involved in bile resistance, -lactam acylases involved in resistance to β-
lactams and N-acyl homoserine lactone acylases involved in quorum sensing. Tn6073 
has  integrated  in  a  different  target  site  compared  to  CTn1,  intragenic  between 
homologues  of  a  predicted  membrane  protein  (CD0651)  and  a  transcriptional 
regulator (CD0652).  
Strains QCD-63Q42 and BI9 contain nearly identical CTn1-like elements (99% sequence 
identity) which both have integrated between homologues of a predicted fructokinase 
(CD1806)  and  an  NADPH-dependent  FMN  reductase  (CD1807)  (Figure  3.1).  The 
accessory region of these CTn1-like elements differ from CTn1 in 630 and encode a 
putative  ABC  transporter  system,  a  70  sigma  factor  and  three  transcriptional 
regulators  of  the  TetR,  Xre  and  CheY  families.  Excluding  the  insertions  in  the 
conjugation region and the differences in the accessory region, the elements have 83% 
nucleotide sequence identity to CTn1. 
Strain  QCD-63Q42  contains  a  second  CTn1-like  element  integrated  between 
homologues  of  630  hypothetical  proteins  (CD1564  and  CD1565).  An  insertion  of 
approximately 20 kb is present in the conjugation module, (Figure 3.2). This insertion  
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has 92% nucleotide sequence identity to sequences present in φC630-1 of strain 630 
but, as the sequence is currently incomplete, it is currently not possible to be sure if 
the element contains a complete phage [206]. The accessory region of most CTn1-like 
elements described here are approximately the same size (9.5 kb) as that of CTn1 in 
630.  However,  the  accessory  region  of  the  element  in  strain  QCD-63Q42  is 
approximately  33  kb,  and  the  length  of  the  whole  element  is  nearly  70  kb.  The 
accessory module encodes 34 CDS including two predicted 70 sigma factors, five site 
specific recombinase proteins and two transcriptional regulators, one of the AraC and 
one of the MarR families. The accessory region also encodes a homologue of ardA also 
present on Tn916 and Tn6000 [210,211]. ArdA mimics the structure of DNA and binds 
endonucleases in order to evade the host restriction modification system. Excluding 
the phage-like insertion described above and the accessory region, the element has 
73% nucleotide sequence identity to CTn1. 
 
  
 
 
 
 
Figure 3.2 Schematic representation of CTn1 and phage 1 in 630 and the CTn1-like element in QCD-63Q42. 
CDS are represented by arrows. All blue CDS have homologues in CTn1 in strain 630. Green CDS are not present in CTn1. Red brown and yellow boxes show regions with sequence 
similarity. Red boxes are part of the recombination module, blue boxes are part of the regulation and accessory module, brown boxes are part of the conjugation module, and 
yellow boxes are part of phage 1. Black arrows indicate gaps in the sequence of QCD-63Q42. Blue boxes are part of the regulation and accessory module but do not show sequence 
similarity. A digital version of this image is included on the disc at the back of this thesis.  
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Strains 2007855 and M68 contain CTn1-like elements which are 99% identical to each 
other. The conjugation region of these elements is 94% identical to CTn1 (Figure 3.3). 
Amino acid sequence comparison predicts the genes in the recombination module of 
the elements encode tyrosine recombinase and excisionase proteins, although these 
do not have any DNA sequence homology to any known recombinase and excisionase 
genes. Therefore, if functionality of the recombinase is shown in future study, it would 
be interesting to include in the recombinase library used here. The elements have 
integrated into different target sites, the element in 2007855 is intragenic in a gene 
encoding a hypothetical protein (homologue of 630 CD2831) and in M68 is intragenic 
in a putative oxidoreductase gene (CD3317). The accessory modules of the elements 
contain a region of approximately 2.2 kb that has 97% nucleotide sequence identity to 
a  part  of  Tn5398  containing  homologues  of  erm(B),  ORF3  and  ORF298  [172]. 
Furthermore,  the  accessory  modules  of  both  elements  encode  homologues  of  the 
omega-epsilon-zeta  operon,  a  toxin-antitoxin  system  which  is  involved  in  plasmid 
maintenance in Gram-positive bacteria [212]. In Vibrio cholerae, a similar system has 
been shown to stabilise the CTn SXT after circularisation [213,214]. A mutation in the 
zeta  toxin  gene  results  in  an  early  stop  codon  in  both  elements  at  R52,  halfway 
through the conserved toxin domain indicating that a toxin is unlikely to be produced. 
The fact that both elements encode the same mutation suggests the mutation was 
acquired before dissemination of the element to, or between these C. difficile strains. 
An alternative role for orphan antitoxin genes has previously been described as an 
anti-addiction  system,  protecting  the  cell  from  elements  encoding  similar  toxin-
antitoxin systems entering the cell [215], and the antitoxin and regulator from this 
operon may therefore still be functional.  
 
 
Figure 3.3 Schematic representation of CTn1 and the CTn1-like elements in strains 2007855 and M68. 
CDS are represented by arrows. All blue CDS have homologues in CTn1 in strain 630. Green CDS are not present on CTn1. Coloured boxes show regions with sequence similarity. 
The blue box is part of the regulation and accessory module, brown boxes are part of the conjugation module. A digital version of this image is included on the disc at the back of 
this thesis.  
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3.4.2. CTn4-like elements 
Strain QCD-23M63 contains a CTn4-like element (Figure 3.4) that has integrated in a 
different target site than CTn4 in 630, within a homologue a gene encoding a putative 
cell surface protein (CD1036). In this element, approximately 5 kb of the conjugation 
module  of  CTn4  is  absent  and  therefore  the  element  may  not  be  capable  of 
conjugative transfer.  
 
 
 
 
Figure 3.4 Schematic representation of CTn4 and the CTn4-like element in strain QCD-23M63.  
CDS are represented by arrows. All blue CDS have homologues in CTn1 in strain 630. Green CDS are not present on CTn1. Coloured boxes show regions with sequence similarity. 
The red box is part of the recombination module, the blue box is part of the regulation and accessory module, brown boxes are part of the conjugation module. A digital version of 
this image is included on the disc at the back of this thesis.  
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3.4.3. CTn5-like elements 
Strain R20291 contains an element that has previously been reported as unique to 
ribotype 027 strains, designated CTn027, and reported to contain a 20 kb phage island 
called Stoke Mandeville Phage Island (SMPI) [14]. Bioinformatics shows that only a part 
of the SMPI sequence is present in other ribotype 027 strains such as QCD-66C26 
(Figure 3.5). Here, in-depth analysis of the integration site of the SMPI showed that the 
sequence  actually  consisted  of  three  separate  elements  integrated  into  two 
homologues of CTn5 CDS (Figure 3.6). The complete element was renamed Tn6103 
and  the  three  insertions  were  designated  Tn6104,  Tn6105  and  Tn6106  as  they  all 
resemble transposons in their own right.  
The core element of Tn6103, excluding Tn6104, Tn6105 and Tn6106, has 85%-99% 
sequence identity with CTn5. Tn6103 is present in the same target site as CTn5 in 630 
and nearly all CDS of CTn5 are present.  
At the left end of Tn6104 (Figure 3.6), CDS 1744 and 1745 are homologues of the 
serine recombinase tnpX and tnpV of Tn4451 and Tn4453, respectively, mobilisable 
transposons of C. perfringens and C difficile [166,216,217].  Although TnpV has some 
similarity  to  Xis  from  Tn916  (18%),  only  TnpX  is  essential  in  the  excision  of  these 
elements  from  their  respective  chromosomes  and  the  function  of  TnpV  remains 
unknown  [166,217].  Furthermore,  Tn6104  also  contains  a  mobA/mobL  homologue 
(CDS 1758). In contrast to the single catP accessory gene present on Tn4451/Tn4453, 
Tn6104  encodes  thirteen  putative  accessory  proteins  including  a  predicted 
transcriptional regulator of the Xre family (CDS 1747), a two-component regulatory 
system (CDS 1748-1749), an ABC transporter system (CDS 1750-1752), three σ24 sigma 
factors (CDS 1754-1756) and a toxin-antitoxin system (CDS 1759-1760).  
 
 
 
 
Figure 3.5 Schematic representation of CTn5 and the CTn5-like elements in strains R20291, QCD-66C26, QCD-63Q42 and QCD-23M63.  
CDS are represented by arrows. All blue CDS have homologues in CTn5 in strain 630. Green CDS are not present in CTn5. Red, brown and yellow boxes show regions with sequence 
similarity. Red boxes are part of the recombination module, blue boxes are part of the regulation and accessory module, brown boxes are part of the conjugation module, yellow 
boxes show sequence similarity between regions of the elements that are not present in CTn5. Blue boxes are part of the regulation and accessory module but do not show 
sequence similarity. The element presented for Tn6110 in QCD-66C26 also represents Tn6111 in QCD-32G58 which is 99% identical. A digital version of this image is included on 
the disc accompanying the thesis.  
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Both Tn6105 and Tn6106 encode two predicted serine recombinases which could be 
involved in excision of these elements from the genome (respectively CDS1771-1772 
and 1788) (Figure 3.6). Both elements also encode TnpV homologues (CDS 1765 and 
1777) and putative mobilisation proteins (CDS 1768 and 1784). Tn6105 encodes eight 
putative accessory genes including a transcriptional regulator (CDS 1766) and a σ70 
sigma factor whereas Tn6106 encodes nine accessory proteins including a multidrug 
efflux pump protein (CDS 1779) and a transcriptional regulator of the Xre family. 
 
 
Figure 3.6 Schematic representation of CTn5 and the insertions present in Tn6103. 
CTn5 and Tn6103, are compared to show the sites where Tn6104, Tn6105 and Tn6106 have inserted in 
the sequence. CDS are represented by arrows. All Blue CDS have homologues in CTn5 in strain 630, all 
green CDS are not present in CTn5, red boxes show sequence similarity. Insertion sites are indicated by 
red dotted arrows. A digital version of this image is included on the disc accompanying the thesis. 
 
Strains QCD-66C26 and QCD-32G58 each contain a CTn5-like element which have been 
shown  to  excise  from  their  respective  chromosomes  into  circular  intermediates 
(Chapter 4) and were designated Tn6110 and Tn6111 respectively. Strain QCD-37X79 
has  a  CTn5-like  element  containing  99%  sequence  identity  with  Tn6110.  All  three 
elements  have  insertions  identical  to  Tn6105  in  Tn6103,  however,  none  contains 
Tn6104 or Tn6106 (Figure 3.5). All three elements are present in similar target sites, 
between 630 homologues CD3369 and CD3393 which is the target site of CTn7 in 630. 
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Strains QCD-63Q42 and BI9 contain CTn5-like elements that are 99% identical to each 
other,  containing  similar  accessory  modules  as  CTn5  in  630  but  containing  a 
substitution in the conjugation module (Figure 3.5). Excluding this substitution, there is 
approximately 88% sequence identity between the elements in QCD-63Q42 and BI9 
and CTn5 in 630. The substituted region in the new elements encodes a predicted 
restriction  modification  endonuclease  and  two  methylase  proteins.  These  could 
function  as  a  form  of  molecular  vaccination  in  which  methylation  protects  the 
incoming element from host endonucleases and, following integration, will protect the 
host  chromosome  from  endonucleases  present  on  other  mobile  genetic  elements 
when these enter the cell [218]. Due to frameshift mutations, there are no functional 
homologues of several CDS in the conjugation module and it is therefore conceivable 
that the element no longer transfers via conjugation. The CTn5-like elements in strains 
QCD-63Q42 and BI9 are both present in tandem with a homologue of CTn7 in the 
homologue of the CTn7 target site.  
Strains  QCD-23M63  (Figure  3.5)  and  2007855  (Figure  3.7)  both  contain  CTn5-like 
elements which have integrated in the CTn7 target site without homologues of CTn7 
being present. The element in QCD-23M63 was shown to excise from the genome and 
was designated Tn6107 (Chapter 4). The element in strain 2007855 has an insertion in 
the  homologue  of  a  conjugation  related  gene  which  encodes  a  predicted  serine 
recombinase and a MobA mobilisation protein and is therefore hypothesized to be a 
mobilisable transposon. 
  
 
 
 
 
 
 
 
 
Figure 3.7 Schematic representation of CTn5 and the CTn5-like element in strain 2007855.  
CDS are represented by arrows. All blue CDS have homologues in CTn5 in strain 630. Green CDS are not present in CTn5. Pink CDS are interrupted by an insertion. Coloured boxes 
show regions with sequence similarity. The red box is part of the recombination module, the blue box is part of the regulation and accessory module, brown boxes are part of the 
conjugation module. A digital version of this image is included on the disc at the back of this thesis.  
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3.4.4. Tn916 
Strain M68 contains an element with 98% sequence identity to Tn916 excluding two 
insertions (Figure 3.8). The accessory module of Tn916 is present on the element, 
including tet(M), which indicates the element may confer tetracycline resistance. The 
first of the two insertions is between homologues of Tn916 orf21 and orf22 and is 
predicted to encode a protein containing a metallo -lactamase domain, which may 
play a role in resistance to -lactams [219]. Although C. difficile isolates are generally 
resistant to a high number of -lactams, not all isolates are resistant and -lactamases 
may account for some of the resistance that has been recorded [220,221]. The second 
insertion replaces orf24 with a homologue of the putative cell surface protein found on 
CTn1  (93%  DNA  sequence  identity)(see  3.4.7).  The  element  has  integrated  in  a 
predicted exosporium glycoprotein gene (CD0332).  
 
Strain M120 contains a Tn916-like element that has 97% sequence identity to Tn916 
which was designated Tn6190 as conjugative transfer of the element has been shown 
(Chapter 4). The difference between Tn6190 and Tn916 is the absence of a homologue 
of orf12 of on Tn6190 (Figure 3.9). ORF12 is involved in transcriptional regulation of 
Tn916 [222].   
 
 
Figure 3.8 Schematic representation of Tn916 compared the Tn916-like element in strain M68 and CTn1.  
CDS are represented by arrows. All blue CDS have homologues in Tn916 in E. faecalis. Green CDS are not present in Tn916. Coloured boxes show regions with sequence similarity. 
The red boxes are part of the recombination module, blue boxes are part of the regulation and accessory module, brown boxes are part of the conjugation module. A digital 
version of this image is included on the disc at the back of this thesis.  
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Figure 3.9 Schematic representation of Tn6190 in M120 compared to Tn916 in E. faecalis.  
CDS are represented by arrows. Coloured boxes show regions with similarity. The red box is part of the 
recombination module. The blue box is part of the regulation and accessory module, the brown box is 
part of the conjugation module. 
 
3.4.5. Tn6164 
The sequence of a 107 kb element in strain M120 is derived from several different 
genetic elements (Figure 3.10). The element is present in the target site of CTn2. As 
circularization of the element has been shown, it was designated Tn6164 (Chapter 4). 
On the left end of the element is 7.3 kb of sequence that has no homology to known 
sequences. The fragment encodes two putative modification methylases and a LlaJI 
restriction  endonuclease,  which  indicates  a  restriction  modification  system,  as 
discussed above for the CTn5-like element of QCD-63Q42. 
This sequence is followed by an element of approximately 39.5 kb, which shows 92% 
sequence identity to a Thermoanaerobacter sp. sequence. Both of these sequences 
appear to be complete prophages yet neither has previously been reported.  
A  4.5  kb  fragment  of  sequence  is  99%  identical  to  part  of  the  E.  faecalis  plasmid 
pEF418 (Figure 3.10). The sequence encodes three putative nucleotidyl transferases 
which could play a role in resistance to aminoglycosides, one has most homology to  
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kanamycin  resistance  proteins,  the  second  to  streptomycin  and  the  third  to 
spectinomycin resistance proteins and it is known that pEF418 confers streptomycin 
and spectinomycin resistance [223]. 
The right end of the element is homologous to part of the conjugation and accessory 
modules of Tn1806 of Streptococcus pneumoniae [224]. An insertion of approximately 
4.5 kb in the conjugation module has 90% sequence identity to a multidrug resistance 
cassette of the transferable pathogenicity island of Campylobacter fetus subsp. fetus. 
This  sequence  contains  4  CDS  which  encode  three  putative  antibiotic  resistance 
proteins and a padR transcriptional regulator. In C. fetus subsp. fetus the tet(44) and 
ant(6)-Ib  genes  confer  tetracycline  and  streptomycin  resistance  respectively  [225].  
 
Figure 3.10 Schematic representation of Tn6164 and E. faecalis pEF418, S. pneumoniae Tn1806, Thermoanaerobacter sp. prophage and  the C. fetus pathogenicity island.  
CDS are represented by blue arrows. Blue, brown and yellow boxes show regions with sequence similarity. Blue boxes are for accessory genes, brown boxes are part of the 
conjugation module, yellow boxes are phage related genes. A digital version of this image is included on the disc at the back of this thesis.  
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3.4.6. Non-conjugative genetic elements 
A genetic element is present in strain ATCC 43255 that has 99% sequence identity to 
Tn5398 excluding the erythromycin resistance conferring erm(B) cassette (Figure 3.11). 
The sequence between the direct repeats of the erm(B) cassette is not present and a 
hypothetical  gene  is  present  which  in Tn5398 has  been  interrupted  by  the  erm(B) 
cassette. As it is currently unknown what the mechanism of transfer of Tn5398 is, it is 
impossible to predict if  the element in strain ATCC-43255 can transfer in a similar 
fashion. 
 
Figure 3.11 Schematic representation of Tn5398 compared to the Tn5398-like element in ATCC-43255. 
CDS are represented by arrows. The blue CDS are present in strain 630. The green CDS present in ATCC-
43255 is present in 630, shown in pink, but was interrupted by the erm(B)-cassette. The CDS shown in 
pink has acquired a number of early stop codons and frame-shift mutations. The brown box shows CDS 
with similar predicted functions. 
 
In  strain  QCD-63Q42  a  novel  putative  transposon  has  integrated  into  a  predicted 
transcriptional regulator (Figure 3.12). The element is flanked by a GG dinucleotide 
direct repeat and was designated Tn6115. The element consists of 12 CDS including a 
serine  recombinase,  an  ABC  transporter  system  and  a  two-component  regulator 
system.  
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Figure 3.12 Schematic representation of the putative mobilisable element Tn6115 in QCD-63Q42. 
The blue arrows represent the CDS on the element, the pink arrow represents the interrupted CDS, 
homologue of CD1573, into which the element has integrated. 
 
3.4.7. Cell surface proteins encoded on CTns 
All CTn1-like elements, including CTn7 from 630, encode a putative cell surface protein 
which has been annotated as a putative collagen binding protein because of its amino 
acid sequence similarity to the Staphylococcus aureus collagen binding protein [226]. 
The S. aureus collagen binding protein consists of a CnaA domain, which can bind 
collagen, and seven CnaB domains, which can form a stalk-like structure projecting the 
collagen binding domain away from the cell wall [226] (Figure 3.13). The protein also 
contains an N-terminal signal peptide to transport it to the cell membrane and a C-
terminal LPXTG domain, a signal for sortase mediated cell wall anchoring, which is 
found  commonly  in  Gram-positive  cell  surface  proteins  [227].  A  similar  protein  is 
predicted to be encoded on Tn5386, a Tn916-like element discovered in E. faecium, 
which contains eight CnaB domains [228]. These domains are predicted to act as a 
stalk for an intimin / invasion domain (Figure 3.13) a conserved domain that is involved 
in adherence in Gram-negative organisms [229]. 
The cell surface protein encoded on CTn1 contains two CnaB domains but does not 
contain any other known protein domains (Figure 3.13). This suggests the protein is  
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not involved in collagen binding [230]. The gene was not essential for conjugative 
transfer (Chapter 4), which indicates this is the only accessory gene conserved over all 
CTn1-like elements investigated here. With the exception of strains CF5 and M120, all 
C. difficile strains described here contain a CTn1-like element. The fact that a highly 
conserved accessory gene with no apparent function in conjugation is present in nearly 
all C. difficile strains studied here supports the idea that the cell surface protein would 
confer some advantage to its host cell.  
The next step in the study of this protein should be to determine whether the protein 
is expressed and at what location, eg. on the cell surface or in the cytoplasm. If the 
protein is expressed on the cell surface it could be involved in interactions with the 
environment and the host, indicating the importance of further study of this protein. 
 
 
Figure 3.13 Schematic representation of the cell surface proteins of S. aureus, C. difficile and E. 
faecium.  
Representation of the collagen binding protein of S. aureus and the putative cell surface proteins of C. 
difficile and E. faecium. Symbols for the protein domains are listed above the figure, the location of the 
domains on the peptide sequence is indicated by amino acid numbers below each domain. The N-
terminus is depicted at amino acid 1.  
99 
3.5.  Conclusions 
A new approach was used during this study to identify MGEs by searching genome 
sequences for similarity with the conserved sequences of recombinase genes. A full 
overview of all C. difficile CTns described so far is presented in Table 3.1. A total of 37 
novel  elements  were  identified  by  searching  for  known  recombinases  and  also  by 
searching with the CDS of CTns of strain 630.  
A re-annotation of all of the CDS of the C. difficile 630 genome was recently published 
[230]. This has led not only to an update to the putative functions of a large number of 
CDS but also to the modifications of predicted CDS start sites and the prediction of 
new CDS. However, no changes were made to the annotations of the mobile genetic 
elements in strain 630. 
The analysis of the element previously reported as the SMPI on CTn027 [14] in strain 
R20291 showed the element is not a phage island. CTn027 was renamed Tn6103 [206] 
and the integrated SMPI was shown to consist of three separate insertions which were 
named Tn6104, Tn6105 and Tn6106. Some new predicted functions were assigned to 
the CDS on these three elements including four genes predicted to be sigma factors of 
the σ24 and σ70 families. It is interesting that these relatively small elements contain 
more than one sigma factor in combination with other transcriptional regulators and it 
is  conceivable  that  these  will  not  only  affect  the  regulation  of  the  genes  on  the 
element itself but may also affect the transcription of chromosomal genes. 
During this bioinformatics analysis it became clear that many of the novel elements 
contain accessory genes which are homologues of accessory genes in elements in 630 
and R20291. For those of which the accessory module was different, a number of ABC- 
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transporter  systems  were  found.  Prokaryotic  ABC  transporter  systems  consist  of  a 
minimum of two nucleotide binding domains (NBD) that bind and hydrolyse ATP and 
two transmembrane domains that provide the passageway through the membrane for 
the  transported  molecules  encoded  on  one  or  several  polypeptides  [231].  In  the 
results described above, when at least one NBD and one TMD was discovered in one or 
more CDS adjacent to each other, this was described as a predicted ABC transporter 
system, regardless of the number of NBD and TMD. In prokaryote ABC transporters the 
NBD  and  TMD  are  often  separate  polypeptide  chains  in  importing  transporters 
whereas for exporting transporters these domains are fused on a single polypeptide 
chain [231]. As all of the ABC transporter systems that were studied here consist of 
separate polypeptide chains for the NBD and TMD domains, these ABC transporters 
are  likely  to  function  as  importers,  although  no  prediction  can  be  made  for  their 
substrates. 
MGEs are known to encode antibiotic resistance proteins in their accessory domains. 
Predicted  antibiotic  resistance  genes  that  were  described  here  include  tetracycline 
resistance genes tet(A) on a CTn1-like element in ATCC-43255, tet(44) on Tn6164 and 
tet(M)  on  Tn6190,  both  in  M120.  Furthermore,  Tn6164  encodes  a  putative 
streptomycin  resistance  gene  ant(6)-Ib  as  well  as  three  predicted  aminoglycoside 
resistance  proteins  which  could  confer  resistance  to  kanamycin,  streptomycin  and 
spectinomycin  [223].  Strain  M120  is  tetracycline,  streptomycin  and  spectinomycin 
resistant  but  it  is  currently  unknown  if  the  proteins  encoded  on  Tn6164  are 
responsible  for  this  phenotype  [208].  Further  putative  antibiotic  resistance  genes 
found in this study are erm(B) on the CTn1-like elements in strains M68 and 2007855 
and  the  predicted  aminoglycoside  phosphotransferase  and  aminoglycoside  
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acetyltransferase on the CTn5-like element in 2007855 that may confer resistance to 
aminoglycosides.  
Marsden et al. [232] have reported a comparative genomic hybridisation of 94 clinical 
isolates as well as a number of laboratory reference strains using probes of the entire 
630 genome and part of the R20291 genome. The main aim of the study was to find a 
specific ribotype 027 or hypervirulence gene target which could be tested for in clinical 
isolates. With regards to the MGEs of strain 630 they conclude only CTn7 is present in 
a limited number of strains, in contrast with the results presented here where CTn1-
like elements are found in nearly all strains. The observations by Marsden et al. were 
made  from  looking  at  the  accessory  modules  of  the  elements  (Marsden,  personal 
communication).  The  work  presented  here  shows  the  accessory  module  is  not 
appropriate for analysing conservation of MGEs as the accessory module is the most 
variable. 
The target sites of the elements described in this chapter are mostly new target sites in 
which no elements in C. difficile have previously been described. However, some of 
these target sites have been described before such as the homologue of the CTn2 
target site in which Tn6164 has integrated in strain M120. Although both of these 
elements encode a serine recombinase, the amino acid sequence identity between the 
two  proteins  is  only  66%.  It  is  interesting  that  two  recombinases  with  limited 
homology  can  integrate  two  different  elements  with  little  homology  into  identical 
target sites. Furthermore, it was shown here that 4 different CTn5-like elements in 5 
different strains, some with up to 99% sequence identity with the CTn5 recombinase, 
have all integrated in the homologue of the target site of CTn7 in 630. Presumably, 
because the preferred target site in strain 630 is occupied by CTn7, CTn5 integrated in  
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a different target site.  However, in strains QCD-63Q42 and BI9 CTn5-like and CTn7-like 
elements are present which have integrated in tandem in the homologue of the CTn7 
target site. CTn5 in strain 630 may also be capable of integrating in tandem with CTn7. 
 
In conclusion, I have shown here the presence of 37 novel elements in 16 sequenced 
strains of C. difficile. Most of these elements were shown to be related to CTn1 and 
CTn5 respectively of the Tn916 and Tn1549 families. All strains analysed contained at 
least  one  CTn  of  either  of  these  families  of  elements  although  most  strains  were 
shown to contain multiple elements. The abundance of these elements in the genomes 
suggests  an  important  role  in  the  evolution  of  C.  difficile.  Although  the  accessory 
functions  of  most  of these  elements  are  still  unknown, the  bioinformatics  analysis 
performed here has predicted functions for a number of genes including a number of 
sigma  factors  and  other  types  of  transcriptional  regulators  as  well  as  antibiotic 
resistance proteins of several classes.  
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Chapter 4  Mobility of putative mobile genetic elements 
4.1.  Introduction 
4.1.1. CTns circularize upon excision 
During the evolution of genomes and the MGEs they contain, some MGEs become 
fixed in the genome as a result of mutations in genes associated with mobility. As the 
transfer  of  a  CTn  usually  happens  when  the  element  is  present  as  a  circular 
intermediate,  the  excision  of  the  element  from  the  genome  is  the  first  step  in 
conjugative transfer [127].  
Excision from the chromosome and circularisation of the element can be shown by PCR 
[156]. A primer pair located on the chromosome, flanking the target site, can be used 
to show the regenerated target site is present in a sub-population of the cells. PCR 
using primers on the ends of the element, facing outwards, can be used to amplify the 
joint of the circular intermediate of the element (Figure 4.1). For CTn4 and CTn5 from 
strain 630 this method was previously used to determine the ends of these elements 
[8].  
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Figure 4.1 Schematic representation of a conjugative transposon within the genome and circularized 
after excision.  
The genome is represented in purple lines, the conjugative transposon in blue. a) The conjugative 
transposon is inserted within the genome. b) The conjugative transposon is in its circular form. c) The 
genomic target site is regenerated. Primer pairs 1 & 2 and 3 & 4 are designed to amplify the genome-
element junction, primer pair 1 & 4 to amplify the genomic target site and primer pair 2 & 3 to amplify 
the joint of the circular molecule. 
 
4.1.2. CTn integration sites and copy number 
The integration site of a CTn can be hard to predict in a recipient strain as elements 
often behave differently in different strains. For example, Tn916 has a highly preferred 
target site in CD37, however, in other strains it can insert in a large number of target 
sites. A recent study reported sequencing of 112 unique insertion sites in 630∆erm and 
102 unique insertion sites in R20291 for Tn916 with some transconjugants containing 
up to four copies of the element [155]. These sequences were used to generate a 15 
bp degenerate consensus sequence which was similar for both strains and was present 
over  100,000  times  in  the  genome  of  strain  630∆erm.  This  consensus  sequence  is 
similar to the highly preferred target site in CD37 and is present abundantly in this 
genome, however, the element only integrates in one site in the genome of this strain, 
suggesting that  other factors  beside  the target  sequence play  a  role in  target  site 
selection [155,233].   
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Similarly, Tn5397 has a single preferred target site in C. difficile strain 630, which is 
present twice in strain R20291 and the element can insert in both [163]. This site is not 
present  in  B.  subtilis  and  Tn5397  has  been  reported  in  five  different  sites  [156], 
however, when the sequence from the 630 target site is cloned into B. subtilis, Tn5397 
usually integrates at this site [234]. 
4.1.3. Mobilisation of non-conjugative DNA elements 
The transfer of non-conjugative DNA elements has been reported for a number of 
Gram-positive  organisms.  Transconjugants  from  filter-matings  between  different  B. 
subtilis strains have been shown to inherit not only the conjugative transposon present 
in the donor but also non-conjugative plasmids [235]. This type of in trans mobilisation 
only  requires  the  plasmid  to  encode  an  origin of  transfer  (oriT)  and  a  conjugative 
relaxase  encoded  by  mob  [127].  However,  a  recent  study  has  shown  that  the 
replication  relaxase  encoded  by  rep  and  the  origin  of  replication  oriV,  which  are 
essential  for  plasmid  replication,  together  can  function  to  facilitate  in  trans 
mobilisation [236]. Furthermore, conjugative transposons can also integrate into non-
conjugative  plasmids,  which  can  render  the  plasmid  self-transmissible,  a  process 
known as mobilisation in cis [127,237].  
Transfer of conjugative and mobilisable elements starts when a single strand of the 
DNA is nicked at the oriT. These specific regions usually consist of multiple inverted 
and direct repeats and have a somewhat higher AT ratio than the rest of the sequence 
of the element [134]. Nonetheless, the regions are not easily identified, a number of 
specific sequences has been described for conjugative plasmids but for CTns these 
have  only  been  identified  for  the  extensively  studied  Tn916  and  ICEBs1  and  the 
SXT/R391 family of ICEs [134,236,238].  
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Two types of putative mobilisable elements have been reported in C. difficile, Tn4453 
and  Tn5398.  Mobilisable  transposons  can  excise  from  the  genome  into  a  circular 
intermediate for transposition but while in this state, they can be mobilised in the 
same fashion as mobilisable plasmids [169]. In C. difficile, Tn4453 can be excised from 
the genome by a TnpX serine recombinase protein [82]. Furthermore, the element is 
mobilised by the TnpZ-RSA mobilization system and carries a copy of catP, encoding a 
chloramphenicol resistance gene [82]. Tn5398 is an erythromycin resistance-conferring 
MGE for which the mechanism of transfer is still unknown as no obvious conjugation, 
mobilisation or recombination proteins are encoded by the element [169].  
 
4.1.4. Co-transfer of CTns 
CTns have the ability to enhance the transfer frequency of other CTns. It was shown 
that the transfer frequency of Tn916 and Tn916∆E was higher when both elements 
were present than when only one of these element was present in the donor cell 
[239].  Additionally,  over  half  of  the  transconjugants  resulting  from  these  matings 
contain both of the elements [239]. As Tn916∆E was derived from Tn916 and these 
elements  have  the  same  conjugation  proteins,  it  is  expected  that  the  conjugation 
machinery  of  the  elements  is  shared  in  cells  that  contain  both  elements.  It  is 
conceivable that other related CTns can have similar effects on transfer frequency and 
co-transfer by sharing conjugation machinery. As the C. difficile 630 genome contains 
multiple Tn916 and Tn1549-like elements, transconjugants that were generated in this 
study were analysed to determine if co-transfer of other elements had occurred. 
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4.1.5. ClosTron provides C. difficile targeted mutagenesis tool 
The lack of genetic tools for clostridia has severely held back the study of this genus. 
Chemical transformation and electroporation of C. difficile is currently still not possible 
[190].  For  a  long  time, DNA  could  only  be  introduced  efficiently  using  conjugative 
transposons [131]. Finally, by using a plasmid replicon of the C. difficile plasmid pCD6 
from  strain  CD6  (in  the  literature  also  referred  to  as  R8375),  and  by  evading  the 
restriction modification systems by methylation of the vector or specifically taking out 
the restriction enzyme recognition site of the vector, the first autonomously replicating 
C. difficile shuttle vectors were produced [190].  
Recently  mutagenesis  tools  for  clostridia  have  been  developed.  For  targeted 
mutagenesis, there have been several reports of different systems, however, these 
were  inefficient,  mutation  frequencies  were  not  always  reported  and  plasmids 
inserted into specific genes via single cross-over mutation looped out in a proportion 
of the population [47,107,190,240].  
The  ClosTron  system  is  the first efficient tool for  the production  of  targeted  gene 
knockouts  in  C.  difficile  and  other  clostridia  [241].  The  system  is  based  on  the 
TargeTron system, which is commercially available from Sigma-Aldrich and has been 
validated for the use in a number of organisms [242].  
The TargeTron system is based on retargeting a group II intron into a specific target 
site. Group II introns splice from mRNA into an RNA lariat which is site-specifically 
integrated into a target site by the intron-encoded reverse transcriptase protein, a 
mechanism  called  retrohoming  [243].  The  specific  site  recognised  within  the 
chromosome for reverse splicing is designated the intron binding site (IBS) which is 
complementary to the exon binding site (EBS) encoded by the lariat RNA sequence.  
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The target site can therefore be changed by altering the sequence of the EBS, thus 
allowing  the  retargeting  of  the  intron  to  a  specific  site  (Figure  4.2).  A  computer 
algorithm was designed to identify suitable target sites [244].  
In order to ensure the intron does not splice from its intended target site and integrate 
elsewhere, the reverse transcriptase gene is removed from the sequence and included 
on  the  shuttle  vector  that  is  used  to  introduce  the  intron  into  the  recipient  cell, 
allowing the reverse transcriptase to splice the intron in trans from the target gene 
only if the shuttle vector is present. However, the shuttle vector is an unstable plasmid 
and is lost from the cell after selection is removed [243]. A second selection marker is 
present at the original location of the reverse transcriptase on the group II intron, 
which is interrupted by a self-splicing group I intron [242]. The group I intron can only 
splice from the transcribed group II intron RNA lariat, allowing transcription of the 
resistance determinant only from the group II intron after it has integrated into the 
target  gene  and  not  from  the  shuttle  vector,  a  tool  called  the  retrotransposition-
activated  selectable  marker  (RAM).  After  integration  the  targeted  cells  should  be 
resistant to the RAM encoded resistance and susceptible to the shuttle vector-encoded 
resistance. Integration of the group II intron can be tested for by PCR analysis. 
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Figure 4.2 Group II intron used for retrohoming 
Schematic  representation  of  the  secondary  structure  of  the  group  II  intron.  EBS1  and  2  are 
complimentary to IBS1 and 2, which is recognised by the reverse transcriptase before it integrates the 
group II intron into the chromosomal target site. The non-structural loop LtrA ORF encodes the reverse 
transcriptase,  which  is  replaced  by  the  RAM  in  the  TargeTron.  Figure  taken  from  the  Protocol  for 
clostridial Gene knockout using pMTL007 [245]. 
 
Heap et al. [241] adapted the TargeTron system for use in clostridia. The group II 
intron was cloned into a clostridial shuttle vector and the resistance genes for the RAM 
and shuttle vector were replaced for antibiotics clostridia are susceptible for (Figure 
4.3). Furthermore, an IPTG inducible promotor was cloned in, although in a revised 
system,  this  promotor  was  exchanged  for  the  constitutive  tcdB  promoter  [246]. 
Further  changes  in  the  second  version  of  the  ClosTron  system  was  the  choice  of 
different Gram+ replicons, which enabled the system to be used in C. difficile R20291, 
which was not efficiently targeted by the previous system [246].  
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Figure 4.3 Method of gene disruption by the ClosTron. 
The ClosTron shuttle plasmid is unstable and only maintained under the influence of chloramphenicol 
resistance conferred by catP. The group II intron is transcribed and the group I intron splices from the 
RNA and is lost. The EBS sites on the group II intron were changed to recognise regions in the target 
gene and the reverse transcriptase (blue circular protein) recognises this site and integrates the group II 
intron. After the construct is inserted in the target site it is reverse transcribed. Without the disruption 
of the group I intron, erm(B) can confer erythromycin resistance. 
 
4.1.6. Using the ClosTron system to create selectable markers 
As the putative CTns of strain 630 and R20291 do not contain any known resistance 
genes, ClosTron mutagenesis was used to introduce erm(B), encoding resistance to 
macrolides, lincosamides and streptogramin B antibiotics, into each of the elements 
for which excision from the genome and circularisation was shown. The target sites for 
the ClosTron insertions were chosen in such a way that the chance of affecting the 
mobility functions of the elements was minimised. Target genes were all within the 
predicted accessory modules of the elements [8,138] and were therefore not expected 
to play a role in excision, insertion and / or conjugation.  
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4.2.  Aims of this chapter: 
  Determining  if  the  previously  described  putative  CTns  of  strains  630  and 
R20291 and the novel elements described in Chapter 3 for strains M120, QCD-
66C26, QCD-23M63 and QCD-32G58, are capable of excision from the genome 
and circularisation.  
  Introducing a selectable marker into CTns of strains 630 and R20291 which are 
capable of excision and circularisation. 
  Determining if the CTns of strains 630, R20291 and M120 can transfer via filter-
matings. 
  Determining the number of integration sites and the copy number for the CTns 
in transconjugant cells. 
  Determining  if  co-transfer  of  conjugative  or  non-conjugative  elements  has 
occurred. 
  Determining if transfer is likely to occur by the recently described nanotubes in 
B. subtilis.  
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4.3.   Materials and methods 
4.3.1. C. difficile growth curve 
Cultures of strains 630 and R20291 were grown for approximately 16 h in BHI broth 
and were used 1:10 (v/v) to set up a fresh culture of 20 ml at a starting OD600 of 0.1. 
The OD600 was measured every 60 min for 10 h until the cells were in stationary phase. 
When the OD600 reached above 0.5, the sample was diluted 1:2 and the reading was 
multiplied accordingly. 
4.3.2. Detection of CTn circularisation and excision from the 
chromosome 
In  order  to  amplify  the  joints  between  the  genome-element  junction,  the  circular 
forms and the empty target sites of CTns using PCR, four primers were designed for 
each element to act in 4 separate reactions as shown in Figure 4.1. Each product was 
sequenced in order to define the precise ends of each of the elements. The primers 
used for each of the elements are listed in Table 4.1. 
 
Table 4.1 Oligonucleotides for Tn excision 
Primer   Sequence 5’- 3’   Amplicon 
CTn1 LEO   GGGCTTATCAAGCAATCCAA   0.7 kb 
CTn1 REO   GAAATCTGGTCGGCACTCAT  
CTn1 TSF   GCAAAAGTTGCAGGAATCAT   0.4 kb 
CTn1 TSR   GAGAAAATGGCTCTGCTATGC  
CTn2 LEO   CGAAATTGATCCTGCAATGA   - 
CTn2 LEO2  GTTCCAAGTCCGTTTTCGCT  1.5 kb 
CTn2 REO   GTTCCAAGTCCGTTTTCGCT  
CTn2 TSF   ACCCTCCTAGACCAGGCATT   0.4 kb 
CTn2 TSR   CAACATGAGAAACCAGACGGTA  
CTn3 LEO   CCACTTGATATGAAAAATCAAATGGCTC  0.3 kb 
CTn3 REO   CCGTTCTATGCTGTGTGAGCTG  
CTn3 TSF   GGCGAAAACTGCTTGGATT   0.4 kb 
CTn3 TSR   CCTTTGTTTTCTACATCAAGTATAGCC  
CTn4 LEO   TGAACCCCAAAGCATTGCAG   0.7 kb  
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Primer   Sequence 5’- 3’   Amplicon 
CTn4 REO   TGGTGGTTGCTCATAACCG  
CTn4 TSF   GGATAATGCAATAGAAGCATGTG   0.5 kb 
CTn4 TSR   CATATCACCTTCCTATCCAATTCTT  
CTn5 LEO   CATCCCACCTGATAGGCAAG   1.3 kb 
CTn5 REO   GATGCCGTTGCTGAGGTAAT  
CTn5 TSF   GCGCCATTGGAAATGACTAT   0.6 kb 
CTn5 TSR   CCAGTCCATGGTTGAAAAGTT  
CTn6 LEO   CCAAAGACGCAAGCCAGTAT   0.6 kb 
CTn6 REO   CGGCAGGGAGGATAACTACA  
CTn6 TSF   CGCTCTTGCCCATATTTCAG   0.8 kb 
CTn6 TSR   CGCATCAGGAACATTGACTA  
CTn7 LEO   GACCCTGCACAGTTGACCTT   0.5 kb 
CTn7 REO   CTTGTGAGCTTCGCCATACT  
CTn7 TSF   CCGAAATCGCTTTACAGTGG   0.3 kb 
CTn7 TSR   CCCACCTAGAAAGGGATGTG  
R20291 CTn1 LEO   GTGAGGGATTGCCAAAGGTA   0.6 kb 
R20291 CTn1 REO   CGGCACTCATACGGGTACTT  
R20291 CTn1 TSF   GATTCGTTAAATGCCTCTTTATTG   0.6 kb 
R20291 CTn1 TSR   GAGTGAAGAAGACTGGTTGACAGA  
R20291 Tn6103 LEO   CCAACCATTGGTATTCCGTA   1.3 kb 
R20291 Tn6103 REO   GATGCCGTTGCTGAGGTAAT  
R20291 Tn6103 TSF   GCGCCATTGGAAATGACTAT   0.6 kb 
R20291 Tn6103 TSR   CCAGTCCATGGTTGAAAAGTT  
R20291 Tn6104 LEO   GCTCATGTCCTTGATGACGA  0.6 kb 
R20291 Tn6104 REO   GCTCTGGTCGGACAAGGTAG 
R20291 Tn6104 TSF   GCTTGAAGATAACGGATATGAGATAA  0.7 kb 
R20291 Tn6104 TSR   CTCTCTTGAACGGATTGTTGC  
R20291 Tn6105 LEO   GCTTTCAGTTCCTCGGTGAC  0.6 kb 
R20291 Tn6105 REO   GATGTTCCATACCGAGCAGG 
R20291 Tn6105 TSF   GTATAGGCGGACGATTACC  0.4 kb 
R20291 Tn6105 TSR   CATTTTCCACCGTCCATTAC 
R20291 Tn6106 LEO   CTCACAATTCAGCGTTTCGC  0.5 kb 
R20291 Tn6106 REO   CCATTCAGGAATACGCCAAT 
R20291 Tn6106 TSF   CTTTGAAAAAGGCGATTTGA  1.0 kb 
R20291 Tn6106 TSR   GGTTGAAATAGCAACTACAGTTC 
23M63 CTn1 LEO   GAAGCCCGTACACAATCGTT   0.9 kb 
23M63 CTn1 REO   GGGCTTATCAAGCAATCCAA  
23M63 CTn1 TSF   GGCTTCTTTAATTTGCTCTTTA   1.0 kb 
23M63 CTn1 TSR   GGTTGTGTTTGCAGCTGTTA  
23M63 CTn5 LEO   CGCCTTTGGTAACCATTTGT   1.0 kb 
23M63 CTn5 REO   GCATTGAAGAAAAGGCTTGAG  
23M63 CTn5 TSF   GGGAAGGCAGAGGAAATTGT  0.8 kb 
23M63 CTn5 TSR   GCTAAAGGAATCTTGGAATTTGG 
66C26 CTn1 LEO   GTGAGGGATTGCCAAAGGTA   0.6 kb 
66C26 CTn1 REO   CGGCACTCATACGGGTACTT  
66C26 CTn1 TSF   GATTCGTTAAATGCCTCTTTATTG   0.6 kb 
66C26 CTn1 TSR   GAGTGAAGAAGACTGGTTGACAGA  
66C26 CTn5 LEO   CGCCTTTGGTAACCATTTGT  1.3 kb 
66C26 CTn5 REO   GCATTGAAGAAAAGGCTTGAG 
66C26 CTn5 TSF   GGGAAGGCAGAGGAAATTGT  0.6 kb  
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Primer   Sequence 5’- 3’   Amplicon 
66C26 CTn5 TSR   GCTAAAGGAATCTTGGAATTTGG 
32G58 CTn1 LEO   GTGAGGGATTGCCAAAGGTA   0.6 kb 
32G58 CTn1 REO   CGGCACTCATACGGGTACTT  
32G58 CTn1 TSF   GATTCGTTAAATGCCTCTTTATTG   0.6 kb 
32G58 CTn1 TSR   GAGTGAAGAAGACTGGTTGACAGA  
32G58 CTn5 LEO   CCAACCATTGGTATTCCGTA  1.3 kb 
32G58 CTn5 REO   GATGCCGTTGCTGAGGTAAT 
32G58 CTn5 TSF   GTCTGGAAATCACCTCCTCATT  0.6 kb 
32G58 CTn5 TSR   TGGAAAGGCAGAGGAAATTG 
43255 CTn1 LEO   GTGAGCTTGCGTCTGTTCTG  1.2 kb 
43255 CTn1 REO   CGTGAGCTTCCATTGACAGA 
43255 CTn1 TSF   GGAGAAGATGGGAAGAGTTCAA  1.0 kb 
43255 CTn1 TSR   GAAACCAAACAATAAGGGCG 
M120 Tn6164 LEO  TCTATCCTGCCTTCTCAACC  0.5 kb 
M120 Tn6164 REO  GAGGAATTTAACAGAACAGTATTT 
M120 Tn6164 TSF  GTTTATTGCTGGGGATGTGG  0.5 kb 
M120 Tn6164 TSR  CATTGATGAAGTACCACCTATTGC 
M120 Phage REO  GGAAATGCCAAGGGACAATA  0.5 kb 
M120 Phage TSR  TATGGAGATGTTGGCAGTGG 
M120 Phage REO2  CGAATCGCTGAAATGACTGA  0.5 kb 
M120 Phage TSR2  GGCAGTAACAATTCCGTGCT 
 
4.3.3. ClosTron mutagenesis 
In this study, several mutants were generated using the ClosTron system. The original 
system consisted of designing a retargeting sequence and cloning this sequence into 
the shuttle vector pMTL007 [241]. After the plasmid has been transferred into the 
target  C.  difficile  strain,  expression  of  the  gene  encoded  on  the  group  II  intron  is 
induced by IPTG. 
For  the  refined  ClosTron  protocol,  the  plasmids  can  be  ordered  commercially. 
Furthermore, the group II intron is expressed constitutively, making the IPTG induction 
unnecessary [246].   
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4.3.3.1.  ClosTron mutagenesis with original protocol 
ClosTron  mutagenesis  was  performed  as  described  by  Heap  et  al.  [241].  Suitable 
ClosTron target sites were identified using the TargeTron algorithm at the TargeTron 
design site for which access was gained through the TargeTron Gene Knockout System 
kit (Sigma-Aldrich Ltd). Primers were designed by the algorithm and synthesized by 
Sigma-Aldrich Ltd, primers IBS, EBS1d and EBS2 are target site specific, primer EBS 
universal  is  common  to  all  PCRs  for  intron  retargeting  (Table  4.2).  The  ClosTron 
plasmids were constructed as described by Heap  et al. [241] and sequenced using 
primers  5402F-F1  and  pMTL007-R1  to  confirm  the  correct  sequence  for  intron 
retargeting. The plasmids were conjugated into C. difficile 630∆erm and presence of 
the plasmid was checked by performing a colony PCR on the sub-cultured plates using 
the  ErmRAM-F  and  ErmRAM-R  primers  (Table  4.2).  Colonies  that  were  shown  to 
contain the non-spliced ErmRAM product, a 1.3 kb PCR product, were used for the 
IPTG induction. After this, mutants were selected on BHIB plates containing 40 μg/ml 
lincomycin  and  C.  difficile  selective  supplement  instead  of  25  μg/ml  erythromycin. 
Colonies were sub-cultured onto fresh selective plates and checked by PCR with the 
ErmRAM-F and ErmRAM-R primers to contain the integrated intron with an expected 
size of 0.9 kb. After this, PCR was performed for the specific target site using ErmRAM-
F and Target-R as well as Target-F and ErmRAM-R (Table 4.2) (Figure 4.4). PCR products 
for these PCR reactions were all sequenced to confirm the intron is integrated in the 
correct target site. 
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Figure 4.4 PCR screening for intron integration. 
The intron on the plasmid is represented by the upper yellow arrow. The intron integrated in the target 
site is shown by the lower yellow arrow. The red arrows show the interrupted target site. The blue 
arrows represent the ErmRAM, which in the upper schematic is interrupted by the group I intron, shown 
as a grey arrow. PCR primers are represented by black half-arrows. Reproduced from the protocol for 
clostridial Gene Knockout using pMTL007 [245]. 
 
Table 4.2 Oligonucleotides for ClosTron mutagenesis  
As numerous primer combinations were used, the expected amplicon sizes are not shown. 
Primer  Sequence 5’-3’ 
EBS universal  CGAAATTAGAAACTTGCGTTCAGTAAAC 
IBS CD0364 
AAAAAAGCTTATAATTATCCTTATGACACAGAAA
TGTGCGCCCAGATAGGGTG 
EBS1d CD0364 
CAGATTGTACAAATGTGGTGATAACAGATAAGTC
AGAAATGTTAACTTACCTTTCTTTGT 
IBS CD0386/CD3392 
AAAAAAGCTTATAATTATCCTTAGTCATCCATTA
CGTGCGCCCAGATAGGGTG 
EBS1d CD0386/CD3392 
CAGATTGTACAAATGTGGTGATAACAGATAAGTC
CATTACTTTAACTTACCTTTCTTTGT 
EBS2 CD0386/CD3392 
TGAACGCAAGTTTCTAATTTCGATTATGACTCGA
TAGAGGAAAGTGTCT 
IBS CD1873  AAAAAAGCTTATAATTATCCTTATAAAACATTTA
CGTGCGCCCAGATAGGGTG 
EBS1d CD1873 
CAGATTGTACAAATGTGGTGATAACAGATAAGTC
ATTTACCATAACTTACCTTTCTTTGT 
EBS2 CD1873 
TGAACGCAAGTTTCTAATTTCGGTTTTTTATCGA
TAGAGGAAAGTGTCT 
pMTL007-R1  AGGGTATCCCCAGTTAGTGTTAAGTCTTGG 
5402F-F1  TTAAGGAGGTGTATTTCATATGACCATGATTACG 
CD0364 TSF  GATTAAAGCCCTCGCACAAG 
CD0364 TSR  CGTAACCAGCGGACACATTA 
CD0386/CD3392 TSF  CCCAAAATGAAAGGAGCATT 
CD0386/CD3392 TSR  GCGTCCGCTAATTTTGTGAT 
CD1873 TSF  CAATAATGAAATCAAGCAATGAAA 
CD1873 TSR  GCTTCGAGTGAAACAACATTCT 
CD0428 TSF  CATGGAATCTTCGCATCAGA 
CD0428 TSR  GCGAATGTCCTCACTAACCG 
CD1099 TSF  GTCCATACCGGGCATCATAA 
CD1099 TSR  CAGAAAGGACGGGTGTTGTT  
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Primer  Sequence 5’-3’ 
ErmRAM-F  ACGCGTTATATTGATAAAAATAATAATAGTGGG 
ErmRAM-R  ACGCGTGCGACTCATAGAATTATTTCCTCCCG 
 
4.3.3.2.  ClosTron mutagenesis 2.0 with refined protocol 
The intron target site and the intron redirection sequence were determined using the 
Intron  targeting  and  design  tool  as  described  by  Heap  et  al.  [246].  The  intron 
redirection sequence was ordered to be cloned into vector pMTL007C-E5 (DNA2.0, 
Menlo Park, USA).  
ClosTron mutants were constructed as described by Heap et al. [246] with the only 
modification  that  mutants  were  selected  on  BHIB  agar  plates  containing  40  μg/ml 
lincomycin. PCR was used to determine if the ErmRAM had spliced and to determine if 
the intron had inserted in the desired target site as described above. 
 
4.3.4. Filter-matings 
Filter-matings were performed as described in Chapter 2. ClosTron mutants were used 
as  donor  strains  for  CTn1  (630∆erm  CD0364::ErmRAM  and  630∆erm 
CD0386::ErmRAM),  CTn2  (630∆erm  CD0428::ErmRAM),  CTn4  (630∆erm 
CD1099::ErmRAM),  CTn5  (630∆erm  CD1873::ErmRAM),  CTn7  (630∆erm 
CD3392::ErmRAM) and Tn6103 (R20291 1803::ErmRAM). CD37 and B. subtilis CU2189 
were used as recipient strains. The filter-matings with R20291 1803::ErmRAM as donor 
were performed using C. difficile 630∆erm, CD37 and B. subtilis CU2189 as recipients. 
Strain M120 was used as donor for the elements Tn6164 and Tn6190 where CD37 was 
used as recipient strain.  
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Serial dilutions of the mixture of donor, recipient and transconjugant cells from the 
filters were set up to determine the cell counts for donor and recipient cells. Donor 
cells of the elements containing the ClosTron insertion were selected on lincomycin 40 
µg/ml plates. M120 donor cells were selected on tetracycline 10 µg/ml plates. CD37 
recipient cells were selected on rifampicin 25 µg/ml plates. B. subtilis CU2189 recipient 
cells were selected on antibiotic free plates incubated in aerobic conditions. 630∆erm 
recipient cells were selected on tetracycline 10 µg/ml plates. 
CD37 transconjugant cells were selected on lincomycin 40 µg/ml and rifampicin 25 
µg/ml  plates  or  tetracycline  10  µg/ml  and  rifampicin  25  µg/ml  plates.  B.  subtilis 
CU2189  recipient  cells  were  selected  on  lincomycin  40  µg/ml  plates  incubated  in 
aerobic conditions. 630∆erm recipient cells were selected on lincomycin 40 µg/ml and 
tetracycline 10 µg/ml plates. 
Identity of the transconjugants was confirmed by two sets of PCRs, one using a primer 
pair that is specific for the recipient strain and using a primer pair that is specific for 
the CTn that was transferred (Table 4.3, Table 4.4). For elements that contain erm(B) 
introduced by the ClosTron system, the ErmRAM primers were used. The 16S PCR 
product of B. subtilis was sequenced and checked using BLASTn. 
 
Table 4.3 Primers for the detection of CTns in transconjugant cells. 
Element  Primer  Sequence 5’-3’  Amplicon 
ClosTron  ErmRAM-F 
ACGCGTTATATTGATAAAAATAATAATA
GTGGG 
0.9 kb 
  ErmRAM-R 
ACGCGTGCGACTCATAGAATTATTTCCT
CCCG 
Tn6164  Tn6164 Acc reg-F  CAGCTGCAGTTTTTCCATGA 
0.5 kb 
  Tn6164 Acc reg-R  GCAGCTAACGGTGATGACAA 
Tn6190  Tn916Int-F  GACGGAAGATACTTATACA 
1 kb 
  Tn916Int-R  GCCTTTGGATTCATTCCTGC  
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Table 4.4 Primers for the identification of the transconjugants. 
CD37 is negative for the Binary toxin PCR but positive for the Lok PCR that amplifies the region in which 
the  PaLoc  has  integrated  in  toxigenic  strains  (Braun  et  al.  1996).  The  16S  primers  were  previously 
described in (Weisburg et al. 1991). The CD0242 primer pair partially amplifies CD0242 in strains 630 
and 630∆erm, a CDS not present in R20291. Y=(C/T) 
Strain  Primer  Sequence 5’-3’  Amplicon 
CD37  Binary toxin-F  YAATACTACTTACAAGGCTCC 
0.4 kb 
  Binary toxin-R  TTTCGTTTTGATTTTYTGTTC 
  Lok1  AAAATATACTGCACATCTGTATAC 
0.6 kb 
  Lok3  TTTACCAGAAAAAGTAGCTTTAA 
630∆erm  CD0242-F  GTAAACTGTGCAGGTAGAGGAAG 
0.6 kb 
  CD0242-R  CCTCAATTCAACATGAGCTAT 
B. subtilis  16S F  AGAGTTTGATCMTGGCTCAG 
1.4 kb 
  16S R  TACGGYTACCTTGTTACGACTT 
 
4.3.5. Southern blotting 
Southern blots were carried out using the Amersham ECL Direct Nucleic Acid Labelling 
and  Detection  System  (GE  Healthcare,  Bucks,  UK)  according  to  the  manufacturer’s 
instructions.  
DNA was digested overnight using HindIII at 37 °C. The DNA sample was loaded onto a 
0.9% agarose gel and run overnight at low voltage (20V). The DNA was blotted onto a 
Hybond N+ nylon membrane (Amersham, UK) by capillary blotting. The DNA was UV-
fixed to the nylon membrane using a UV Stratalinker 1800 (Stratagene, Cheshire, UK). 
The membrane was pre-hybridized in hybridization buffer for 1-3 h before the labeled 
probe was added.  
Probes were prepared by standard PCR amplification and gel extraction as described in 
Chapter 2. Probes were constructed using primers listed in Table 4.5. The probe and 
DNA  marker  were  labeled  in  separate  reactions  and  both  were  mixed  into  the 
hybridization buffer for hybridization.   
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After  hybridization,  the  membrane  was  washed  and  10  ml  detection  reagent  was 
spread onto the membrane. After 1 min incubation the reagent was drained on a piece 
of filter paper and wrapped in plastic foil in a film cassette. In a dark room, a sheet of 
Hyperfilm ECL (Amersham, UK) was exposed in the film cassette for initially 1 minute. 
Depending  on  the  signal  that  was  visible  on  this  film  a  second  sheet  of  film  was 
exposed for 1 to 16 h. Films were developed using an AGFA CURIX 260 (AGFA, UK). 
 
Table 4.5 Primers used for the Southern blot probe construction. 
Primer   Sequence 5’-3’  Amplicon 
CD0355 958F  GGTATGGTGCGAGGACTGAT  0.2 kb 
CD0355 1184R  GCCAGTCTTTCCAGTTCTGC 
CD0436 48F  AACTGCATCAGGCTGTGTTG  0.4 kb 
CD0436 443R  GTCAAAAGCAATTCGCCATC 
CD0511 1215F  CGAGCGGAAGTCAGAAGATT  0.2 kb 
CD0511 1399R  GCTTTGCACTACCTCTGCTTG 
CD1091 691F  GGATTGACGGAAGCTGACAT  0.2 kb 
CD1091 928R  CGTTCCGGTTAAGGAACAGA 
CD1878 904F  GGCAAGAACATGAGGACACA  0.2 kb 
CD1878 1122R  CTCAGCAACGGCATCATCTA 
CD3370 447F  TTCTGTTGCACAGCAGGAAG  0.2 kb 
CD3370 647R  CCAGCACCATCAACATAACG 
 
4.3.6. PCR analysis for detection of co-transfer 
To  perform  the  analysis  of  co-transfer  and  to  confirm  the  identity  of  each  of  the 
transconjugants, PCR analysis was performed on each sample with a number of primer 
pairs, all listed in Table 4.6.   
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Table 4.6 PCR primers for CTn detection.  
Primer pair CD0364 F+R is for the detection of the presence of CTn1. Primer pair CD0428 F+R is for the 
detection of the presence of CTn2. Primer pair CD1873 F+R is for the detection of the presence of CTn5. 
Primer pair CD0511 F+R is for the detection of the presence of Tn5397. Primer pair 9371 F + 9387 R is for 
the detection of the presence of Tn5398. Primer pair tcdB 3120 F + 3521 R is for the detection of the 
presence of tcdB encoded on the PaLoc. Primer pair Lok1 + Lok3 is for the detection of the empty target 
site of the PaLoc. Primer pair cdtA F+R is for the detection of the presence of cdtA encoded on the 
binary toxin locus. 
Primer   Sequence 5’- 3’   Amplicon 
CTn1 CD0364 F  GATTAAAGCCCTCGCACAAG  0.3 kb 
CTn1 CD0364 F  GCGTCCGCTAATTTTGTGAT 
CTn2 CD0428 F  CATGGAATCTTCGCATCAGA  0.4 kb 
CTn2 CD0428 R  GCGAATGTCCTCACTAACCG 
CTn5 CD1873 F  CAATAATGAAATCAAGCAATGAAA  0.2 kb 
CTn5 CD1873 R  GCTTCGAGTGAAACAACATTCT 
Tn5397 CD0511 F  CGAGCGGAAGTCAGAAGATT  0.2 kb 
Tn5397 CD0511 R  GCTTTGCACTACCTCTGCTTG 
Tn5398 9371F  GGATAGAAATACTCGTCAACAG  0.9 kb 
Tn5398 9387 R  ATTTTTTATTTTTAGGAGTCATA 
tcdB 3120 F  AGGTGCAGCAATCAAAGAGC  0.4 kb 
tcdB 3521 R  CCACCTTCCATTCTCCAGAT 
Lok1  AAAATATACTGCACATCTGTATAC  0.6 kb 
Lok3  TTTACCAGAAAAAGTAGCTTTAA 
cdtA F  YAATACTACTTACAAGGCTCC  0.3 kb 
cdtA R  TTTCGTTTTGATTTTYTGTTC 
4.3.7. Nanotube transfer of antimicrobial resistance proteins 
CD37,  R20291,  CD37  pMTL960/GusA  and  R20291  pMTL9301  were  grown  for  16  h 
(section  2.1).  CD37  pMTL960/GusA  and  R20291  pMTL9301  were  grown  in  broth 
supplemented with 30 μg/ml thiamphenicolor 40 μg/ml lincomycin, respectively. 30 μl 
of each culture was spotted on an antibiotic free BHIB agar plate, as well as a mixture 
of  equal  volumes  of  CD37  pMTL960/GusA  and  R20291  pMTL9301.  After  4  h  of 
incubation, the cells were replica plated onto BHIB agar plates supplemented with 30 
μg/ml  thiamphenicol,  40  μg/ml  lincomycin,  30  μg/ml  thiamphenicol  and  40  μg/ml 
lincomycin or antibiotic free. Plates were incubated for 24 h at 37°C before growth was 
assessed. 
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4.4.  Results 
4.4.1. Circularisation of CTns in different growth phases 
A growth curve was performed to determine the growth phases of C. difficile (Figure 
4.5.a). Genomic DNA samples of strains 630 and R20291 were isolated from cells in lag, 
exponential and stationary phase, respectively after 2 h, 5 h or 10 h of growth. These 
samples were used as template in PCR reactions to determine when the CTns excise. 
CTn1,  CTn2,  CTn4,  CTn5,  CTn7  and  Tn5397  excised  in  all  of  these  growth  phases 
whereas excision of CTn6 could not be detected. An example is shown for CTn1 (Figure 
4.5.b + c). The template DNA of strain R20291 was used a control; the homologue of 
the  CTn1  target  site  in  R20291  is  empty  and  was  expected  to  generate  a  similar 
product as seen for the target site of CTn1 in 630. Primers for the product of the joint 
of the circular intermediate are the LEO + REO primers, the joint of the empty target 
site is amplified by the TSF + TSR primers (Table 4.1).  
 
Sebaihia et al. [8] have predicted the size and the ends of the putative CTns based on 
the  630  genomic  sequence.  The  primers  used  here  were  designed  using  these 
predictions.  For  CTn2,  the  PCR  with  the  CTn2  LEO  +  REO  amplifying  the  circular 
intermediate did not produce any product. PCR for the regenerated target site with 
CTn2 TSF + TSR was larger than expected. Sequencing of this product showed that the 
region CD0404 - CD0406 was present in the regenerated target site. Primer CTn2 LEO2 
was designed further into the left side of CTn2 that resulted in a product of the circular 
intermediate of CTn2. This confirms that the region CD0404 - CD0406 is not part of the 
element (Figure 4.6).  
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Figure 4.5 Excision of CTn1 in different growth phases. 
Excision  of  CTn1  from  the  genome  into  a  circular  intermediate  was  shown  in  lag,  exponential  and 
stationary growth phases. a) Growth curve for C. difficile strains to determine the growth phases. DNA 
samples were extracted for stationary phase after 1 h growth, for exponential phase after 4 h growth 
and for stationary phase after 8 h growth. b)  PCR product of the joint of the circular intermediate 
generated with primers CTn1 LEO + REO. c) PCR product of the regenerated target site generated with 
primers CTn1 TSF + TSR. The template for each reaction is shown below the lanes. C is strain 630, R is 
strain R20291. Lag is lag phase, Exp is exponential phase, Stat is stationary phase. The left lane in b) and 
c) is the molecular weight marker. 
 
Figure 4.6 ORFs of CTn2 
ORFs shown in blue are part of CTn2 and are present in the circular form of the element. ORFs shown in 
red were previously predicted to be part of the element but were shown to remain in the regenerated 
target site in the genome after the element excised. The green arrow represents primer CTn2 LEO that 
could not produce a PCR product of the circular molecule with primer CTn2 REO shown in red. The blue 
arrow represents primer CTn2 LEO2 that amplified the circular intermediate of CTn2 with CTn2 REO.  
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4.4.2. Circularisation of C. difficile CTns 
PCR  was  carried  out  using  primers  to  amplify  the  junctions  of  the  circular 
intermediates of the CTns from strains 630, R20291, M120, QCD-23M63, QCD-66C26, 
QCD-32G58 and ATCC-43255. These PCRs were performed with the Left End Out and 
Right End Out (LEO and REO) primers (Table 4.1). In addition, the regenerated target 
site in the chromosome was amplified with the Target Site Forward and Target Site 
Reverse (TSF and TSR) primers (Table 4.1). The element-chromosome junctions were 
amplified with primer pairs LEO + TSF and REO + TSR. Products of the expected size 
were obtained for CTn1, CTn2, CTn4, CTn5 and CTn7 from strain 630, Tn6103 from 
R20291,  Tn6073  and  Tn6107  from  QCD-23M63,  Tn6115  from  QCD-63Q42,  Tn6110 
from QCD-66C26, Tn6111 from QCD-32G58 and Tn6164 from M120. An example for 
this is shown for CTn5 in Figure 4.7. These PCR products were sequenced to determine 
the direct repeats on either side of the element (Figure 4.8).  
 
Figure 4.7 PCR products to show excision of CTn5 from the chromosome.  
PCRs were carried out for the joints of the circular molecule, the regenerated target site and the ends of 
the transposon in the chromosome. Lane 1 is product of the joint of the circular intermediate of CTn5 
using primers CTn5 LEO+REO. Lane 2 is product of the regenerated target site within the chromosome 
using primers CTn5 TSF+TSR. Lane 3 and 4, respectively, are products of the left and right junctions of 
the  element  and  the  chromosome  using  primer  pairs  CTn5  TSF+LEO  and  TSR+REO.  Template  in  all 
reactions was DNA of 630 isolated from the exponential growth phase. Lane M is a molecular weight 
marker. Size of the fragments is shown left of the figure.   
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CTn1, CTn4 and Tn6073 all encode predicted tyrosine recombinases and an excisionase 
which  are  predicted  to  be  responsible  for  the  excision  and  integration  of  these 
elements. CTn2, CTn5, CTn7, Tn5397, Tn6103, Tn6104, Tn6107, Tn6110, Tn6111 and 
Tn6164 all encode predicted serine recombinases which are probably responsible for 
the excision and integration of these elements.  
126 
 
Figure 4.8 Sequences of transposon-chromosome junctions and direct repeat sequences  
Sequences of the PCR products of the joint of the circular molecule, the joint of the chromosome-CTn 
junction and the regenerated target site of each of the CTns which were shown to excise from the 
chromosome. Bases in red are part of the CTn, bases in blue are part of the chromosome, and bases in 
black and underlined are the direct repeat sequences at the ends of the elements.  
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For the putative mobilisable transposon Tn6104, located on Tn6103 in R20291, only 
the product for the circular intermediate of the element was amplified (Figure 4.9). 
Amplification of the empty target site could not be shown. For the two other putative 
mobilisable transposons within Tn6103, Tn6105 and Tn6106, only products for the 
joints of the elements in the chromosome could be amplified. This suggests that these 
elements did not excise from the chromosome in the bacterial population tested. 
 
Figure 4.9 Excision of Tn6104.  
PCR amplification of the joint of the circular intermediate of the putative mobilisable transposon Tn6104 
demonstrates the element excises from Tn6103. Tn6103 is shown in blue, Tn6104 is shown in orange, 
Tn6105 is shown in purple, Tn6106 is shown in green. The elements are not drawn to scale. 
 
The joint of the empty target site or the circular intermediate could not be amplified 
for the CTn1-like elements in strains R20291, QCD-66C26 and QCD-32G58, indicating 
these  elements  did  not  excise  from  the  chromosome  in  the  tested  bacterial 
populations. Strain ATCC-43255 contains a CTn1-like element which has integrated in 
skin
Cd, see Chapter 3. Although circularization of the CTn1-like element could not be 
shown here, circularization of the skin
Cd, which includes the CTn1-like element was 
previously shown in this strain [179].  
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4.4.3. ClosTron mutagenesis 
Using the original ClosTron protocol [241], the intron was retargeted to two locations 
in CTn1 in separate isolates of 630∆erm. The first location was in CD0364, an ABC 
transporter ATP binding protein, the second in CD0386, a putative cell surface protein. 
CTn7  has  a  homologue  of  this  cell  surface  protein,  CD3392,  which  could  also  be 
targeted by the same ClosTron construct (Figure 4.10). Sequencing of the intron-target 
site junctions of six mutants demonstrated that in half of the mutants, the intron was 
inserted in CD0386 and in half of the mutants the intron was inserted in CD3392. 
The ClosTron 2.0 protocol [246] was used with 630∆erm to retarget the intron to CTn2 
CD0428,  a  predicted  AraC  transcriptional  regulator.  For  CTn4,  the  intron  was 
retargeted to CD1099, a predicted two component response regulator. For CTn5, the 
intron  was  retargeted  to  CD1873,  a  predicted  ABC  transporter  permease  protein 
(Figure 4.11).  
Strain  R20291  contains  Tn6103,  which  is  85%  identical  to  CTn5.  The  intron  was 
retargeted  in  this  strain  using  the  same  construct  used  for  CD1873  on  CTn5. 
Sequencing of the intron-genome junction confirmed the ClosTron had inserted in ORF 
1803, the homologue of CD1873 on CTn5 (Figure 4.12).  
PCR was used to confirm that the introduction of the intron did not prevent excision of 
the elements from the genome.  
 
Figure 4.10 ClosTron insertions in CTn1 and CTn7. 
ORFs that were shown to contain the ClosTron insertion are shown in pink, the integration sites of the ClosTron constructs are indicated by red arrows. ORFs in the recombination 
module are shown in grey. ORFs on the conjugation module are shown in blue. ORFs on the accessory module are shown in green.  
 
 
Figure 4.11 ClosTron insertions in CTn2, CTn4 and CTn5. 
ORFs that were shown to contain the ClosTron insertion are shown in pink, the integration sites of the ClosTron constructs are indicated by red arrows. ORFs in the recombination 
module are shown in grey. ORFs in the conjugation module are shown in blue. ORFs in the accessory module are shown in green.  
 
Figure 4.12 ClosTron insertion in Tn6103.  
The schematic of Tn6103 is shown as two parts which should be joined at the grey diagonal line. ORF 1803 that was shown to contain the ClosTron insertion is shown in pink, the 
integration site of the ClosTron construct is indicated by a red arrow. ORFs on the recombination module of Tn6103 and the recombinases of Tn6104, Tn6105 and Tn6106 are 
shown in grey. ORFs on the conjugation module of Tn6103 are shown in blue. ORFs on the accessory module are shown in green. ORFs that were interrupted by an insertion of a 
DNA fragment, compared to CTn5, are shown in orange. ORFs of the putative mobilisable elements Tn6104, Tn6105 and Tn6106 are shown in yellow.  
132 
4.4.4. Conjugative transfer of CTns and analysis of transconjugants 
4.4.4.1.  Conjugative transfer of CTn1 can occur with co-transfer 
of CTn5 and Tn5397 
Conjugative  transfer  of  CTn1  was  carried  out  using  the  donor  strains  630∆erm 
containing erm(B) in the ABC-transporter gene (CD0364) or in the cell surface gene 
(CD0386)  (Figure  4.10)  using  C.  difficile  CD37  and  B.  subtilis  CU2189  as  recipients. 
Transconjugants were only detected where CD37 was recipient. Donor, recipient and 
transconjugant  cell  numbers  were  determined  and  the  transfer  frequency  was 
calculated as the number of transconjugant cells per donor cell (Table 4.7). Putative 
transconjugants were sub-cultured onto fresh selective plates and screened by PCR to 
confirm the CTn is present by amplifying the ErmRAM. 
Table 4.7 Transfer frequencies of CTn1.  
The transfer frequency was calculated per filter as the number of transconjugants that resulted from a 
filter-mating, divided by the number of donor cells present on the filter. Each filter-mating experiment 
consisted of four technical replicates and each experiment was repeated at least three times. The mean 
of  the  transfer  frequency  and  standard  deviation  were  calculated  from  the  frequencies  of  each 
independent filter. The detection limit for the filter-matings is approximately 10
-9 transconjugants per 
donor. 
Original 
element 
(strain) 
Gene containing 
the ClosTron 
insert 
Recipient strain  Frequency of 
transconjugants per 
donor (σ)  
CTn1 
(630erm) 
CD0364   CD37  7.0 x 10
-9  (9.0 x 10
-9)
  
    B. subtilis CU2189  < 10
-9 
CTn1 
(630erm) 
CD0386   CD37  2.0 x 10
-8  (1.7 x 10
-8)  
    B. subtilis CU2189  < 10
-9 
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PCR analysis was carried out on all transconjugants to detect co-transfer of elements 
that were not selected for in the filter-matings. Examples of the PCR results are shown 
in Figure 4.13 including results for the transconjugants described below in sections 
4.4.4.1 - 4.4.4.5.  
The control primer pairs tcdB and PaLoc TS are expected to be mutually exclusive as 
these generate a product from tcdB within the PaLoc and the empty PaLoc target site 
in the genome, respectively. As expected, all transconjugants generated a product with 
only one of these primer pairs. As a number of isolates were positive for tcdB, a second 
control PCR was performed with cdtA primers, amplifying the gene encoding one of 
the peptide chains of the binary toxin on the CDT locus, which is absent in CD37 [58]. 
PCR analysis using this primer pair was carried out by Dr. P. Warburton. The tcdB and 
cdtA primers generated products of the expected size in the transconjugant samples 
CD0364-4, CD0386-7 + 8, CD1099-2 + 4 and CD3392-6. All of the CTns tested for were 
also present in these samples and these were concluded to be donor isolates that 
became rifampicin resistant by spontaneous mutation. These isolates will be indicated 
in the relevant sections.  
PCR  results  for  the  transconjugants  of  CTn1  are  summarised  in  Table  4.8.  Isolates 
CD0386-5, 6 and 11 contain copies of Tn5397. Sub-culturing these isolates on plates 
containing  tetracycline  confirmed  that  these  isolates  had  become  tetracycline 
resistant, as expected. Furthermore, CTn5 was also detected in CD0386-6. The transfer 
of  these  elements  had  not  been  selected  for  in  the  filter-matings.  Additionally, 
CD0386-6 also contains a copy of the PaLoc but is negative for other 630 specific CTns 
and is also negative for cdtA encoded on the binary toxin locus. This transconjugant is 
further analysed in Chapter 5.  
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Figure 4.13  PCR results for the analysis of co-transfer in CD37 transconjugants.  
Examples of each of the PCR reactions are shown. The order of the templates for each reaction is similar 
to the samples of the previously performed Southern blots. a) Template CTn1 transconjugants, primers 
Tn5397  CD0511  F+R.  b)  Template  CTn2  transconjugants,  primers  CTn1  CD0364.  b)  Template  CTn2 
transconjugants, primers CTn1 CD0364 F+R. c) Template CTn7 transconjugants, primers CTn2 CD0428 
F+R. d) Template CTn4 transconjugants, primers CTn5 CD1873 F+R. e) Template CTn5 transconjugants, 
primers Tn5398 9371F  + 9387R. f)  Template  CTn4 transconjugants, primers PaLoc TS Lok1+Lok3. g) 
Template CTn7 transconjugants, primers tcdB 3120F + 3521R.  
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Table 4.8 Summary of PCR analysis on transconjugants of CTn1 filter-matings.  
PCR reactions that contain a product of the expected size are shown in green, reactions that do not 
contain the expected product are red. Template 1-13 are putative transconjugant DNA, CD37 and 630 
are positive and negative controls. Primers: CTn2 CD0428 F+R, CTn5 CD1873 F+R, Tn5397 CD0511 F+R, 
Tn5398 9371 F-9387 R, tcdB ToxB 3120F + 3521R, PaLoc TS Lok1 + Lok3, cdtA BiTox-1F + 1R. 
  CD0364  CD0386 
  1  2  3  4  5  6  7  8  9  10  11  12  13  CD37  630 
CTn2                               
CTn5                               
Tn5397                               
Tn5398                               
tcdB                               
PaLoc TS                                 
cdtA                               
 
Southern blots were performed in order to detect if CTn1 integrated into the recipient 
genome at multiple sites and if multiple copies of the element were present in the 
transconjugants. The probe binds to the recombinase which is present on a fragment 
of at least 3 kb, but possibly larger depending on the HindIII sites  surrounding the 
target site of the element. The transconjugants for CTn1, both for the element marked 
in the ABC-transporter and the element marked in the cell surface protein, were all 
probed on a single blot. The probe was specific for CD0355, the tyrosine recombinase 
gene in CTn1 (Figure 4.14). This blot was performed to identify the number of target 
sites  that  CTn1  has  in  CD37.  The  control  of  CD37  DNA  indicates  that  the  probe 
hybridises  to  a  fragment  in  the  CD37  genome  >10  kb,  all  transconjugants  have 
hybridisation to a similar fragment. This result was expected as CD37 was shown to 
have a CTn1-like element [182].   
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For  the  DNA  of  the  CD0364  transconjugants  1,  2  and  3,  the  probe  hybridised  to 
fragments of different sizes and to multiple fragments in each sample. This indicates 
that multiple copies of CTn1 have integrated into different sites in the chromosome. 
Putative transconjugants CD0364-4, CD0386-7 and 8 are expected to be  rifampicin 
resistant donors, which explains hybridisation to a similar size fragment as seen for the 
630 control DNA. As expected based on the 630 sequence, the minimal fragment size is 
>3 kb. 
 
 
Figure 4.14 Southern blot of CTn1 transconjugants probed with the CTn1 recombinase CD0355.  
All DNA was HindIII digested.  Lane 1-4 is DNA of CD37 transconjugants  containing CTn1 marked in 
CD0364. Lane 5-13 is DNA of CD37 transconjugants containing CTn1 marked in CD0386. Lane CD37 is 
DNA of strain CD37, lane 630 is DNA of strain 630, and lane M is a molecular marker. Green arrows 
indicate  DNA  fragments  that  are  expected  to  be  visualised  through  specific  binding  of  the  probe, 
assessment was made based on the size of the DNA fragments. 
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4.4.4.2.  Conjugative transfer of CTn2 
Filter-matings  were  carried  out  for  CTn2  using  the  630∆erm  ClosTron  mutant 
containing erm(B) in the transcriptional regulator CD0428 (Figure 4.11) and C. difficile 
CD37 and B. subtilis CU2189 as recipient strains. The transfer frequency into recipient 
CD37 was 2.1 x 10
-4 transconjugants per donor (standard deviation is 5.5 x 10
-4). No 
transfer  was  observed  into  the  B.  subtilis  recipient  and  the  transfer  frequency  is 
considered below the detection limit of 10
-9 transconjugants per donor. PCR analysis 
could not detect co-transfer of elements that were not selected in the filter-matings. 
 
The Southern blot for the transconjugants of CTn2 was probed with the CTn2 serine 
recombinase gene CD0436 (Figure 4.15) to detect the number of integration sites and 
copy number of CTn2 in transconjugants. A HindIII restriction site is present in CTn2 
and  the  recombinase  is  expected  to  hybridize  to  a  fragment  >  10  kb.  The  probe 
hybridised to a single 6 kb fragment in all samples, including the positive and negative 
controls which is therefore predicted to be non-specific binding. In addition, the probe 
hybridised  to  one  or  more  greater  than  10  kb  fragments  of  the  DNA  from  the 
transconjugants and 630∆erm. This suggests the element can integrate into multiple 
target  sites  and  multiple  copies  of  the  element  are  present  in  three  of  the 
transconjugants.   
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Figure 4.15 Southern blot of CTn2 transconjugants probed with the CTn2 recombinase CD0436.  
All DNA was HindIII digested. Lane 1-10 is DNA of CD37 transconjugants containing CTn2 marked in 
CD0428. Lane CD37 is DNA of strain CD37, lane 630∆erm is DNA of strain 630∆erm, and lane M is a 
molecular marker. Coloured arrows indicate DNA fragments of varying sizes. Green arrows indicate DNA 
fragments that are expected to be visualised through specific binding of the probe, red arrows indicate 
DNA fragments that are expected to be visualised through non-specific binding of the probe, assessment 
was made based on the size of the DNA fragments. 
 
4.4.4.3.  Conjugative transfer of CTn4 shows co-transfer of CTn5 
Filter-matings for CTn4, carried out using the 630∆erm ClosTron mutant containing 
erm(B) in the transcriptional regulator CD1099 (Figure 4.11) as donor and C. difficile 
CD37  and  B.  subtilis  CU2189  as  recipients.  Transfer  into  CD37  was  observed  at  a 
frequency of 2.3 x 10
-6  transconjugants per donor (standard deviation is 4.2 x 10
-6), 
whereas  no  transfer  in  B.  subtilis  was  observed  and  the  transfer  frequency  is 
considered to be below the detection limit of 10
-9 transconjugants per donor. 
 
 
PCR analysis for the co-transfer of elements that were not selected showed co-transfer 
of CTn5 in transconjugants 1 and 5 (Table 4.9). The PCRs also suggest that isolates 2  
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and 4 are not transconjugants but spontaneous mutants of the donor isolate which 
became rifampicin resistant, as described in section 4.4.4.1. 
 
Table 4.9 Summary of PCR analysis on transconjugants of CTn4 filter-matings. 
PCR reactions that contain a product of the expected size are shown in green, reactions that do not 
contain the expected product are red. Template 1-6 are putative transconjugant DNA, CD37 and 630 are 
positive and negative controls. Primers: CTn1 CD0364 F+R, CTn2 CD0428 F+R, CTn5 CD1873 F+R, Tn5397 
CD0511 F+R, Tn5398 9371 F-9387 R, tcdB ToxB 3120F + 3521R, PaLoc TS Lok1 + Lok3, cdtA BiTox-1F + 1R. 
 
  1  2  3  4  5  6  CD37  630 
CTn1                 
CTn2                 
CTn5                 
Tn5397                 
Tn5398                 
tcdB                 
PaLoc TS                 
cdtA                 
 
Southern blot for the transconjugants of CTn4 was performed with a probe for the 
CTn4 recombinase. No known HindIII sites are present in the sequence of CTn4. The 
genomic DNA from C. difficile CD37 hybridises to a > 10 kb fragment as expected since 
a CTn4-like element is known to be present [182]. The probe hybridises in each of the 
transconjugants to a fragment of approximately the same size. This could indicate that 
CTn4 only integrates in the transconjugants at the same site as the CTn4-like element 
that is native to CD37, or a fragment of similar size. 
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Figure 4.16 Southern blot for CTn4 transconjugants probed with the CTn4 recombinase CD1091. 
All DNA was HindIII digested.  Lane 1-6 is DNA of CD37 transconjugants containing CTn4 marked in 
CD1099. Lane CD37 is DNA of strain CD37, lane 630 is DNA of strain 630, and lane M is a molecular 
marker. A green arrow indicates the DNA fragment that is expected to be visualised through specific 
binding of the probe, assessment was made based on the size of the DNA fragment. 
 
4.4.4.4.  Conjugative  transfer  of  CTn5  into  C.  difficile  and  B. 
subtilis 
Filter-matings were carried out using the ClosTron mutant in 630∆erm for the ABC-
transporter on CTn5, CD1873 (Figure 4.11). Transconjugants were detected using C. 
difficile CD37 or B. subtilis CU2189 as recipient strains. The frequency of transfer was 
determined for both recipients (Table 4.10). The frequency of transfer for CTn5 into B. 
subtilis was determined by Miss C. MacKenzie, UCL.  
PCR  analysis  of  the  transconjugants  of  CD37  indicated  that  no  elements  had  co-
transferred into the CTn5 transconjugants.   
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Table 4.10 Transfer frequencies of CTn5.  
The transfer frequency was calculated per filter as the number of transconjugants that resulted from a 
filter-mating, divided by the number of donor cells present on the filter. Each filter-mating experiment 
consisted of four technical replicates and each experiment was repeated at least three times. The mean 
of  the  transfer  frequency  and  standard  deviation  were  calculated  from  the  frequencies  of  each 
independent filter. The detection limit for the filter-matings is approximately 10
-9 transconjugants per 
donor. 
Original 
element 
(strain) 
Gene containing 
the ClosTron 
insert 
Recipient strain  Frequency of 
transconjugants per 
donor (σ)  
CTn5 
(630erm) 
CD1873   CD37  2.8 x 10
-5  (2.6 x 10
-5) 
    B. subtilis CU2189  4.0 x 10
-6  (3.4 x 10
-6) 
 
Southern  blots  were  performed  for  the  CTn5  transconjugants  using  the  CTn5 
recombinase  as  probe.  The  CTn5  recombinase  is  present  on  an  internal  HindIII 
fragment of approximately 4 kb. As expected, the probe hybridised to a 4 kb fragment 
for the 630 control DNA and all transconjugants (Figure 4.17).  
 
Figure 4.17 Southern blot of CTn5 transconjugants probed with the CTn5 recombinase CD1878.  
All DNA was HindIII digested. Lane 1-10 is DNA of CD37 transconjugants containing CTn5 marked in 
CD1873. Lane CD37 is DNA of strain CD37, lane 630 is DNA of strain 630, and lane M is a molecular 
marker. A green arrow indicates the DNA fragment that is expected to be visualised through specific 
binding of the probe, assessment was made based on the size of the DNA fragment. 
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4.4.4.5.  Conjugative transfer of CTn7 
Filter-matings  were  carried  out  for  CTn7  using  630∆erm  containing  a  ClosTron 
mutation in the cell surface protein CD3392 (Figure 4.10) as donor strain and C. difficile 
CD37 and B. subtilis CU2189 as recipients. The transfer frequency into recipient CD37 
was 9.6 x 10
-9 transconjugants per donor (standard deviation is 4.4 x 10
-9). No transfer 
was observed into the B. subtilis recipient and the transfer frequency is considered 
below the detection limit of 10
-9 transconjugants per donor.  
 
PCR analysis was performed to detect co-transfer of elements other than CTn7 whose 
transfer was not selected during the filter-mating experiments. Co-transfer of CTn2 
was seen in five out of six transconjugants (Table 4.11). Sample 6 was shown not be a 
transconjugant  but  a  spontaneous  mutant  of  the  donor  isolate  for  rifampicin 
resistance, as described in section 4.4.4.1. 
Table 4.11 Summary of PCR analysis on putative transconjugants.  
PCR reactions that contain a product of the expected size are shown in green, reactions that do not 
contain the expected product are red. Template 1-7 are putative transconjugant DNA, CD37 and 630 are 
positive and negative controls. Primers: CTn1 CD0364 F+R, CTn2 CD0428 F+R, CTn5 CD1873 F+R, Tn5397 
CD0511 F+R, Tn5398 9371 F-9387 R, tcdB ToxB 3120F + 3521R, PaLoc TS Lok1 + Lok3, cdtA BiTox-1F + 1R. 
  1  2  3  4  5  6  7  CD37  630 
CTn1                   
CTn2                   
CTn5                   
Tn5397                   
Tn5398                   
tcdB                   
PaLoc TS                   
cdtA                   
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The  Southern  blot  of  the  CTn7  transconjugants  was  probed  with  the  CTn7  serine 
recombinase CD3370 to identify the number of target sites and the copy number of 
the element in CD37 transconjugants (Figure 4.18). The probe is expected to hybridize 
to a fragment >2.5 kb, based on the 630 sequence. The probe hybridised with DNA 
fragments of 6 kb in 6 out of 7 transconjugants and in controls CD37 and 630∆erm. 
CD37 contains a CTn7-like element [182] but transconjugants 1, 3 and 4 only hybridise 
to a single fragment, and it is hypothesised that the native CTn7-like element may have 
been lost in these transconjugants.  
 
 
Figure 4.18 Southern blot of CTn7 transconjugants probed with the CTn7 recombinase CD3370. 
All DNA was HindIII digested. Lane 1-7 is DNA of CD37 transconjugants containing CTn7 marked in 
CD3392. Lane CD37 is DNA of strain CD37, lane 630∆Erm is DNA of strain 630∆erm, and lane M is a 
molecular marker. Green arrows indicate DNA fragments that are expected to be visualised through 
specific binding of the probe, assessment was made based on the size of the DNA fragments. 
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4.4.4.6.  No conjugative transfer of Tn6103 was observed 
No transconjugants were observed in the matings using R20291 as the donor of the 
element Tn6103 with any of the recipient strains CD37, 630∆erm or B. subtilis CU2189. 
The  transfer  frequency  for  this  element  into  any  of  these  recipients  is  therefore 
considered to be below the detection limit of 10
-9 transconjugants per donor cell. 
 
4.4.4.7.  Conjugative transfer of the CTns of strain M120 
Strain M120 was shown to contain 2 putative CTns, one 107 kb element designated 
Tn6164 and a Tn916-like element designated Tn6190 [88] (Chapter 3). Filter matings 
were carried out using M120 as a donor and CD37 as a recipient. As both Tn6164 and 
Tn6190 encode a predicted tetracycline resistance gene, filter-matings selecting for 
rifampicin  and  tetracycline  resistance  would  select  for  CD37  transconjugants 
containing either of these elements. A large number of putative transconjugants were 
obtained and 70 putative transconjugants from 2 separate experiments were checked 
by PCR for identity of the strain with the Lok1+Lok3 primer pair. This primer pair spans 
the  PaLoc  integration  site  and  can  only  produce  an  amplicon  if  the  PaLoc  is  not 
present,  confirming  the  isolate  is  the  non-toxigenic  recipient  strain  CD37  [32]. 
Furthermore, the presence of both Tn6164 and Tn6190 were tested with the primer 
pairs  Tn6164  acc  region  F+R  and Tn916  integrase  F+R  (Table  4.3),  respectively.  All 
transconjugants were shown to be CD37 containing the Tn916-like element Tn6190 
(Figure 4.19). Conjugative transfer of Tn6164 was not detected.  
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Figure 4.19 Transconjugant analysis of M120 filter-matings 
Panel A shows the product of the PCR to confirm the putative transconjugants are CD37, the primer pair 
is lok1 + lok3 and the expected product size is 0.8 kb. Panel B shows the PCR analysis for the presence of 
Tn6164 with primer pair Tn6164 acc region F+R, expected product size is 0.5 kb. Panel C shows the PCR 
analysis for the presence of the Tn6190 with primer pair Tn916 integrase F+R, expected product size is 
1.0 kb. The template in lanes 1-20 are transconjugants 1-20, lanes 21 are M120 and lanes – are H2O. 
Lanes M are a molecular weight marker, the size of the fragments is indicated left of the figures. 
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4.4.5. Nanotube transfer of antimicrobial resistance proteins 
Nanotubes  were  shown  to  allow  for  the  transfer  of  antibiotic  resistance  proteins 
between  bacterial  cells  without  the  genetic  element  encoding  the  resistance  gene 
transferring  [187].  Nanotubes  were  also  shown  to  be  capable  of  transferring  non-
conjugative  DNA  elements  between  B.  subtilis  strains.  To  study  if  nanotubes  are 
formed  between  C.  difficile  cells  and  to  see  if  antibiotic  resistance  proteins  are 
transferred,  the  experiments  described  by  Dubey  and  Ben-Yehuda  [187]  were 
repeated with C. difficile. 
Cultures  of  single  C.  difficile  strains  and  mixed  cultures  of  strains  with  different 
resistance phenotypes were co cultured on an antibiotic free agar plate for 24 hours 
after which these were replica plated onto plates containing different combinations of 
antibiotics and to an antibiotic free plate. These plates were checked after 24 and 48 h 
incubation and the experiment was performed three times with similar results. On 
thiamphenicol plates, CD37 pMTL960/GusA (thiamphenicol
R) and the mixed culture of 
CD37 pMTL960/GusA and R20291 pMTL 9301 grew (Figure 4.20). On lincomycin plates, 
R20291 pMTL 9301 (lincomycin
R) and the mixed culture grew. On the thiamphenicol + 
lincomycin plates none of the cultures grew. This indicates that antibiotic resistance 
proteins and non-conjugative plasmids were not transferred when two cultures with 
different  resistance  phenotypes  were  co-cultured.  On  the  antibiotic  free  plates  all 
cultures grew.  
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Figure 4.20 Nanotube transfer of antimicrobial resistance proteins.  
The occurrence of transfer of antimicrobial resistance proteins through nanotubes was studied by co-
culturing C. difficile strains which are resistant for different antibiotics. a) Position of strains on agar 
plates;  1  CD37  pMTL960/GusA  (thiamphenicol
R,  lincomycin
S);  2  wildtype  CD37  (thiamphenicol
S, 
lincomycin
S);  3  mixed  culture  of  CD37  pMTL960/GusA  and  R20291  pMTL9301;  4  wildtype  R20291 
(thiamphenicol
S,  lincomycin
S);  5  R20291  pMTL9301(thiamphenicol
S,  lincomycin
R).  b)  Agar  plates  of 
replica  plated  cells  after  24  h  incubation.  Plates  were  also  checked  after  48  h  incubation.  The 
supplemented  antibiotics  present  in  the  agar  are  indicated  above  the  plates;  Thi  30  is  30  g/ml 
thiamphenicol, Linc 40 is 40 g/ml lincomycin, Abf is antibiotic free. 
 
a) 
b)  
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4.5.  Discussion 
4.5.1. Circularisation of C. difficile putative CTns 
The first step in conjugative transfer of a CTn is considered to be excision from the 
genome into a circular intermediate [128]. Therefore, the presence of these circular 
intermediates  was  investigated  for  each  element  before  further  study.  The  joint 
between the ends of the elements present in a circular molecule was PCR amplified for 
CTn1, CTn2 and CTn7 present in strain 630 and the excision of CTn4 and CTn5 as 
previously described was confirmed [8]. In five other strains the excision of another 
seven CTns was shown which demonstrates that a large number of C. difficile predicted 
CTns are active elements. 
Sequencing of the circular intermediate, empty target site and the junctions between 
the CTn and the chromosome has  identified the direct repeats at the ends of the 
elements. Most of the elements that were analysed here encode serine recombinases 
and  all  of  these  were  shown  to  create  the  original  regenerated  target  site  upon 
excision.  Two  elements  encoding  serine  recombinases  in  C.  difficile  that  were 
previously studied have 2 bp direct repeats at the ends of the element as well as in the 
target site and joint of the circular intermediate  [156,168], although a 5 bp direct 
repeat was described for CTn5 [8]. Only two out of eight serine recombinase-encoding 
elements analysed here had a 2 bp direct repeat, whereas the direct repeats of the 
other  elements  ranged  between  8-15  bp.  Further  study  could  determine  if  the 
sequence of these direct repeats are required to be conserved in order for integration 
and excision of these elements to take place.   
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Excision of two elements encoding tyrosine recombinases described here resulted in 
regeneration of the target site without any heteroduplexes. These elements have 6-7 
bp direct repeats at either end of the element. Although tyrosine recombinases often 
create  heteroduplexes  upon  integration  and  excision,  as  described  for  CTn4  in  C. 
difficile [8,157], if the direct repeats of the element are identical to the target site and 
joint of the circular intermediate, no heteroduplexes are formed [247].  
In strains R20291, QCD-66C26, and QCD-32G58, CTn1-like elements are present that 
share 98-100% sequence identity and all lack a homologue to the predicted xis of CTn1 
(Chapter 3). Excision could not be shown for any of these elements under our growth 
conditions,  which  is  presumably  because  of  the  absence  of  a  xis  homologue.  To 
demonstrate  if  xis  is  essential  for  the  excision  of  these  elements,  CTn1  could  be 
introduced  into  these  strains  to  provide  xis  in  trans  which  may  complement  the 
deletion in these strains. 
Most of the elements that were analysed here were able to excise from the genome 
into a circular intermediate, indicating these are active mobile elements that play a 
role in the plasticity of the  C. difficile genome. These elements may be capable of 
conjugative transfer and so contribute to genetic exchange between C. difficile isolates 
and  between  C.  difficile  and  other  species,  which  warrants  further  study  of  these 
elements. 
4.5.2. Conjugative transfer of CTns 
Six CTns that were shown to excise from the genomes in strains 630 and R20291 were 
marked  by  introducing  erm(B)  into  the  element  using  the  ClosTron.  In  order  to  
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minimise the effect of this insertional mutation on the conjugative properties of the 
element, the mutations were made in predicted accessory genes.   
Filter-mating experiments showed that all of the elements to which the ClosTron was 
retargeted in strain 630 were capable of conjugation, confirming that none of these 
genes  are  essential  for  conjugation.  The  conjugation  frequencies  of  the  Tn916-like 
elements CTn1 and CTn7 were similar and ranged between 10
-8-10
-9 transconjugants 
per donor, similar to the frequencies reported for the transfer of Tn916 and Tn5397 
between C. difficile strains [164,248]. 
The transfer frequencies of the Tn1549-like elements CTn2, CTn4 and CTn5 ranged 
from 10
-4-10
-6, which is comparable to the transfer frequency of Tn1549 between E. 
faecalis strains [148]. Although these frequencies are somewhat higher than those of 
the Tn916-like elements studied here, it is unknown if this is a statistically significant 
difference and further study is needed to determine if Tn1549-like elements actually 
have a higher transfer frequency.  
Culturing  a  donor  strain  of  Tn916  in  the  presence  of  tetracycline  prior  or  during 
matings enhances the transfer frequency up to 15-fold [249]. This has led to a model 
for the regulatory mechanism of Tn916 in which the presence of tetracycline results in 
the  destruction  or  silencing  of  the  transcriptional  terminator  orf12.  This  allows 
expression  of  the  downstream  genes  including  the  transposition  and  conjugation 
genes  [138,250].  As  none  of  the  elements  in  C.  difficile  strain  630  encode  orf12 
homologues,  it  is  unlikely  that  these  elements  are  affected  by  tetracycline.  It  is 
possible  though  that  the  regulation  of  these  elements  is  also  affected  by 
environmental  factors  and  future  study  determining  these  factors  is  important  for 
fundamental research of these elements.  
151 
4.5.3. Co-transfer of CTns from strain 630∆erm 
The filter-matings performed here have all selected for the transfer of a single element 
carrying erm(B). Besides the elements that were selected for, co-transfer of several 
elements was demonstrated by Southern blot and PCR. When selecting for the transfer 
of CTn1, the transfer of Tn5397 was observed multiple times, once in combination with 
CTn5 and the PaLoc. CTn5 was also shown to transfer when the transfer of CTn4 was 
selected for. However, both of these elements have also transferred independently, 
indicating transfer of neither element is reliant on the other element. In contrast, the 
transfer of CTn7 was observed in combination with the transfer of CTn2 in five out of 
six  transconjugants.  Although  it  appears  that  CTn7  is  a  complete  conjugative 
transposon, it is possible that the element is dependent on CTn2 for its transfer. The 
CTn7 transconjugant in which CTn2 is not present may have lost the element during 
transposition. To test if CTn7 relies on CTn2 for transfer, more transconjugants could 
be analysed for co-transfer. If this is inconclusive, then knockout mutants could be 
made for any genes on CTn2 that are essential for transfer and determining the effect 
of this on the transfer of CTn7. 
Although  the  term  co-transfer  has  been  used  here,  it  is  uncertain  that  the 
transconjugants containing more than one element have always arisen from a single 
transfer event. Possibly, when two cells are in close range, after the first element has 
been transferred, a second transfer event between these two cells could occur, or one 
recipient cell may also receive elements from more than one donor cell. This could 
help to explain the observation of co-transfer of CTn2 when only the transfer of CTn7 
is selected for because the transfer frequency of CTn2 is so much higher than that of 
the other elements. Furthermore, the co-transfer of CTn5 was observed several times,  
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which is the element with the highest transfer frequency after CTn2. However, this 
does not explain why the co-transfer is not seen in the CTn1 and CTn4 transconjugants.  
During the selection for the transfer of CTn1, the co-transfer of Tn5397 was detected 
several times. After selection on erythromycin only, these cells were also plated out 
onto  tetracycline,  showing  that  tetracycline  resistance  was  acquired  during  these 
matings without any selection for this event. The transfer of antibiotic resistance genes 
without selection pressure demonstrates the clinical importance of the research into 
horizontal  gene  transfer  in  order  to  understand  which  factors  may  induce  these 
events. 
4.5.4. Number of integration sites in transconjugants 
The  results  of  the  PCRs  that  were  performed  to  detect  co-transfer  led  to  the 
conclusion that samples CD0364-4, CD0386-7 and 8, CD1099-2 and 4 and CD3392-6 are 
rifampicin resistant donor strain mutants . All of these samples contain all of the 630 
CTns as well as the PaLoc and CDT-locus which means no CD37 specific sequence could 
be  determined.  Southern  blots  were  performed  on  these  samples  before  these 
conclusions had been reached. 
To  probe  the  Southern  blots,  the  recombinases  of  the  transposons  were  used. 
Sequence  comparison  demonstrated  diversity  between  the  genes  which  suggested 
these probes would not hybridize to the sequence of other CTns. However, during the 
experiments, it became apparent that CD37 has a number of related CTns with similar 
recombinases. During the PCR analysis of the transconjugants to look for co-transfer of 
other unmarked CTns, genes on the accessory regions of the conjugative transposons 
were used after it was determined these are specific for the 630 CTns. Co-transfer of 
CTn4 and CTn7 could not be tested for here as CD37 was positive for the accessory  
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genes  of  these  elements.  After  these  experiments  were  performed,  the  shotgun 
genome sequence of CD37 (Chapter 6) showed that CTn4 and CTn7-like elements, with 
96% and 98% sequence identity respectively, are present in CD37.  
The recombinases of the CTns were also used as probes for the Southern blots as these 
genes are all at one side of the element which limits the chance of HindIII sites being 
present between the probe and the end of the element in the target site. This enables 
to determine if the element can integrate in multiple sites in the recipient genome. 
However, examination of the results of the CTn5 transconjugants showed the probe 
used hybridized to an internal HindIII fragment and could not be used to determine the 
number of  integration  sites.  This  experiment  could  be  repeated using  a  restriction 
enzyme that does not have restriction sites between the CTn5 recombinase and the 
end of the element. 
In  the  Southern  blots  of  the  CTn1  transconjugants  the  CTn1  recombinase  probe 
hybridised to two or three fragments of different sizes for the DNA of transconjugants 
CD0364-1,  2  and  3.  This  indicates  that  the  element  has  integrated  into  at  least  5 
different target sites in the transconjugants and that multiple copies of the element 
are present. The fact that the probe only hybridises to a single fragment for all CD0386 
transconjugants may indicate that the marked CTn1 element has integrated in the 
same  fragment  as  the  native  CTn1  recombinase  or  that  the  marked  element  has 
replaced the native element carrying the CTn1-like recombinase. 
Southern  blot  of  the  CTn2  transconjugants  shows  hybridisation  with  the  CTn2 
recombinase probe to >10 kb fragments in all transconjugants; at least 3 separate size 
fragments  can  be  distinguished  indicating  multiple  integration  sites  and  multiple 
copies of the element in at least three of the transconjugants.  
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The  Southern  blot  of  the  transconjugants  of  CTn4  was  hybridised  with  the  CTn4 
recombinase  probe  which  hybridised  at  a  >10  kb  fragment  in  all  transconjugant 
samples  as  well  as  CD37  and  630.  There  was  no  indication  of  two  copies  of  the 
element,  which  could  indicate  the  native  CTn4-like  element  was  lost  in  the 
transconjugants or the elements have recombined, however, CTn4 and the CTn4-like 
element from CD37 may have been present on DNA fragment of similar sizes and were 
too big to be separated on the gel. To determine if both elements are present, the 
Southern blot could be repeated with another restriction enzyme that has a restriction 
site within CTn4 or the gel for the Southern blot could be performed pulsed field gel 
electrophoresis in order to get a better separation of the large DNA fragments. 
CD37 contains a CTn7-like element integrated in the same target site as in 630. In 
three out of six transconjugants, the CTn7 recombinase probe hybridised with two 
fragments, which could mean both the native CD37 CTn7-like element is present as 
well as the donor copy and the element can integrate in a different target site when 
the preferred target site is occupied. Only a single copy of the element is present in the 
other three transconjugants which suggests that the native CTn7-like element was lost 
or the elements have recombined. Whole genome sequencing of the transconjugants 
could determine what exactly happened with these elements. 
4.5.5. C. difficile elements that were not shown to transfer 
In Tn6103 from strain R20291, the ClosTron was retargeted to an ABC-transporter, a 
homologue of the ABC-transporter in 630 where the ClosTron was retargeted in CTn5. 
No transfer was observed for Tn6103 from R20291 into CD37, 630∆erm or B. subtilis 
CU2189. Although CTn5 can transfer from 630∆erm into CD37 and B. subtilis CU2189,  
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this was not unexpected as three predicted mobilisable transposons are integrated in 
predicted conjugal transfer genes in Tn6103 (Chapter 3).  
Strain M120 contains two predicted conjugative transposons that encode tetracycline 
resistance  proteins,  Tn6164  and  Tn6190  [208].  Tn6190  is  97%  identical  to  Tn916, 
whereas Tn6164 is a composite element that consists of fragments of several MGEs 
(Chapter 3). It was therefore expected that filter-matings using M120 as donor and 
selecting for tetracycline resistant transconjugants, would result in isolates containing 
Tn6190  and  possibly  in  isolates  containing  Tn6164.  All  of  the  transconjugants 
contained Tn6190. Although no conjugation of Tn6164 was shown in the experiments 
performed here, the element was shown to excise from the genome into a circular 
molecule, indicating that the element is an active MGE. No final conclusion can be 
drawn on whether Tn6164 may be able to transfer via conjugation as our findings 
could be the result of Tn6190 having a much higher transfer frequency than Tn6164. 
Studying a larger number of transconjugants  could have resulted in detection of a 
Tn6164 transconjugant. Furthermore, Tn6164 may transfer under different conditions 
than those we have used in our experiments or strain CD37 may not be a suitable 
recipient strain for Tn6164. Although Tn6164 is considerably larger than any of the 
elements in strain 630 for which transfer has been shown here, transfer of large CTns 
have been shown in other species such as CTnscr94 from Salmonella senftenberg (100 
kb) and the R7a symbiosis island from Mesorhizobium loti (500 kb) [146,251].  
Further study of the transfer of Tn6164 could be performed by constructing a mutant 
strain in which the tet(M) of Tn6190 is knocked out. This would allow for filter-mating 
experiments to be conducted in which the selection on tetracycline would select only 
for  Tn6164  transconjugants.  Alternatively,  erm(B)  could  be  introduced  into Tn6164  
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using  the  ClosTron  system,  as  was  done  here  for  the  CTns  from  strains  630  and 
R20291. 
4.5.6. Nanotube transfer of antimicrobial resistance proteins 
Dubey and Ben-Yehuda have shown that co-culture of two organisms can result in a 
mixed culture where both cell types show a resistant phenotype although only one of 
the organisms contains the specific antibiotic resistance gene necessary to survive in a 
specific environment [187]. The network of nanotubes connects cells to each other, 
even from different species, and it was shown that antibiotic resistance proteins as 
well as non-conjugative plasmids could be transferred  through them. Although the 
study shows that the transfer of the plasmid does not occur through transformation, it 
is not clear if the donor strain used in these experiments contains other MGEs that 
could mobilise the non-conjugative plasmid. 
It was attempted here, to show if this transfer of resistance proteins could also be 
shown to occur between C. difficile strains and to determine if transfer of CTns could 
occur through nanotubes. The experiments as described by Dubey and Ben-Yehuda 
[187]  were  repeated  using  C.  difficile  but  no  evidence  was  found  for  transfer  of 
resistance proteins. Possibly, a nanotube transfer system does not exist for C. difficile, 
although the related species B. subtilis was used in the Dubey study. Although great 
care was taken to reproduce the conditions of the experiments described by Dubey 
and Ben-Yehuda, the conditions in which the experiments were undertaken may affect 
the frequency at which nanotubes are formed [188], and variations, such as the fact 
that the experiments here were performed under anaerobic conditions, are inevitable. 
To exclude this possibility, these experiments could be repeated using B. subtilis under 
aerobic and anaerobic conditions. At the moment, because of the lack of evidence for  
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the existence of a nanotube system for C. difficile, the transfer of DNA seen in this 
chapter is considered to occur through conjugation. 
4.5.7. Conclusions 
The mobility of 15 C. difficile CTns was tested here and 10 were shown to be able to 
excise from their respective genomes indicating that most of the C. difficile CTns are 
active elements that can excise from the genome into a circular transfer intermediate. 
The conjugative transfer between C. difficile strains was shown for six out of eight 
tested elements and one element was shown to transfer into B. subtilis, showing it is 
possible  these  elements  contribute  to  genetic  exchange  with  different  strains  and 
species. 
Southern  blots  of  transconjugants  were  performed  to  test  if  the  elements  could 
integrate into multiple target sites and to see if multiple copies are present in the 
transconjugant genome. CTn1, CTn2 and CTn7 were shown to be able to insert in three 
to five different sites each in CD37 and CTn1 and CTn2 were shown to have multiple 
copies in transconjugant cells. 
Ten out of forty transconjugants that were studied here were shown to contain CTns 
that co-transferred when the transfer of another element was selected. It is unknown 
if  these  elements  transferred  in  a  single  transfer  event  or  in  multiple  events.  The 
transfer  of  Tn5397,  conferring  tetracycline  resistance  to  the  transconjugants  when 
lincomycin resistance encoded on a different element was selected for, indicates these 
transfer events can have clinical implications. 
One CTn1 transconjugant was demonstrated to contain CTn5, Tn5397 and the PaLoc 
and this transconjugant is further studied in Chapter 5.  
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Chapter 5  Mobilisation of the PaLoc 
5.1.   Introduction 
The PaLoc is a 19.6 kb genetic element encoding 5 predicted proteins including the 
main virulence factors TcdA and TcdB (discussed in Chapter 1). The PaLoc was shown 
to be a separate genetic element that has integrated uni-directionally in the same 
target site in all toxigenic C. difficile strains, whereas a 115 bp sequence is present at 
this locus in all nontoxigenic strains [32]. As the PaLoc encodes a putative phage holin 
and other members of the family of large clostridial toxins, C. botulinum neurotoxins 
C1 and D, are encoded on the neurotoxin-converting phages [252] the PaLoc has been 
hypothesized  to  be  of  phage  origin  [174].  It  was  therefore  hypothesized  that  the 
presence of prophages in the genome may have an effect on toxin production through 
the presence of phage transcriptional regulators and several studies have looked into 
this  [174,176,177].  Although  these  studies  show  that  phages  can  affect  toxin 
production, these effects are strain and phage specific and no common effect has been 
described.  
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5.2.  Aims of this chapter: 
  Reproducing the transfer of the PaLoc from the donor 630∆erm into the non-
toxigenic recipient strain CD37. 
  Determining if the transconjugant Paloc386 from Chapter 4, which contains the 
PaLoc, produces the PaLoc toxins. 
  Studying  the  CD37  transconjugants  containing  the  PaLoc  by  genome 
sequencing  in  order  to  predict  what  transfer  mechanism  is  likely  to  be 
responsible for PaLoc transfer.  
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5.3.  Materials and methods 
5.3.1. Tissue culture and cytotoxicity assays 
Human foreskin fibroblast (HFF)-1 cells (ATCC SCRC-1041) were grown in Dulbecco’s 
Modified Eagle’s Medium (Gibco-Invitrogen, UK) supplemented with 10% foetal calf 
serum (Hyclone, USA), 0.1% glutamine (Cambrex, Belgium), penicillin/streptomycin mix 
(100 U ml-1) (Lonza, Belgium). Cells were grown at 37 °C at 5% CO2 in vented flasks. 
Depending on confluence of growth, the cells were split 1-2 times per week by washing 
the  cells  twice  with  sterile  PBS  (Sigma  Aldrich  Ltd.)  using  1  ml  trypsin  (Cambrex, 
Belgium) and incubating approximately 15 min at 37 °C. When most cells were not 
adhering, pre-warmed medium was added to the cells and these were split over 2 or 3 
flasks.  
Bacterial strains were grown in TY broth for 48 h and spun down for 10 min at 4500 x 
g. The supernatant was filter sterilised (filter pore size 0.45 µm) and stored at 4 °C. The 
cytotoxicity  assay  was  performed  using  the  C.  difficile  toxB  test  kit  (Techlab  Inc, 
Blacksburg, VA, USA) according to the manufacturer’s instructions. HFF-1 cells were 
trypsinized and seeded into a 96-well plate at 1x10
4 cells per well. After 24 h it was 
checked  that  the  growth  of  the  cells  was  confluent  in  the  wells.  Filter  sterilised 
bacterial supernatant was 4 fold serial diluted and neat to 1:4096 were all added to the 
fibroblast  monolayer  in  duplicate.  Polyclonal  anti  C.  difficile  TcdB  antibodies  were 
added to one series of dilutions. Purified C. difficile TcdB was added to one well as a 
positive control. Cells were incubated at 37 °C for 24 h before they were assessed 
under an inverted microscope for the characteristic cell rounding also referred to as 
the cytopathic effect (CPE) [44]. The toxin end titre point has been defined as the first  
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dilution  point  where  no  difference  is  seen  between  the  sample  and  the  negative 
control that has been treated with anti TcdB antibodies [45]. The toxin end titre point 
was determined for the dilution series of each of the samples. 
 
5.3.2. Filter-matings 
Filter-matings  were  performed  as  described  in  Chapter  2.  The  ClosTron  mutant 
630Δerm tcdB::ErmRAM was used as  the donor strain as this strain has an  erm(B) 
insertion in tcdB. CD37 was used as the recipient strain. Serial dilutions of the mixture 
of donor, recipient and transconjugant cells from the filters were set up to determine 
the cell counts for donor and recipient cells. Donor cells were selected on lincomycin 
(40 µg/ml) containing plates and recipient cells were selected for on rifampicin (25 
µg/ml)  containing plates.  Transconjugant  cells were  selected  for  on  lincomycin  (40 
µg/ml) and rifampicin (25 µg/ml) containing plates.  
5.3.2.1.  PCR analysis 
PCR was used to identify transconjugants and to look for co-transfer of elements that 
were not selected for in the filter-mating. PCR analysis was performed as described in 
Chapter 2. PCR was performed with the primers listed in Table 5.1.  
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Table 5.1 PCR primers for CTn detection. 
Primer pair CD0364 F+R is for the detection of the presence of CTn1. Primer pair CD0428 F+R is for the 
detection of the presence of CTn2. Primer pair CD1873 F+R is for the detection of the presence of CTn5. 
Primer pair CD0511 F+R is for the detection of the presence of Tn5397. Primer pair 9371 F + 9387 R is for 
the detection of the presence of Tn5398. Primer pair ToxA F + R is for the detection of the presence of 
tcdA encoded on the PaLoc. Primer pair Lok1 + Lok3 is for the detection of the empty target site of the 
PaLoc. Primer pair cdtA F+R is for the detection of the presence of cdtA encoded on the binary toxin 
locus. 
Primer   Sequence 5’- 3’   Amplicon 
CTn1 CD0364 F  GATTAAAGCCCTCGCACAAG  0.3 kb 
CTn1 CD0364 F  GCGTCCGCTAATTTTGTGAT 
CTn2 CD0428 F  CATGGAATCTTCGCATCAGA  0.4 kb 
CTn2CD0428 R  GCGAATGTCCTCACTAACCG 
CTn5 CD1873 F  CAATAATGAAATCAAGCAATGAAA  0.2 kb 
CTn5CD1873 R  GCTTCGAGTGAAACAACATTCT 
Tn5397 CD0511 F  CGAGCGGAAGTCAGAAGATT  0.2 kb 
Tn5397 CD0511 R  GCTTTGCACTACCTCTGCTTG 
Tn5398 9371F  GGATAGAAATACTCGTCAACAG  0.9 kb 
Tn5398 9387 R  ATTTTTTATTTTTAGGAGTCATA 
ToxA F   CATCTATAAGTTCTCATATTCCTTC  1.2 kb 
ToxA R   CCAGAAACTTATATTGTCC 
Lok1  AAAATATACTGCACATCTGTATAC  0.6 kb 
Lok3  TTTACCAGAAAAAGTAGCTTTAA 
cdtA F  YAATACTACTTACAAGGCTCC  0.3 kb 
cdtA R  TTTCGTTTTGATTTTYTGTTC 
 
5.3.3. Phage experiments 
5.3.3.1.  Preparation of phage suspensions 
A culture of 630Δerm tcdB::ErmRAM was grown for 16 h and was used to inoculate a 
50 ml culture 1:10 (v/v), which was grown for approximately 20 h. Mytomycin C was 
added  to  a  final  concentration  of  3  g/ml  and  the  cells  were  incubated  for  4  h 
anaerobically. The cells were centrifuged for at 7800 x g for 10 min, at 4 °C. 1 M NaCl 
and 20% (w/v) PEG 6000 were added to the supernatant [253]. The phages were left to 
precipitate on ice at 4 °C overnight. The phages were harvested by centrifugation at 
7800  x  g  for  20  min,  at  4  °C.  The  supernatant  was  discarded,  the  phages  were  
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resuspended in 2 ml PBS and filter sterilised. The phage suspensions were stored at 4 
°C. 
5.3.3.2.  Phage infection assay 
A CD37 culture was grown in 10 ml broth for 16 h after which it was incubated with 1 
ml of the phage suspension. The cells were incubated for 2 h at 37 °C and the cells 
were centrifuged 10 min at 4500 x g. The pellet was resuspended into 1 ml of pre-
reduced broth and 200 l spread onto plates containing rifampicin (25  µg/ml) and 
lincomycin (40 µg/ml). 
5.3.3.3.  Plaque assay 
CD37 and CD843 cultures were grown for 16 h. CD843 was previously described as a 
propagating strain for both C630-1 and C630-2 of strain 630 [175]. 100 l of culture 
and 100 l of phage suspension was added to 4 ml of 50 °C top agar, BHI 0.6% agar, in 
sterile polystyrene tubes (Sterilin Ltd, Newport, UK). The tube was inverted several 
times for mixing and spread out onto a BHI plate. Plaque plates were evaluated after 
24 h incubation for the presence of clear plaques in the bacterial lawn that had grown. 
5.3.4. DNA shotgun sequencing  
Full genome shotgun sequencing was carried out by UCL Genomics, University College 
London. Dr. Tony Brooks prepared the samples as part of a 72 bp paired end multiplex 
reaction, and sequencing was performed on an Illumina GAII-X. 
Dr.  Warren  Emmett  performed  the  assembly  and  annotation  of  the  genome 
sequences. Initial genome assembly was done using the Velvet software suite [254]. 
The  assembled  genome  was  compared  and  mapped  against  the  annotated  CD630  
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reference  genome  (Genbank  AM180355)  using  xBase  [255].  Gene  prediction  was 
performed  using Glimmer  [193],  tRNA  genes  were  searched  for  with tRNAScan-SE 
[256], Ribosomal RNA genes were searched for with RNAmmer [257], Protein BLAST 
[258] was run using the translated coding sequences as a query against the CD630 
reference sequence. The best result for each BLAST search was imported as the gene 
annotation. A comparison file with concatenated reference and sequence files was 
produced using MUMMER [259]. Analysis of the genome was performed using ACT 
[204].  
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5.4.  Results 
5.4.1. Transconjugant Paloc386 is cytotoxic  
To  determine  if  the  transconjugant  isolate  Paloc386  described  in  Chapter  4  that 
contains the PaLoc expresses the toxin genes, a cytotoxicity assay  was performed. 
Filter-sterilised  cell  free  supernatant  was  serial  diluted  and  added  to  HFF-1  cells. 
Supernatant of Paloc386 was compared to that of the recipient strain CD37 and donor 
strain 630. The CPE was assessed visually for rounding of the cells using an inverted 
microscope (Figure 5.1). The toxin end titre point was  determined for each of the 
samples (Figure 5.2). Similar toxin levels were present in the culture supernatant of 
donor 630∆erm and transconjugant Paloc386, whereas no CPE was seen for the culture 
supernatant  of  recipient  CD37.  No  difference  could  be  distinguished  between  the 
negative control containing only tissue culture medium and the wells containing the 
neat culture supernatant that was neutralized with the TcdB antibodies. 
 
Figure 5.1 Example of the effect of C. difficile culture supernatant on Hff-1 in the cytotoxicity assay. 
HFF-1 cells were incubated with cell free supernatants for 24 hours. a) Supernatant of transconjugant 
Paloc386 causes CPE and therefore rounding of the cells can be observed, similar to strain 630∆erm. b) 
Supernatant of CD37 causes no CPE. 
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Figure 5.2 Cytotoxicity assay.  
HFF-1 cells were incubated with cell free supernatant for 24 h. End toxin titre point was assessed by 
inverted  microscope.  The  mean  is  shown  for  3  independent  experiments,  error  bars  indicate  the 
standard deviation. 
 
5.4.2. PaLoc transfer is reproducible 
In order to determine if the PaLoc transfer from 630∆erm into CD37 was reproducible, 
a  tcdB  ClosTron  mutant  was  used  as  donor  in  filter-matings  using  CD37  as  the 
recipient. Rifampicin and lincomycin resistant colonies were screened for the presence 
of the tcdA gene, present on the PaLoc, as well as for the presence of the binary toxin. 
Ten putative transconjugants that were tcdA positive and cdtA negative were screened 
by PCR for the co-transfer of other mobile elements. PCR amplification was performed 
on the same genes to study co-transfer as described in Chapter 4. An example of 
transconjugant Paloc 3.5 is shown (Figure 5.3). Co-transfer of CTn5 has occurred in this 
transconjugant. Co-transfer of Tn5397 was also observed in transconjugant Paloc 3.7. 
This transconjugant was tested for tetracycline resistance, as Tn5397 contains tet(M), 
and was tetracycline resistant.  
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The  transfer  frequency  for  the  PaLoc  into  CD37  was  calculated  at  7.5  x  10
-9 
transconjugants per donor cell (standard deviation is 4.1 x 10
-9), based on 3 biological 
replicates each containing at least 3 technical replicates. 
 
Figure  5.3  PCR  analysis  for  co-transfer  of  CTn1,  CTn2,  Tn5397,  CTn5  and  Tn5398  in  the  PaLoc 
transconjugants. 
Examples of each of the PCR reactions are shown. Template in lanes 630 is 630∆erm DNA, lanes CD37 is 
CD37 DNA, lanes 1 is transconjugant 1 DNA. Lanes M are molecular marker. Primers for the reactions 
are: CTn1 CD0364 F+R, CTn2 CD0428 F+R, Tn5397 CD0511 F+R, CTn5 CD1873 F+R, cdtA BiTox-1F + 1R, 
tcdA F+R, Tn5398 9371F + 9387R. The positive control 630 with primers for cdtA resulted in a faint band 
which is indicated by a black arrow. 
 
5.4.3. Phage assay to check for transfer of PaLoc 
As  the  PaLoc  has  been  proposed  to  be  of  phage  origin  [175],  the  PaLoc  may  be 
transferred via generalised transduction by either of the prophages that are present in 
strain  630  [8,104].  Concentrated  phage  suspensions  were  made  by  mitomycin  C 
induction of 630∆erm tcdB::ErmRAM. These phage suspensions were incubated with 
CD37  and  then  grown  on  selective  plates  to  determine  if  transfer  of  the  PaLoc 
occurred. No lincomycin resistant transductants were obtained in this phage assay.   
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To check if CD37 is sensitive for the C630-1 and C630-2 phages of 630, a plaque 
assay was performed with CD37 and CD843, a control strain which is sensitive to both 
C630-1 and C630-2 [175]. The plaque assays resulted in 100-200 plaques per CD843 
plate but none on the CD37 plates; this experiment was performed in triplicate. These 
results indicate that CD37 is not susceptible to  C630-1 and C630-2 and that the 
mechanism of transfer of the PaLoc is not through phage transduction by C630-1 and 
C630-2. 
5.4.4. Full genome sequencing 
In order to be able to predict the mechanism of transfer of the PaLoc and to see if 
further DNA was transferred, the genomes of the CD37 recipient strain, the Paloc386 
transconjugant,  containing  the  whole  PaLoc,  and  6  other  Paloc  transconjugants 
containing the tcdB ClosTron mutation were sequenced. 
5.4.4.1.  CD37 genome shotgun sequence 
The sequencing of strain CD37 has resulted in a total of 7,515,781 72bp paired end 
reads, which is approximately 130-fold coverage of the genome. The sequence of the 
245 contigs has been deposited in Genbank as a shotgun sequence under accession 
number  AHJJ01000000  [182].  These  contigs  were  mapped  to  the  630  reference 
sequence and annotated. The sequence was analysed using ACT. 
As expected, the PaLoc is not present in CD37 and a 115 bp sequence is present at the 
PaLoc integration site. This sequence is identical to the sequence in strain 7322 [32]. 
Furthermore, the sequence confirms the previous report that the CDT-locus is not 
present in CD37 [58].   
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Analysis  of  the  CD37  sequence  demonstrates  that  the  genome  contains  CTn1-like, 
CTn4-like and CTn7-like elements as well as a putative prophage [182](see Chapter 3).  
5.4.4.2.  Sequencing of transconjugants 
Whole genome shotgun sequencing was performed on the transconjugant Paloc386 
containing the wildtype PaLoc as well as for six of the transconjugants containing the 
PaLoc  with  a  ClosTron  insertion.  PCR  analysis  had  previously  shown  that 
transconjugants Paloc35 and Paloc37 respectively contain a copy of CTn5 and Tn5397, 
whereas Paloc386 contains a copy of both of these elements, (see Chapter 4). This was 
confirmed  by  the  genome  sequence  of  these  isolates.  Furthermore,  the  genetic 
elements described for CD37 were present in each of the transconjugants. 
To determine what part of the genome of the transconjugants is CD37 specific and 
what part is 630 specific, 30 regions of 10 kb were chosen, evenly spaced along the 630 
genome (Figure 5.4). Regions were chosen not to include CTns, Tn5398 the skin
Cd or 
either of the prophages. These regions were aligned with CD37 and for each region 
there were 7-123 SNPs between the CD37 and 630 sequences. The sequence of these 
regions is included in Appendix II. All of the seven PaLoc transconjugants were then 
aligned with these regions of CD37 and 630 in order to determine the origin of the 
DNA.  All  of  the  sequence  was  CD37  or  630  specific  although  some  gaps  in  the 
sequences were observed. Each of the transconjugants contained 630 specific SNPs in 
region 6 or 7 and Paloc386 contained 630 specific SNPs in regions 5 and 6. The PaLoc is 
situated between region 6 and 7 (Figure 5.4). Regions 1-4 and 8-30 were CD37 specific 
for each of the transconjugants (Table 5.2). 
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Figure 5.4 Circular representation of the regions used for SNP analysis on the 630 genome. 
Regions used for SNP analysis are shown in green. Positions of the MGEs are shown in blue. The PaLoc is 
shown in red. 
 
 
Table 5.2 Summary of the results of the SNP analysis in the transconjugants.  
Region 5, 6 or 7 contained 630 specific SNPs in each of the transconjugants. The PaLoc is situated 
between  region  6  and  region  7.  Regions  1-4  and  8-30  were  CD37  specific  for  each  of  the 
transconjugants. 
Region  Paloc386  Paloc12  Paloc22  Paloc26  Paloc35  Paloc37  Paloc46 
4  CD37  CD37  CD37  CD37  CD37  CD37  CD37 
5  630  CD37  CD37  CD37  CD37  CD37  CD37 
6  630  CD37  630  CD37  630  CD37  630 
7  CD37  630  CD37  630  CD37  630  CD37 
8  CD37  CD37  CD37  CD37  CD37  CD37  CD37 
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The sequence of the transconjugants between regions 4 and 8 were aligned with the 
630 and CD37 sequences in order to determine the precise size of each of the 630 
specific fragments that had transferred. The distance between the first and last 630 
specific fragment ranges between 66 kb and 271 kb (Table 5.3). The precise site of the 
630 specific fragments in the transconjugant genomes are shown in Figure 5.5. The 
sequence at the ends of the transferred DNA in each of the transconjugants is included 
in Appendix II. 
 
Table 5.3 Amount of 630 specific sequence for each of the Paloc transconjugants. 
Transconjugant  Size of 630 specific fragment 
Paloc386  271992 bp 
Paloc12  151692 bp 
Paloc22  157688 bp 
Paloc26  66034 bp 
Paloc35  224973 bp 
Paloc37  250027 bp 
Paloc46  141658 bp  
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Figure 5.5 Fragments of 630 specific sequence in CD37 transconjugants.  
A quarter of the circular representation of the 630 chromosome as shown in Figure 5.4 was magnified to 
show the locations of the 630 specific sequences present in each of the PaLoc transconjugants. All 
genetic fragments are labelled. Regions used for SNP analysis are shown in green. Positions of the MGEs 
are shown in blue. The PaLoc is shown in red. The 630 specific DNA fragment present in each of the 
transconjugants is shown with the transconjugant number. 
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5.5.  Discussion 
5.5.1. Transfer of the PaLoc 
Reproducible transfer of the PaLoc has been demonstrated here for the first time. 
Although the PaLoc has been hypothesised to be a mobile genetic element or a phage 
remnant [32], the transfer events described here are unlikely to be PaLoc specific as 
variable  amounts  of  630  DNA  have  transferred.  Analysing  the  transconjugants 
containing  the  PaLoc  could  not  indicate  a  specific  MGE  with  which  the  PaLoc  co-
transfers,  although  co-transfer  of  the  PaLoc  with  CTn1,  CTn5  and  Tn5397  was 
demonstrated. Although Tn5397 had transferred on the same transferred fragment as 
the PaLoc, CTn1 and CTn5 never transferred on the PaLoc fragment and transfer of 
these elements could be a separate event. Because of the presence of CTn4 and CTn7-
like elements in CD37, co-transfer of these two elements cannot be excluded. 
The  transfer  mechanism  of  the  PaLoc  was  not  determined,  although  a  number  of 
known mechanisms are considered to be highly unlikely. Transformation of free DNA 
has never been observed in C. difficile despite multiple attempts in our laboratory and 
others [105,107]. However, to rule out this possibility, filter-matings will be repeated in 
our lab on agar plates containing DNase.   
The PaLoc could have been transferred via transduction however, the size of the DNA 
fragments that were shown to transfer makes this unlikely as the transferred DNA is 
over three times the size of the phage genomes of C630-1 and C630-2 of strain 630. 
Furthermore, CD37 was shown not to be susceptible to the two prophages of 630 and 
transduction of the PaLoc from phage suspensions could not be shown.  
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The transfer of the PaLoc could be facilitated by a high frequency recombination (Hfr)-
type mechanism. During Hfr, a conjugative element mobilises the chromosome in cis 
by integrating into the chromosome or in trans by mobilising another element within 
the chromosome after which (part of) the chromosome is transferred into a recipient 
cell  [114,115,260].  The  transferred  fragment  of  DNA  will  recombine  with  the 
chromosome of the recipient cell through a double-crossover event replacing part of 
the recipient genome, a process which depends on the recombination protein RecA 
[104,114,115].  The  mechanism  has  been  described  in  a  number  of  Gram  negative 
bacteria but in Gram positive bacteria it has only been described in L. lactis [261]. The 
L. lactis sex factor is chromosomally located and can mobilise the chromosome but it 
can also transpose through site-specific recombination into non-conjugative plasmids 
in order to mobilise these [120,121] (Chapter 1). 
To  determine  if  the  transfer  event  is  Hfr,  a  number  of  experiments  need  to  be 
performed. As Hfr is a  RecA dependent event in the recipient strain, a CD37  recA 
mutant could be constructed and used as recipient in filter-matings. Hfr in C. difficile 
630 would most likely be mobilisation in cis by one of the CTns. In cis mobilisation 
would involve using the oriT of the CTn that facilitated the transfer which means the 
element rarely comes across completely as part of the element would be the last 
sequence to be transferred to the transconjugant. Part of the element that does come 
across may be lost during the double crossover event that integrates the transferred 
DNA  fragment  into  the  chromosome.  Furthermore,  if  the  element  responsible  for 
transfer is unique to 630 then recombination would not occur with this sequence and 
the  transferred  fragment  of  the  responsible  element  would  be  lost.  As  the  whole 
sequence of Tn5397 was present on the DNA fragment that transferred into CD37 in  
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two of the transconjugants, it is unlikely that the oriT of this element is used as the 
whole of the chromosome would have to have been transferred into the recipient cell. 
However, CTn1 and CTn2 are located close to this element and were not present in any 
of the transconjugants on the integrated DNA fragment (Figure 5.5). Therefore, one of 
these two elements may facilitate the Hfr transfer. In order to test this hypothesis, 
mutants could be made for genes that are essential for conjugative transfer of these 
elements. If genes which are essential for one of the elements are also essential for 
Hfr, then the element responsible for Hfr is identified. However, more than one of the 
CTns may be capable of mobilising the genome in this manner. 
The PaLoc contains the two major virulence factors that have been identified in C. 
difficile, making transfer of this locus clinically important. C. difficile has been shown 
here, and in previous studies, to exchange DNA with a number of species including B. 
subtilis [164], E. faecalis [163] and S. aureus [170]. Transfer of the PaLoc into any of 
these species is therefore theoretically possible and when the transfer mechanism of 
the  PaLoc  transfer  is  determined,  experiments  should  be  carried  out  in  order  to 
determine the host range. If the transfer mechanism is shown to be Hfr, transfer into 
unrelated species would be less likely. 
The cytotoxicity assay showed that the CD37 transconjugant has the same level of 
cytotoxicity as the donor strain. Although horizontally acquired DNA can be silenced 
after transfer, the PaLoc encodes two hypothetical regulators, tcdC and tcdD, which 
may also regulate toxin expression in transconjugants [52,53]. Furthermore, a recent 
paper  by  Dingle  et  al.  [89]  described  MLST  data  which  suggests  that  a  toxigenic 
sequence type-11 strain diverged millions of years ago but had only recently acquired  
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the PaLoc. This data suggests that the PaLoc transfer that was described here may 
have also occurred in vivo. 
Protective  colonization  with  non-toxigenic  C.  difficile  strains  is  a  new  strategy  to 
prevent colonization by toxigenic C. difficile. Protective colonization in hamsters was 
shown to lead to colonization resistance of toxigenic strains and to prevent disease 
symptoms [262]. Currently, human phase II trials are being conducted [263] however, 
if in vivo transfer of the PaLoc can occur, this treatment strategy may be less effective 
than expected and the effect on C. difficile epidemiology cannot be predicted. 
 
5.5.2. Conclusions 
The data in this chapter describes the transfer of the PaLoc from a toxigenic donor 
strain to a non-toxigenic recipient strain. The recipient strain becomes cytotoxic and 
produces similar levels of toxin as the wildtype donor strain. 
The transfer mechanism of the PaLoc transfer is still unknown although a number of 
transfer methods have been ruled out. Transfer via transformation is unlikely due to 
the  natural  inability  of  C.  difficile  to  take  up  DNA  under  laboratory  conditions. 
Furthermore, the size of the transferred DNA fragment in some of the transconjugants 
is more than three times larger than the phage genomes of C630-1 and C630-2 of 
strain 630, making transduction of the DNA fragment highly unlikely. As the size of the 
DNA fragment that was incorporated in the recipient chromosome varies between the 
transconjugants, the donor DNA could be incorporated by non-specific recombination. 
This leads to the hypothesis that a Hfr-like transfer mechanism could be responsible 
for the transfer of the PaLoc into non-toxigenic strains.  
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Chapter 6  The effects of CTns on the transcriptome 
6.1.  Introduction 
6.1.1. The effect of MGE acquisition on the transcriptome 
Many  CTns  contain  predicted  transcriptional  regulators,  two-component  regulatory 
systems and alternative 70 sigma factors, as discussed in Chapter 3. These regulators 
are hypothesised to regulate the genes encoded on the element [138]. However, some 
elements  encode  a  disproportionally  large  number  of  putative  transcriptional 
regulators  such  as  Tn6103  in  R20291,  which  encodes  a  two-component  regulator 
system and also has the putative mobilisable elements Tn6104, Tn6105 and Tn6106 
inserted into it, which encode another five putative transcriptional regulators and five 
predicted alternative sigma factors (Chapter 3). 
The transcriptional regulation system of CTns has been studied primarily in Tn916 but 
this is still not completely understood. A mechanism of transcriptional attenuation by 
orf12 on Tn916 regulates tet(M) transcription, which is de-repressed by the presence 
of tetracycline [222]. Read-through from this gene into the downstream recombination 
and conjugation modules is hypothesised to be responsible for the increase in transfer 
frequency of Tn916 in the presence of tetracycline [127,138]. 
The ORFs involved in transcriptional regulation of Tn916 are conserved in Tn5397 and 
these elements induce the loss of the other element upon entering the cell [156]. This 
loss of a residing copy of Tn916 is not seen when a second copy of Tn916, marked with 
erm(B), is introduced. Similarly, Tn5397 can stably reside in strain 630 with 5 other 
CTns. It is expected that the transcriptional regulators of Tn916 and Tn5397 can act in 
trans, however, differences in the regulation of the excision and integration modules  
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of these elements cause the loss of the residing element upon introduction of the new 
element [156]. 
Another example of MGEs affecting the expression of other MGEs is the Salmonella 
Pathogenicity  Island  1  (SPI-1)  which  is  essential  for  Salmonella  enterica  to  invade 
epithelial cells in the intestine. Recently, the std fimbrial cluster, another horizontally 
acquired genetic element, was shown to regulate the expression of SPI-1 genes and 
overexpression of the std genes resulted in an invasion defect [264].  
Besides the effects that transcriptional regulators encoded on MGEs may have on the 
transcription  of  genes  encoded  on  other  MGEs,  MGEs  can  also  affect  the  general 
transcriptome  of  their  host  cell.  In  three  Pseudomonas  spp.  a  comparison  of  the 
transcriptome was made using a microarray between plasmid-free strains and strains 
containing the incompatibility group P7 archetype plasmid pCAR1. Between 73-125 
chromosomal genes per host were shown to be differentially expressed when pCAR1 
was present. Although most of these genes overlap between the hosts, the effects that 
the element has on the transcriptome differs between strains [265].  
These examples demonstrate that MGEs can have effects  in trans on the genes of 
other  MGEs  and  genes  of  their  host  chromosome.  The  transcriptional  regulators 
encoded  on  the  CTns  in  C.  difficile  may  also  affect  the  general  transcriptome.  As 
described in Chapter 4, mutations were made for the AraC transcriptional regulator 
CD0428  encoded  on  CTn2  and  for  the  two-component  transcriptional  regulator 
CD1099  on  CTn4.  The  transcriptomes  of  these  mutants  were  compared  with  the 
transcriptome of the parental strain, 630erm. 630erm is an erythromycin sensitive 
derivative  strain  from  630  containing  a  deletion  in  the  erythromycin  resistance 
conferring  element  Tn5398  [48].  The  strain  was  derived  through  repeated  sub- 
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culturing and, apart from this deletion, acquired 21 SNP mutations of which 5 are 
located in CDS (Dr. S. Kuehne, personal communication). It is unknown if these SNPs 
have  any  influence  on  the  phenotype  of  630∆erm.  As  630erm  is  often  used  for 
mutational  analysis,  the  transcriptome  of  this  strain  was  compared  to  the 
transcriptome of the wildtype strain 630 to determine the biological relevance of these 
SNPs.  Furthermore,  it  was  attempted  to  target  the  ClosTron  to  alternative  sigma 
factors encoded on Tn6104 and Tn6105 in R20291 to compare the transcriptomes of 
these mutants to wildtype R20291. 
 
6.1.2.  RNA-seq 
RNA-seq is a novel technique using high-throughput sequencing of cDNA in order to 
determine the sequences of all transcripts in a cell. Generally, the sequencing data can 
be used for two purposes. First, the start of the transcripts will allow for the detection 
of  start  sites,  untranslated  regions  (UTRs)  and  small  regulatory  RNA  molecules. 
Furthermore, the number of reads for each gene can be used to determine the level of 
transcription for each gene in the transcriptome [266,267]. 
So far, RNA-seq has been used in a number of prokaryote studies. One of these is the 
study of the effect of ethanol on the human pathogen Acinetobacter baumanii studied 
to explain a previously reported increase in virulence in the presence of ethanol [268]. 
Comparison of the cultures grown in the presence and absence of ethanol showed 
expression of 49 genes was induced by ethanol whereas 21 were repressed. Most of 
these  genes  are  involved  in  metabolism,  stress  response  and  permeases  of  efflux 
pumps [268]. Furthermore, the upregulation of phospholipase C was shown, which is a  
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known  virulence  factor  in  a  number  of  bacteria  due  to  its  hydrolase  activity  of 
phospholipids [269]. A phospholipase C knockout mutant in A. baumanii was made 
which was shown to have reduced virulence [268].  
RNA-seq was used here to study the effects on the transcriptome of specific mutations 
of transcriptional regulators encoded on CTns and to analyse differences between the 
transcriptomes of 630 and 630∆erm.  
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6.2.  Aims of this chapter:  
  Retargeting the ClosTron to alternative sigma factors encoded on Tn6104 and 
Tn6105 in R20291.  
  Determining if transcriptional regulators CD0428 and CD1099 encoded on CTn2 
and CTn4, respectively, are transcriptionally active. 
  Determining the effect on the transcriptome of insertional mutations of 
CD0428 and CD1099. 
  Comparing the transcriptome of strain 630 and 630∆erm. 
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6.3.  Materials and methods 
6.3.1. RT-PCR 
RT-PCR was performed using cDNA as template, generated as described in section 
6.3.2.4. The RNA that was used for cDNA generation was used as a negative control. 
PCR was performed as described in Chapter 2. Primers are listed in Table 6.1. 
 
Table 6.1 Primers used for RT-PCR. 
Primer   Sequence 5’- 3’   Amplicon 
CD0428 F  CATGGAATCTTCGCATCAGA  0.4 kb 
CD0428 R  GCGAATGTCCTCACTAACCG 
CD1099 F  GTCCATACCGGGCATCATAA  0.2 kb 
CD1099 R  CAGAAAGGACGGGTGTTGTT 
 
6.3.2. RNA sequencing 
Up to the stage of the generation of cDNA, the protocols described here were all 
performed in an environment that was thoroughly cleaned with RNase Zap (Invitrogen, 
Paisley, UK). Nuclease free H2O and nuclease-free barrier tips and plastic ware were 
used throughout.  
6.3.2.1.  RNA extraction 
Cells were grown for 16 h BHI broth. 2 ml was added to 18 ml of fresh broth and grown 
for approximately 4 h, to OD600 of approximately 0.5 (exponential phase). 10 ml of cells 
were then added to 20 ml of RNA protect (Qiagen, UK) in an anaerobic incubator. Cells 
were vortexed, incubated at RT for 5 min and recovered by centrifugation for 10 min at 
4500 x g. The supernatant was discarded and the tubes were kept upside down for 1  
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min on a piece of absorbent paper. Pellets were stored at -20 °C for a maximum of 2 
weeks. 
RNA  was  extracted  using  the  Fast  RNA pro  blue  extraction  (MP  Biomedicals,  USA) 
according to the manufacturer’s instructions. RNA pellets were resuspended in 100 μl 
H2O. After 5 min of incubation at RT, a 2 μl aliquot was taken for assessment on a 
Bioanalyzer and the remaining sample was stored at -70 °C. 
The RNA was analysed on an Agilent 2100 Bioanalyzer using the Agilent RNA 6000 
Nano Kit (Agilent technologies) for quantification and quality assessment according to 
the manufacturer’s instructions. The Agilent 2100 expert software calculated the RNA 
integrity number (RIN) and the RNA concentration. Where RIN could not be calculated, 
the electropherogram was used to assess the quality of the sample. 
6.3.2.2.  DNase treatment 
RNA  samples  were  treated  with  the  Ambion  DNA-free  kit  (Invitrogen,  Paisley,  UK) 
according  to  the  manufacturer’s  instructions.  Ten  microgram  RNA  was  used  per 
reaction, H2O was added to a total volume of 44 μl. Five microliters of DNase buffer 
and 1 μl of DNase I (2 units per µl) were added after which samples were incubated at 
37 °C for 20 min. Five and a half microliters DNase inactivation reagent was added to 
the reaction. Tubes were incubated at RT for 2 min after which the samples were 
centrifuged at 4 °C for 90 sec at 10,000 x g and the RNA was transferred to a fresh 
tube. EDTA was added to the solution to a final concentration of 1 mM. 
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6.3.2.3.  mRNA isolation 
mRNA was isolated using a MICROBexpress kit (Invitrogen, Paisley, UK) according to 
the manufacturer’s instructions. 10 μl of DNA-free treated RNA was used as input 
containing 2 to 5 μg RNA. Samples were stored at -80 °C and analysed by a Bioanalyzer 
before these were used for downstream protocols. 
6.3.2.4.  Generation of cDNA 
cDNA  was  generated  using  the  Ovation  RNA-seq  System  (NuGEN,  Bemmel,  The 
Netherlands) according to the manufacturer’s instructions. To prepare the samples, 
H2O was added to an aliquot of 30 ng of mRNA up to a final volume of 5 μl. cDNA was 
purified using the Qiaquick PCR purification kit (Qiagen) with minor modifications to 
the manufacturer’s instructions, which are included in the protocol of the NuGEN kit.  
6.3.2.5.  RNA library preparation 
cDNA was fragmented and adaptor molecules added using the Encore NGS Multiplex 
system  I  kit  (NuGEN,  Bemmel,  The  Netherlands),  according  to  the  manufacturer’s 
instructions. 
An aliquot of 5 μg cDNA was diluted to a total volume of 120 μl in TE buffer and 
fragmented in a Covaris S-series sonication system. System settings as recommended 
by the NuGEN kit: Duty cycle 10%, Intensity level 5, 100 cycles, 5 min. Samples were 
analysed on the Bioanalyzer and stored at -20 °C.  
Fragmented cDNA samples were concentrated using the Qiaquick PCR purification kit 
as explained above. 50 μl of H2O heated to 50 °C was loaded to the middle of the 
column and incubated 5 min at RT to elute the cDNA. After 1 min centrifugation at  
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16,000 x g the sample was loaded back onto the column and centrifuged again. The 
samples were quantified on a Nanodrop 1000. 
Aliquots of 200 ng fragmented cDNA were diluted to a total volume of 7 μl in H2O to 
prepare  the  cDNA  libraries.  The  samples  were  analysed  on  a  Bioanalyzer  before 
sequencing. 
6.3.2.6.  RNA sequencing 
Dr. Tony Brooks performed sequencing of the cDNA libraries at UCL genomics, the 
samples were sequenced as a 72 bp paired end multiplex reaction on an Illumina GAII-
X.  
Dr.  Warren  Emmett  assembled  the  RNAseq  data.  Custom  de-multiplexing  was 
performed to sort the reads to the specific samples. The reads were filtered to identify 
exact  duplicates  after  which  they  were  aligned  against  the  reference  genome  630 
(AM18035) using the BWA software [270]. HTseq software [271] was used to generate 
counts  of  the  reads  that  aligned  specifically  to  630  genes.  The  read  counts  were 
processed  using  the  DEseq  package  and  comparisons  were  made  between  the 
transcription levels of genes in strains 630, 630erm, 630erm CD0428::ErmRAM and 
630erm CD0428::ErmRAM [272]. 
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6.4.  Results 
6.4.1. Transcription of CD0428 and CD1099 
Before  RNA-seq  was  performed  on  strains  containing  the  mutated  transcriptional 
regulators CD0428 on CTn2 and CD1099 on CTn4, the expression of these genes was 
studied. cDNA was produced from RNA samples of 630 in exponential growth phase. 
This cDNA was used as template for RT-PCR for these two genes using primer pairs 
CD0428 F+R and CD1099 F+R. mRNA was used as a negative control to determine the 
presence of DNA. Both genes are transcribed in 630 during exponential growth (Figure 
6.1) and the mutant versions of these genes were selected for the RNA-seq study in 
which the transcriptome of the mutants was compared with that of the parental strain. 
 
Figure 6.1 RT-PCR for CD0428 and CD1099.  
RT-PCR was performed on cDNA produced from RNA of strain 630 cells in exponential growth. a) RT-PCR 
for CD0428 using primer pair CD0428 TSF+TSR, expected product size 400 bp. b) RT-PCR for CD1099 
using primer pair CD1099 TSF+TSR, expected product size 400 bp. Template in lanes 1 & 3 is 630 cDNA, 
lanes 2 & 4 is 630 mRNA, lane 5 is 630 genomic DNA, lane – is H2O, lane M is a molecular marker. Size of 
the fragments is shown left of the figure. 
 
6.4.2. ClosTron mutants in R20291 alternative sigma factors 
R20291  Tn6103  contains  insertions  of  the  putative  mobilisable  elements  Tn6104, 
Tn6105  and  Tn6106,  which  encode  five  predicted  alternative  sigma  factors.  The 
ClosTron was retargeted to three of these genes; Tn6104 CDS1748 and CDS1754 and  
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to  Tn6105  CDS1770  (Figure  6.3).  In  parallel  with  these,  the  ClosTron  was  also 
retargeted to CDS1803 on Tn6103, as described in Chapter 4. The ClosTron plasmids 
were conjugated from E. coli into R20291 which resulted in thiamphenicol resistant 
colonies. These were shown to contain the unspliced ErmRAM as  expected (Figure 
6.2). Although the gel bands appear to have shifted a little in lanes 2 and 3 for an 
unknown reason, all of these products are expected to be ClosTron plasmid products. 
Culturing of these isolates on lincomycin only resulted in lincomycin resistant colonies 
for  CDS1803  (Chapter  4)  and  no  ClosTron  mutants  were  obtained  for  CDS  1748, 
CDS1754 or CDS 1770 encoded on Tn6104 and Tn6105. 
 
 
Figure 6.2 PCR for presence of retargeted ClosTron plasmids in R20291.  
Colony  PCR  was  performed  on  thiamphenicol  resistant  R20291  isolates  to  confirm  presence  of  the 
plasmid containing the retargeted ClosTron. The primer pair in all reactions was ErmRAM F+R and the 
expected product size was 1.2 kb. The template in lane 1 was R20291 containing the ClosTron plasmid 
retargeted to CDS1754, lanes 2, 3 and 4 was R20291 containing the ClosTron plasmid retargeted to 
CDS1748 and lane 5 was R20291 containing the ClosTron plasmid retargeted to CDS1803. The template 
in  lane  –  is  H2O,  lane  M  is  a  molecular  marker.  Size  of  the  fragments  is  shown  left  of  the  figure.
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Figure 6.3 Attempts to obtain ClosTron insertions in Tn6104 and Tn6105.  
The schematic of Tn6103 is shown as two parts which should be joined at the grey diagonal line. The targets for ClosTron insertions on Tn6104 and Tn6105 are indicated by red 
arrows. ORF 1803 that was shown to contain the ClosTron insertion is shown in pink. ORFs of Tn6104, Tn6105 and Tn6106 are shown in yellow. ORFs on the recombination module 
of Tn6103 and the recombinases of Tn6104, Tn6105 and Tn6106 are shown in grey. ORFs on the conjugation module of Tn6103 are shown in blue. ORFs on the accessory module 
are shown in green. ORFs that were interrupted by an insertion of a DNA fragment, compared to CTn5, are shown in orange.   
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6.4.3. RNA-seq results 
6.4.3.1.  Biological variation between the samples 
RNA  from  strains  630,  630∆erm,  630∆erm  CD0428::ErmRAM  (CTn2  mutant)  and 
630∆erm CD1099::ErmRAM (CTn4 mutant) was isolated and reverse transcribed into 
cDNA. The cDNA was fragmented into 150 to 400 bp fragments as measured by the 
Bioanalyzer (Figure 6.4). Adaptor ligation was carried out after which sequencing was 
performed by Dr. Tony Brooks at UCL Genomics. 
 
 
Figure 6.4 Size distribution of cDNA samples after fragmentation for RNA-seq.  
The  Bioanalyzer  measures  the  intensity  of  fluorescence  over  time  to  detect  the  size  of  each  DNA 
fragment in the sample. This is plotted as fluorescent units on the y-axis and number of basepairs on the 
x-axis. The peaks at 15 and 1500 bp show the calibration controls in the sample. The horizontal line 
above the sample peak shows the region of the distribution over which the sample concentration was 
calculated. The sample concentration is shown at the top of the distribution in ng/l. 
 
Initial  analysis  of  the  RNA-seq  data  was  performed  by  Dr.  Warren  Emmet  using  a 
number  of  bioinformatics  packages.  The  DEseq  package  was  used  to  process  read 
counts and perform statistical analysis [272]. The expected variation between technical 
replicates and the actual biological variation between the RNA samples are shown in  
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Figure 6.5. These are calculated following a data-driven algorithm that looks at the 
relationship between the mean and standard deviation of the transcription of each 
gene [272]. The variation is expected to be high for low transcription counts but is 
expected  to decrease  for  higher  counts  as  seen  for  sample 630G  (purple  graph  in 
Figure 6.5), which is a sample that was prepared in parallel for another study. All other 
samples show high variation between the replicates for the high transcription counts. 
The plot demonstrates that significant biological variation between the replicates of 
each sample is present. Adjusted p-values for the biological variation are calculated for 
each gene by the package. These adjusted p-values will be high for the genes where 
variation between the replicates is high which may result in differential expression of 
genes being false-negative. This could be corrected for by including a higher number of 
biological replicates, however, these could not be included in this study. 
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Figure 6.5 Plot for the variation between RNA-seq samples.  
The  squared  coefficient  of  variation  is  plotted  against  the  mean  of  transcription  levels  of  the  RNA 
samples. The y-axis show the expected technical variation based on the samples, the x-axis shows the 
read  count  of  the  transcripts.  The  dotted  lines  depict  the  expected  variation  between  technical 
replicates whereas the solid lines show the biological variation between the samples. The legend in the 
figure shows which colour belongs to each sample. 630G are RNA samples for another study, which are 
included to show the expected variation between biological samples. 
 
6.4.3.2.  Differential expression of the CTn2 mutant  
The  transcriptome  of  the  CTn2  AraC  transcriptional  regulator  mutant,  630∆erm 
CD0428::ErmRAM, was compared to the transcriptome of 630∆erm (Table 6.2). The 
transcription  reads  of  the  erm(B)  gene  on  the  ErmRAM  in  the  CTn2  mutant  were 
aligned to the two erm(B) copies on Tn5398 in 630 by the bioinformatics software. 
Although  only  the  non-functional  erm(B1)  is  present  on  Tn5398  in  this  strain,  the 
differences observed in transcription between both erm(B) genes can be ignored as 
these are false positive results generated by the ClosTron insertion.   
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In the CTn2 mutant, a predicted proline  iminopeptidase, CD1997,  was upregulated 
compared  to  630∆erm.  Bioinformatics  analysis  of  the  predicted  protein  indicates 
domains with peptidase activity. Furthermore, the orphan response regulator CD2047 
was upregulated in the CTn2 mutant. Both of these genes are not located on or near 
CTn2 in the chromosome. As the precise functions of these genes are unknown, no 
predictions can be made towards the effects of the differential expression of these 
genes between the mutant and 630∆erm. 
 
 
Table 6.2 Differential expression of 630erm CD0428::ErmRAM vs 630erm.  
Fold  change  was  calculated  as  expression  in  630erm  CD0428::ErmRAM  divided  by  expression  in 
630erm. p-adj is the adjusted p-value. 
Gene  Function  p-adj  Fold change 
CD1997 
 
Proline iminopeptidase 
 
 
3.52 x 10
-2 
 
 
11.15 
  CD2007  Tn5398 erm(B2) 
 
1.81 x 10
-8  31.64 
CD2010  Tn5398 erm(B1)  8.47 x 10
-8  23.14 
CD2047  2-component response regulator  6.97 x 10
-6  18.55 
 
6.4.3.3.  Differential expression of the CTn4 mutant 
The  transcriptome  of  the  CTn4  two-component  transcriptional  regulator  mutant, 
630∆erm CD1099::ErmRAM, was compared to the transcriptome of 630∆erm (Table 
6.3). Transcription of the erm(B) gene on the ErmRAM in the CTn4 mutant was aligned 
to  the  two  erm(B)  copies  on  Tn5398,  although  only  the  non-functional  erm(B1)  is 
present  on  Tn5398  in  this  strain.  The  orphan  response  regulator  CD2047  was 
upregulated in the CTn4 mutant compared to 630∆erm, similar to the CTn2 mutant. As  
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the function of the gene is unknown, no predictions can be made towards the effects 
of the differential expression of CD2047 between the mutant and 630∆erm. 
Table 6.3 Differential expression of 630erm CD1099::ErmRAM vs 630erm. 
Fold change was calculated as expression in 630erm CD0428::ErmRAM divided by expression in 
630erm. p-adj is the adjusted p-value. 
Gene  Function  p-adj  Fold change 
CD2007  Tn5398 erm(B2) 
 
1.59 x 10
-8  30.76 
CD2010  Tn5398 erm(B1)  1.59 x 10
-8  25.07 
CD2047  2-component response regulator  1.62 x 10
-5  13.68 
 
6.4.3.4.  Differential expression of 630 vs 630erm 
The differential mRNA expression of strain 630erm compared to 630 is summarised in 
Table 6.4. 630erm is a derivative of strain 630 which is erythromycin sensitive due to 
a deletion in Tn5398. This deletion has also affected the transcription of the adjacent 
ORFs erm(B1), orf3a and orf13 (Table 6.4). Transcription of the other ORFs encoded on 
Tn5398 has not changed: minimal transcription is measured for effD, orf7 and orf9 
while the predicted transcriptional regulator effR is highly transcribed in both strains 
(data not shown). 
Other genes that were differentially expressed between 630 and 630∆erm are all four 
genes  of  a  predicted  oxidative  stress  operon  (CD0825-CD0828)  which  were 
upregulated in 630erm. Rubrerythrin is an iron binding protein first identified in the 
anaerobic Desulfovibrio vulgaris of which no particular function has been described yet 
[273]. The ferric uptake regulator (Fur) has been shown to regulate iron uptake of the 
cell in the facultative anaerobe  Pseudomonas  aeruginosa where it also regulates a  
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number of other cellular functions  [274]. Desulfoferrodoxin is another iron binding 
protein from D. vulgaris which has oxidoreductase activity [275]. CD0828 contains two 
iron-binding  domains  with  predicted  oxidoreductase  activity,  which  has  been 
annotated  as  an  oxidative  stress  protein  [8],  although  it  seems  there  is  no 
experimental proof of this function.  
The orphan response regulator CD2047 is downregulated in 630erm, however, it is 
unknown  what  the  function  of  the  regulator  is.  Furthermore,  the  trehalose-6-
phosphate hydrolase treA is upregulated in 630erm, which may have a function in 
sugar metabolism.  
 
Table 6.4 Differential expression of 630 vs 630erm.  
Fold  change  was  calculated  as  expression  in  630erm  divided  by  expression  in  630.  0  means  no 
expression was detected in 630erm. p-adj is the adjusted p-value. 
Gene  Function  p-adj  Fold change 
CD0825  Rubrerythrin  7.70 x 10
-8 
 
25.15 
CD0826  Fur transcriptional regulator  4.61 x 10
-7  17.34 
CD0827  Desulfoferrodoxin  4.67 x 10
-6  18.93 
CD0828  Oxidative stress protein  1.89 x 10
-7  21.91 
CD2005  Tn5398 ORF13  4.08 x 10
-7  0.06 
CD2006  Tn5398 ORF3b  4.30 x 10
-5  0.03 
CD2007  Tn5398 erm(B)2  4.15 x 10
-13 
 
0.02 
CD2008  Tn5398 ORF298  1.48 x 10
-16  0.01 
CD2009  Tn5398 ORF3a  3.07 x 10
-5  0 
CD2010  Tn5398 erm(B)1  9.26 x 10
-13  0.03 
CD2047  2-component response regulator  2.34 x 10
-5  0.10 
CD3091  Trehalose-6-phosphate hydrolase  8.62 x 10
-5  7.21  
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6.5.  Discussion   
6.5.1. Design of the experimental methods 
Although great care was taken to treat the samples in identical conditions and the 
cultures were treated with RNA Protect to prevent transcriptomic effects by oxygen 
shock or RNA degradation during centrifugation of the culture or other stages of RNA 
extraction, the RNA-seq results described here suffered from high biological variation 
between the triple replicates of each sample, 
Adjusted  p-values  were  calculated  for  each  differentially  expressed  gene  and  only 
those  genes  with  an  adjusted  p-value    0.05  were  described  here.  Most  RNA-seq 
studies that were described in the literature so far have used different methods for the 
comparison  of  samples.  For  instance,  Camarena  et  al.  [268]  used  RNA  from  two 
replicates but combined the reads before analysis. Effectively, this means there are no 
controls for variation between the samples, which eliminates the possibility to adjust 
the p-value for the biological variation between the replicates and p-values of these 
results may therefore be less significant than as they are presented. Dotsch et al. [276] 
used a similar approach as used in the study described here, using the DEseq package 
for statistical analysis of the biological variation of the samples, however, this study 
only uses duplicate samples for each of the conditions that was studied. Although the 
data from these studies is still valid, it is less robust than studies that use a higher 
number of samples. 
Although  using  less  biological  replicates  would  have  resulted  in  lower  biological 
variation in the study described here, the results would have been less significant. To 
reduce the biological variation between samples a higher number of replicates could  
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be  used.  Furthermore,  our  samples  were  sequenced  in  multiplex  reactions  with  4 
samples per sequencing lane. Using the same number of replicates but fewer samples 
per lane would increase the cost of the study but could reduce the biological variation 
that was observed in this study. 
6.5.2. Effects of CTn mutations on the transcriptome 
No significant differences were observed between the transcriptomes of 630∆erm and 
the  CTn2  and  CTn4  transcriptional  regulator  mutants.  Both  mutants  appeared  to 
upregulate CD2047 compared to 630∆erm, however, the comparison of 630∆erm to 
630  shows  a  downregulation  in  630∆erm.  Comparison  of  transcription  of  CD2047 
between  630  and  both  mutants  shows  no  significant  difference  (data  not  shown) 
which could indicate the effects on CD2047 could be an artefact in the transcriptomic 
data for 630∆erm. 
The lack of differential expression in the transcriptome may have been caused by the 
variation that was measured between the biological replicates. However, other factors 
could have contributed to this such as the type of media that was used to culture the 
strains and the growth phase in which the RNA was isolated. Although these regulators 
appear to have little effect on the transcriptome, further study of other transcriptional 
regulators  could  identify  CTns  that  affect  the  transcription  of  genes  in  the 
chromosome. 
In  order  to  study  the  effects  of  predicted  sigma  factors  encoded  on  Tn6104  and 
Tn6105 in R20291, it was attempted to make ClosTron mutants with the ClosTron 2.0 
system. Although several attempts were made, none of the mutants were generated. 
Although these predicted sigma factors are encoded on MGEs, it is possible that these 
have  become  essential,  or  very  important,  genes  for  the  survival  of  the  strain.  
197 
However, other research groups have confirmed difficulty of generating mutants in 
R20291  (personal  communication  with  Dennis  Bakker,  LUMC,  and  Melissa  Martin, 
LSHTM)  and  choosing  different  target  sites  within  these  genes  may  result  in  the 
mutations. 
6.5.3. Comparison of the 630 and 630∆erm transcriptomes 
The erythromycin susceptible strain 630erm, derived from 630, has a deletion in the 
genetic element Tn5398 which includes orf298, orf3b and erm(B2) [48]. This deletion 
has led to the loss of erythromycin resistance but no other phenotypical differences 
have  been  described  between  the  strains  and  630erm  is  now  a  commonly  used 
laboratory strain as it was the first strain in which targeted mutagenesis using the 
ClosTron  system  was  demonstrated  [241].  RNA-seq  was  used  to  compare  the 
transcriptomes of 630 and 630erm to determine if secondary mutations in 630erm 
may have caused transcriptomic differences between these strains. In contrast with 
630, the transcription of the ORFs adjacent to the deletion in Tn5398, erm(B1), orf3a 
and orf13, was minimal. Transcription of the other ORFs encoded on Tn5398 has not 
changed. 
Differential gene expression was also observed in 630erm for some genes outside of 
Tn5398. A predicted oxidative stress operon was upregulated in 630erm spanning 
CD0825-CD0828 which encodes a putative ferric uptake regulator (fur) and three iron 
binding proteins with predicted oxido-reductase activity. The sequence of 630∆erm 
shows there is a threonine to alanine mutation in codon 41 in the sequence of Fur 
which may be responsible for the differential expression of the operon. This mutation 
was not found in the sequence of any of the genomes of natural isolates that have 
been sequenced.  
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Iron  is  an  essential  nutrient  for  pathogenic  bacteria  and  iron  acquisition  in  Gram-
negative pathogens has been studied thoroughly [277]. Although less is known of iron 
uptake by Gram-positive bacteria, the process is regulated by Fur which also plays a 
role in regulation of further cellular processes [277,278]. Although the upregulation of 
fur  would  be  expected  to  lead  to  great  differences  in  the  transcriptome,  only 
differential expression of a small number of genes was observed here. Perhaps further 
differences in expression were not measured because of the biological variation in the 
samples that was discussed above.  
The  trehalose-6-phosphate  hydrolase  treA  (CD3091)  is  upregulated  in  630erm, 
compared to 630. treA can hydrolyse trehalose-6-phosphate into glucose and glucose-
6-phosphate which can be used by the cell as an energy source [279]. Changes in the 
sugar metabolism of the cell could prove to be advantageous adaptations for growth in 
laboratory conditions. 
 
6.5.4. Conclusions 
Although  great  care  was  taken  to  culture  all  cells  for  RNA  isolation  in  identical 
conditions, significant biological variation was observed in the results described here. 
In  future  experiments, this  variation  will  have  to  be  eliminated  in  order  to  obtain 
higher quality results. 
The only significant difference between the mutants and the parental strain 630∆erm 
was the upregulation of the proline iminopeptidase for the mutant of the regulator on 
CTn2.  However,  some  effects  may  have  been  masked  by  the  biological  variation 
between replicate samples and no definite conclusion can be drawn yet.   
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The results presented in this chapter demonstrate the importance of comparing results 
for ClosTron generated mutants in 630erm to a 630erm control instead of to 630 
wildtype.  Further  study  of  the  differentially  expressed  genes  between  630  and 
630erm  will  have  to  establish  what  precise  effects  these  changes  in  the 
transcriptome may have on the physiology of the cell.  
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Chapter 7  General conclusions 
C.  difficile  is  a  nosocomial  pathogen  with  very  low  genome  conservation  which  is 
hypothesized  to  be  due  to  the  large  number  of  MGEs  that  all  sequenced  strains 
contain [15,88]. The bioinformatics study here of 15 sequenced genomes of C. difficile 
resulted  in  the  discovery  of  34  novel  putative  CTns  and  mobilisable  transposons 
(Chapter3). It was expected that these elements would encode for some antimicrobial 
resistance genes, however, putative resistance genes were only found on 7 of these 
elements. Further analysis showed that accessory regions of the elements described 
here mainly encode ABC-transporters. Furthermore, most of these elements encode a 
number  of  transcriptional  regulators,  sigma  factors  and  two-component  regulatory 
systems.  It  was  hypothesised  that  a  number  of  these  may  have  effects  on  genes 
outside of the CTn on which they are encoded, and acquisition of these CTns could 
lead to phenotypical changes including up or down regulation of virulence factors. 
This was tested by comparing knockout mutants for transcriptional regulators encoded 
on CTn2 and CTn4 generated in strain 630erm to the wildtype 630erm using RNA-
seq (Chapter 6). No significant differences were measured between the CTn4 mutant 
and only upregulation of a predicted proline iminopeptidase was observed for the 
CTn2  mutant.  Additionally,  630erm  was  also  compared  to  the  wildtype  630  and 
showed  significant  upregulation  of  all  four  genes  from  an  oxidative  stress  operon 
including  the  Fur  transcriptional  regulator  which  is  involved  in  diverse  cellular 
functions in other species [274]. As Tn5398 is located away from this operon in the 
genome, it is unlikely that the deletion of erm(B) from this element would cause these 
effects. The difference in transcription of this operon between 630 and 630∆erm could  
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have effects on virulence and needs to be considered by researchers that currently use 
the strain to produce mutants for virulence and other phenotypic studies. 
A previous study described a putative collagen binding protein at the ends of CTn1 and 
CTn7  [8].  Bioinformatics  analysis  has  shown  this  gene  to  be  present  on  CTn1-like 
elements in 16 out of 18 strains of C. difficile that were studied here (Chapter 3). 
Additionally, a recent study by He et al. [280] showed that CTn1-like elements were 
present in all 151 ribotype 027 strains sequenced for a global epidemiological study of 
this  ribotype.  The  putative  cell  surface  gene  has  significant  homology  to  a  known 
collagen  binding  protein  from  S.  aureus  [226]  but  does  not  contain  the  collagen 
binding  domains  and  the  function  of  the  gene  in  C.  difficile  is  unknown.  ClosTron 
insertion in these genes in CTn1 and CTn7 did not stop conjugative transfer and the 
protein is assumed to have an accessory function (Chapter 4). The fact that the gene 
has been conserved on so many related CTns indicates it may confer some advantages 
to the host, however, the function remains currently unknown. 
 
Excision of a CTn from the genome into a circular intermediate is hypothesized to be 
the first step before conjugative transfer [127]. Circular molecules were detected for 
11 elements in six different strains (Chapter 4). Using the ClosTron system, an erm(B) 
gene was introduced into the elements of strains 630 and R20291 that excised. This 
allowed for the selection of erythromycin resistance during filter-mating assays for the 
transfer of these elements. Transfer was shown from strain 630∆erm into C. difficile 
CD37 for all five elements tested; CTn1, CTn2, CTn4, CTn5 and CTn7. Additionally, CTn5 
also transferred to B. subtilis. Tn6103 from R20291 did not transfer in the studies  
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reported here, possibly due to three insertions that are present within genes of the 
conjugation module. 
Transconjugants of these filter-matings were analysed to determine if the elements 
can  integrate  in  multiple  target  sites  in  CD37 and  to  see  if  multiple copies  of the 
elements are present in the transconjugants. CTn1, CTn2 and CTn5 were present in 
transconjugants at several different integration sites in the genome. CD37 contains a 
CTn4  and  a  CTn7-like  element  [182],  which  complicates  the  analysis  of  the 
transconjugants of these elements. CTn7 at least does have multiple target sites in the 
genome in CD37 transconjugants. Further analysis could be performed if the genomes 
of the transconjugants were sequenced. Further study of these transconjugants looked 
into co-transfer of the CTns. As only one element per donor contained erm(B), only this 
element  is  selected  during  filter-matings.  However,  CTn2,  CTn5  and  Tn5397  were 
shown  to  co-transfer  without  any  selection.  The  Tn5397  transconjugants  were 
tetracycline  resistant,  as  expected,  which  demonstrates  the  clinical  importance  of 
research into this type of (co-)transfer to better understand which factors may induce 
such events.  
As CTns are very promiscuous elements, they can spread to other species and disperse 
antibiotic resistance genes and other genes which may be beneficial to pathogens. If 
factors that induce the transfer of CTns are identified then spread may be prevented 
or minimised. Specifically, this could be beneficial when CTns are identified in clinical 
samples. If the transfer inducing substances are present in particular foodstuffs or 
medicine,  changing  the  patient’s  diet  to  exclude  these  substances  could  prevent 
dissemination of CTns in the gut. 
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In one of the transconjugants, transfer of the PaLoc into the recipient had occurred. 
The transconjugant was shown to produce similar levels of toxins as the donor. PaLoc 
transfer  was  shown  to  be  reproducible  by  selecting  for  transfer  using  a  mutant 
containing erm(B) in the PaLoc.  
Genomic sequencing of a set of the transconjugants showed that large fragments of 
donor-specific sequence is present on either side of the PaLoc which indicates the 
transfer is not specific for the PaLoc. The donor-specific fragment of DNA varies in size 
in the transconjugants leading to the hypothesis that the DNA is integrated by RecA- 
dependent  homologous  recombination  rather  than  a  site-specific  recombination 
mechanism. Hfr is a RecA-dependent transfer mechanism described in E. coli where 
chromosomal DNA is mobilised by the integration of a conjugative plasmid after which 
the transferred DNA is recombined with the recipient chromosome [104]. To confirm if 
the PaLoc transfer occurs through a Hfr-like transfer mechanism, a RecA knockout 
recipient strain will have to be generated. As CTn1 and CTn2 are located close to the 
transferred  sequence  in  the  chromosome,  either  of  these  elements  could  be 
responsible for transfer. Generating mutants of these elements that are incapable of 
conjugative  transfer  could  confirm  this.  However,  involvement  of  the  other  CTns 
cannot be excluded. Performing filter-matings with donor strains that contain selection 
markers  at  random  locations  throughout  the  chromosome  would  determine  if  the 
transfer is specific for the region of the chromosome that contains the PaLoc.  
Further work is currently being carried out to determine if this transfer is specific for 
these donor and recipient strains or if transfer can also occur between other strains. 
Transfer  from  the  PaLoc  from  donor  strain  R20291  was  observed  by  Dr.  Haitham  
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Hussain, UCL-EDI , as well as transfer into the non-toxigenic recipient strain OX-904 
(personal communication).  
Transfer  of the  PaLoc  and  transformation  of  non-toxigenic  strains  into  pathogenic, 
toxin producing strains could have great clinical implications. Little research is carried 
out  on  non-toxigenic  strains  and  it  is  therefore  unknown  if  these  strains  have 
additional virulence factors, such as adhesions, that have allowed these strains not to 
be outcompeted by toxigenic strains.  
Furthermore, the PaLoc of hypervirulent strains contains mutations in the negative 
regulator  TcdC  which  results  in  more  expression  of  the  toxins  which  may  be 
responsible for the increased virulence of these strains. Transfer of the PaLoc from 
these strains into non-hypervirulent toxigenic strains could result in replacement of 
the native PaLoc by the hypervirulent PaLoc and could potentially increase the strain’s 
virulence.  Finally,  transfer  of  the  PaLoc  in  vivo  to  other  species  is  potentially  also 
possible. If transfer is Hfr mediated than the species would have to  be related for 
homologous  recombination  to  occur  making  it  an  unlikely  scenario,  however,  the 
possibility cannot be excluded and could result in a highly dangerous pathogen. 
Although PaLoc transfer has currently only been reported under laboratory conditions, 
it  was  previously  reported  that  the  PaLoc  of  strains  from  ribotype  078  are  highly 
similar to the PaLoc from divergent ribotypes [89]. It was suggested that the PaLoc in 
these strains was introduced after they diverged from a common ancestor which is in 
line with our findings here. This further stresses the clinical importance of the findings 
as it eliminates the question if PaLoc transfer could occur in vivo. 
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This study has demonstrated that CTns are present in all strains of C. difficile that were 
sequenced  so  far  and  34  novel  putative  CTns  and  mobilisable  transposons  were 
described here. CTns were shown to transfer when selection pressure was present but 
co-transfer of elements that were not selected also took place, for instance generating 
tetracycline  resistant  transconjugants  in  the  absence  of  tetracycline.  Furthermore, 
transfer of the PaLoc encoding the major virulence factors of the organism through an 
undetermined  mechanism  was  shown  to  transform  non-toxigenic  into  toxigenic 
strains, possibly revealing an important role for mobile genetic elements in C. difficile 
virulence.  
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Appendix I  
Appendix I is on the disk included with the thesis. 
A summary of all of the bioinformatics results as described in Chapter 3 are present in: 
Bioinformatics Table.xsl. 
 
Figures from Chapter 3 which may not be clear in print are included as figure 
number.png.  
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Appendix II  
Appendix II is on the disk included with the thesis. 
Comparisons of the 30 regions of 630 and CD37 that were used for the SNP analysis of 
the PaLoc transconjugants are included as fasta files. 
 
Sequences of the ends of the genomic fragments that transferred from 630 into CD37 
are included as fasta files.  
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Appendix III  
Publications resulting from this study: 
Brouwer  MS,  Warburton  PJ,  Roberts  AP,  Mullany  P,  Allan  E  (2011)  Genetic 
Organisation, Mobility and Predicted Functions of Genes on Integrated, Mobile Genetic 
Elements in Sequenced Strains of Clostridium difficile. PLoS One 6: e23014. 
Brouwer MS, Roberts AP, Mullany P, Allan E (2012) In silico analysis of sequenced 
strains of Clostridium difficile reveals a related set of conjugative transposons carrying 
a variety of accessory genes. Mobile Genetic Elements 2: 1-5. 
Brouwer MS, Allan E, Mullany P, Roberts AP (2012) Draft Genome Sequence of the 
Nontoxigenic Clostridium difficile Strain CD37. J Bacteriol 194: 2125-2126. 
Corver J, Bakker D, Brouwer MS, Harmanus C, Hensgens MP, Roberts AP, Kuijper EJ, 
Van  Leeuwen  HC  (2012)  Analysis  of  a  Clostridium  difficile  PCR  Ribotype  078  100 
Kilobase Island reveals the presence of a novel transposons; Tn6164. BMC Microbiol 
12: 130 
 
 
These publications are included at the back of this thesis. 
 
 